







I dedicate this thesis to my wife whose
encouragement has sustained me throughout its
completion.
" My object has always been to utilise my time in
gratutious work if 1 was otherwise unoccupied. So
the next move in this direction was to accept the
position of Assistant Surgeon to the Glasgow Ophthalmic
Institution "
Prom "Reminiscences of an old physician" by Robert




My interest in the ocular manifestations of
rheumatic disease was aroused just over five years ago,
when I was consulted at the then newly opened Centre
for Rheumatic Diseases, Glasgow, regarding the eye
complications of a patient with rheumatoid arthritis.
Mrs. A. McC. was a 5^-year old housewife who had had
rheumatoid arthritis for 20 years and had been bed¬
ridden for k years despite intensive systemic therapy
including corticosteroids. She gave a three year
history of ocular discomfort, extreme photophobia and
recurrent tenacious discharge from both eyes unrelieved
by topical therapy. I discovered that she suffered
from severe keratoconjunctivitis sicca and in addition
had developed a central corneal perforation in one eye.
The magnitude of this patient's eye disease
stimulated me to study the problems which form the
basis of this thesis.
Some of the data contained in the thesis has been
published or communicated to learned societies.
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In his book "The Struggle for Survival", Lord
Moran recorded of Sir Winston Churchill on the
occasion of his 80th birthday "A fine disregard for
common sense has marked his earthly pilgrimage". I
have often thought that the same might be true of
the most protean of ophthalmological diseases,
Sjogren's syndrome.
Sjogren's syndrome is a chronic, benign,
idiopathic disease comprising the triad of
keratoconjunctivitis sicca (K.C.S.), xerostomia,
and rheumatoid arthritis (R.A.) or other connective
tissue disorders. My thesis presents new facts
about this enigmatic condition, and contains chapters
on diagnosis, histopathology, prevalence in rheumatoid
and non-rheumatoid populations, relationship to
clinical and laboratory features of rheumatoid
arthritis, and clinical and immunological associations
with other autoimmune diseases, such as Hashimoto's
thyroiditis, pernicious anaemia, and primary idiopathic
Addison's disease of the adrenal gland. In addition,
chapters are included dealing with the therapy of
K.C.S. with special reference to the effects of
treatment on the bacterial, fungal and viral flora of
the conjunctival sac.
Chapter I gives a historical outline of Sjogren's
syndrome, and in Chapter II I describe a computer-
assisted mathematical model for diagnosing K.C.S. based
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on an analysis of symptoms and signs. This clinical
diagnostic index will perhaps be of value to
clinicians who have no specialised ophthalmological
expertise in epidemiological research. In Chapter II,
I also present a critical appraisal of diagnostic tests,
such as Schirmer's tear test and biomicroscopy, for
K.C.S.
Despite the fact that Sjogren's syndrome has been
studied for nearly half a century, I discovered on
perusal of the literature a remarkable paucity of
information on the histopathology of the lacrimal
glands. Chapter III describes a detailed pathological
study on lacrimal gland biopsies in patients with
definite K.C.S., patients with possible K.C.S., and
in patients with no evidence of ocular disease. This
study has shown that lacrimal gland histology is
identical in patients with Sjogren's syndrome
uncomplicated by R.A. or other connective tissue
disease (sicca syndrome) and in patients with Sjogren's
syndrome complicated by R.A. Severity and extent of
lacrimal gland inflammation has been found to correlate
with the duration of ocular symptoms, but long-term
corticosteroid therapy had no apparent effect on the
histological appearances.
Since autoimmunity is common in the elderly and
since the aging process itself has been attributed to
an autoimmune mechanism, I thought it of interest to
study the prevalence of K.C.S. in elderly subjects, and
this work is presented in Chapter IV. The diagnosis
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of K.C.S. was made in a surprisingly high number of the
elderly subjects examined, and the absence of any
relationship with autoantibodies which are commonly
found in younger persons with K.C.S. with or without
R.A., has led me to the conclusion that in the elderly
K.C.S. is probably a result of acinar atrophy rather
than chronic inflammation.
In order to try to delineate possible pathogenetic
factors in producing K.C.S., I undertook a detailed
and comprehensive study of K.C.S. in 893 patients with
R.A., relating the presence of K.C.S. with the
clinical and laboratory features of the rheumatoid
disease. This study involved mathematical analysis,
including discriminant analysis, and the results which
are presented in Chapter V show that the development
of K.C.S. is related to the severity and duration of
the arthritis and to the extent of non-articular
rheumatoid complications.
Because of the high prevalence of autoantibodies
in Sjogren's syndrome and because of the histological
similarities between the lacrimal and salivary glands
in this disease and the thyroid gland in Hashimoto's
thyroiditis, gastric mucosa in pernicious anaemia, and
adrenal gland in primary idiopathic Addison's disease,
I decided to investigate the possible associations
between K.C.S. and these organ-specific autoimmune
diseases. The results are discussed in Chapter VII.
Studies of the relationship between salivary duct
autoantibody and K.C.S. and histological changes in
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the labial mucosa are described in Chapter VI. The
findings indicate that salivary duct antibody is not
peculiar to Sjffgren*s syndrome, but appears to be
related to the rheumatoid process. Tests for this
antibody consequently have no diagnostic value for the
ophthalmologist.
Although it has frequently been stated in the
literature that conjunctival infection is common in
K.C.S., a careful review of all available literature
failed to identify one publication where the
prevalence of this complication had been ascertained.
I, therefore, decided that a careful documentation
and investigation of ocular infection in K.C.S. would
be worthwhile, and in Chapter VIII I describe
investigations of bacterial, fungal and viral flora
in K.C.S. The conclusion of this study is that
bacterial and fungal infection is significantly high
in untreated K.C.S., but that lubricant therapy
greatly reduces this secondary infection. A controlled
study of combined antibiotic—corticosteroid topical
therapy revealed a high fungal infection complication
rate. In Chapter IX I conclude the thesis by
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SJOGREN*S SYNDROME is a chronic benign disease of
unknown aetiology, which consists of the triad of
keratoconjunctivitis sicca, xerostomia and rheumatoid
arthritis or another connective tissue disease. The
keratoconjunctivitis sicca and xerostomia of the
syndrome are caused by progressive atrophy of the acinar
parenchyma with round cell infiltration of the lacrimal
and salivary glands. Thus, specific infiltrations of
these glands such as may occur in sarcoidosis,
tuberculosis, lymphomas and Waldenstrom's
macroglobulinaemia are excluded by definition. It is
generally accepted that only two of the three components
are necessary for the diagnosis. When
keratoconjunctivitis sicca and xerostomia are present
alone, the terra sicca syndrome is often used.
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An ocular disorder in which small filaments were
found attached to the cornea and suspended over its
surface was described in 1882 by Leber. Many causes
were suspected for this entity which was named
filamentary keratitis. It was nearly 50 years later
before attention was focused on the combination of
filamentary keratitis and reduced tear secretion (Stock,
1924) although both disorders had been recorded
separately. Thus in 1888 Hadden gave an account of a
63-year old female patient who could not produce tears
even after inhaling "strong ammonia". However, he
detected no corneal or conjunctival abnormality and
clinical examination of the lacrimal and salivary
glands was normal. The main burden of his report was
the description of extreme dryness of his patient's
tongue, cheeks, palate, pharynx and nasal mucosa.
The first description of an arthritic patient who
had filamentary keratitis appears to have been made by
Fischer in 1889# However, the possible significance
of a relationship between arthritis and filamentary
keratitis was not emphasized and was not reported again
for nearly half a century when Houwer in 1927 described
10 patients with this ocular idsorder, six of whom had
chronic arthritis.
It appears from my perusal of the literature,
therefore, that before the year 1900, nearly all of the
components of what was to become known as Sj^gren,s
syndrome (1933) were on record although the disease had
not been defined.
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The complete picture of keratoconjunctivitis sicca,
xerostomia and chronic arthritis was unveiled gradually
between 1919 and 1933* Fuchs in 1919 described a
5^-year old female patient who complained of dry eyes
and a dry mouth and who developed unilateral parotid
gland swelling. Changes in the cornea were not
reported but he noted that a thick secretion, which he
believed to be from the Meibomian glands, covered the
conjunctivae in both eyes. Deutchsman described a
similar case in 1921 and in 1926, Gougerot reported
three patients who were suffering from progressive
atrophy of the "mucous" glands of the conjunctivae and
mouth, of the salivary glands and in some degree the
naso-pharyngeal, laryngeal and vulvar glands. Stock
(1924) attributed filamentary keratitis in two of his
female patients to diminished tear secretion and
Schfininger later that year described the same two
patients in full. One of them had been unable to cry
since birth, the other since aged 18 years. Regardless
of the stimulus, tear secretion was minimal in these two
patients. Their conjunctival sacs contained long
yellowish-white threads which could be separated from
the conjunctival and corneal surfaces only with
difficulty. The cornea of one eye in either patient
was dull and the visual acuity reduced. Both patients
complained intermittently of foreign body sensation and
burning feelings in their eyes and photophobia was
extreme. Important contributions from Houwer followed
in 1927» 1928 and 1929» He described 10 patients
suffering from filamentary keratitis, eight female and
two male, nearly all of whom were past middle-age*
More than half of them had chronic arthritis, the exact
form of which was not defined. Spontaneous remissions
and variations in ocular pathology in the same patient
at different times were emphasized* Furthermore, Houwer
pointed out that the conjunctiva was almost always
involved and appeared thickened and hyperaeraic, The
corneal filaments, usually concentrated over the lower
third of the cornea, were often tiny and at times
absent. Small superficial corneal defects with or
without infiltration of the underlying stroma were
present even during remissions. The probability is that
Houwer included some early and mild cases of
"keratoconjunctivitis sicca" (Sjogren, 1933) in his
series casting his net wider than previous investigators.
Confirmation of this superficial punctate keratitis came
from Betsch in 1928. Two female patients aged k6 and
53 years developed reduced tear secretion and
intermittent filamentary keratitis. Betsch reiterated
the view that filaments were characteristic of relapses,
superficial punctate defects were present constantly.
In addition, one of his patients had bilateral parotid
gland swelling, hoarseness and severe dryness of the
mouth and throat. Neither patient had arthritis.
However, Isakowitz in 1928 described a female patient
suffering from a peri-arthritis who developed reduced
tear secretion and filamentary keratitis)and in 1932
Wissmann reported four of six patients who had
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filamentary keratitis and arthritic changes*
In 1933 Henrik Sjogren published his now famous
monograph "Zur Kenntnis der Keratoconjunctivitis
Sicca" which was translated into English by J* Bruce
Hamilton (19^3) as "A New Conception of
Keratoconjunctivitis Sicca". Sjogren described in
detail a series of 19 women only two of whom were under
kO years of age. All had reduced tear secretion and 13
had arthritis. Sjogren popularised the use of the vital
staining dye bengal rose and this enabled him to
demonstrate the constant and extensive involvement of
the conjunctiva, "It has been revealed that the eye is
hereby stained in a particularly characteristic manner.
The part of the eye corresponding to the rima region
stains an intense red. If the eyelids are held apart,
a bright red, sharply defined triangle with the base
towards the limbus is noticed at each side of the cornea.
On the cornea the filaments and epithelial scales are
stainedj furthermore, the cornea takes up colour to a
considerable extent in regions which, without staining,
look normal. It emerges from this that not only the
cornea but also the conjunctiva is extensively
diseased". With this in mind, Sjogren proposed the
more comprehensive terra - keratoconjunctivitis sicca.
He noted also the diminution in salivary secretion and
the frequency of general symptoms and concluded that "we
have to deal here with a general disease". Sjogren
reasserted this belief in subsequent papers (1935 a,b,o,
1936, 1937. 1938 and 19^8) and as early as 1935 (c)
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stated that the general disease was in most Instances a
chronic rheumatic polyarthritis.
By 1951» Sjogren had diagnosed 80 cases of
keratoconjunctivitis sicca, 50 of whom (62 per cent) had
arthritis. Most of these 50 patients had in fact
rheumatoid arthritis. The frequency of rheumatoid
arthritis in other series varies from 17 per cent of 121
patients (Henderson, 1950) to 87 per cent of 23 patients
(Godtfredson, 1947)# This variation is due partly to
selection of cases and partly to the intensity of the
search for evidence of arthritis. Henderson (1950)
admitted that not all of his patients had x-ray
examinations and that the frequency of arthritis
reported in his series might be unduly low, Bunim
(1961) reported 40 cases of keratoconjunctivitis sicca
in which 17 had definite rheumatoid arthritis (42.5 per
cent) and a further two had probable rheumatoid arthritis.
Bloch, Buchanan, Wohl and Bunim (19^5) in a comprehensive
study of 62 patients suffering from keratoconjunctivitis
sicca discovered definite rheumatoid arthritis in 3°
patients (50 per cent) and probable rheumatoid arthritis
in another two patients. Conversely, the frequency of
keratoconjunctivitis sicca in patients suffering from
rheumatoid arthritis has been examined by several
investigators. Stenstam (1947) was the first to report
a sizeable group of 4-95 patients of whom 9,5 per cent
had dry eyes. Holm (1949) discovered that 14.2 per
cent of 500 arthritic patients examined after
instillation of rose bengal stain had keratoconjunctivitis
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sicca. However, the types of arthritis in Holm's
series were not defined. Nevertheless, his incidence
of dry eyes tallies closely with that in Thomson and
Eadie's group of 1956 in which 14.3 P©r cent of 210
patients suffering from rheumatoid arthritis had
keratoconjunctivitis sicca. According to some reports,
a higher incidence may be encountered in patients with
advanced Joint disease (Reader, Whyte and Elines, 1951 I
Lackington, Charlin and Gormay, 1951). However, when
the full range of rheumatoid arthritic patients is
examined the incidence remains between 9 and 11* per
cent (Gaulhofer, 1954),
Rheumatoid arthritis is the largest member of the
confederacy of disorders commonly termed, the connective
tissue diseases. These include systemic lupus
erythematosus, progressive systemic sclerosis (diffuse
scleroderma), polyarteritis nodosa and dermatomyositis
(polymyositis). The concept that a number of
clinical conditions might be grouped together on grounds
of common pathology was advanced by Klemperer, Pollack
and Baehr in 1942. They demonstrated fibrinoid change
starting in the collagen fibres of the connective
tissues in some cases of systemic lupus erythematosus
and diffuse scleroderma. The lesions extended to
involve the cells and ground substance as well as the
collagen fibres and the use of the term connective
tissue disease eventually became universal.
In 1872, Kaposi described a patient with a dry
fissured tongue and cheeks, parotitis and systemic lupus
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erythematosus. Sixteen years later Hutchison (1888)
reported a case of probable systemic lupus erythematosus
associated with ocular symptoms very suggestive of
keratoconjunctivitis sicca. Yet again many years were
to elapse before interest was revived in a possible
connection between Sjogren1s syndrome and connective
tissue diseases other than rheumatoid arthritis.
Single instances of keratoconjunctivitis sicca and
systemic lupus erythematosus occurring in the same
patient were reported in the 1950*s (Morgan, 195*U
Schapnosnik, Bergna and Conti, 1955l Ramage and
Kinnear, 1956; Bain, i960). MacLean and Robinson
095*0 found lupus erythematosus cells in the blood of
a patient suffering from rheumatoid arthritis and
keratoconjunctivitis sicca and Heaton (1959) described
similar cells in 28 consecutive patients suffering from
Sjogren's syndrome. Nevertheless, comprehensive
examinations of large series of patients suffering from
systemic lupus erythematosus, even when full ocular and
oral examinations appear to have been carried out, have
failed to reveal the components of Sjogren's syndrome in
the majority of cases (Hill, 1957)* In addition, the
inclusion of systemic lupus patients in series of
Sjogren's disease has occurred very rarely (Stoltze,
Hanlen, Pease and Henderson, i960). However, non¬
suppurative parotitis was reported by Shearn and
Pirofsky (1952) in four of 3** patients and in two of
138 patients examined by Harvey, Schulman, Tumulty,
Conley and Schoenrich (195*0* Later Shearn (i960)
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extended his observations to include 6 of 83 patients
suffering from systemic lupus (7*2 per cent) and
microscopic examination of biopsy material from the
parotid gland of one of his patients with parotitis
disclosed a pattern compatible with early Sjogren's
disease.
Reports of single cases of Sjogren's syndrome
occurring in patients suffering from progressive
systemic sclerosis also began to appear after the
Second World War (Leriche, 1 9^7 f Harrington and Dewar,
1951? Caughey and Richardson, 1952} Ramage and
Kinnear, 1956, and Piazzesi, 1956). Two such patients
were described by Shearn (i960) in one of whom autopsy
findings confirmed the diagnosis* Authorities dealing
with large series of progressive systemic sclerosis
failed to mention Sjogren's syndrome (Leinwand, Duryce
and Richter, 1952; Qeigelman, Goldner and Baylis,
1953) until Stava (1958) noted keratoconjunctivitis sicca
in five and xerostomia in two of 65 patients. Kirkham
(1969) studied 9 patients suffering from progressive
systemic sclerosis and was satisfied with the diagnosis
of keratoconjunctivitis sicca in one patient. However,
two others had evidence of reduced tear flow and
conjunctival staining with rose bengal dye. Conversely,
patients with progressive systemic sclerosis have been
included in large Sjogren series (Stoltze and others,
1960; Bloch, Buchanan, Wohl and Bunim, 1965)*
Typical polyarteritis nodosa and severe
keratoconjunctivitis sicca was diagnosed in a patient
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by Ramage and Kinnear (1956) and both diseases were
confirmed at post mortem examination.
As far as I can judge this is the only completely
convincing record of the association of the two diseases.
In 195*4 Cardell and Gurling described a 49-year old
female rheumatoid patient who had keratoconjunctivitis
sicca. At autopsy polyarteritis nodosa, which had not
been suspected, was diagnosed. This probably was the
4»
arteritis commonly found in rheumatoid arthritis
(Cruikshank, 195*4). Shearn (1961) described a 36-year
old female patient who in addition to
keratoconjunctivitis sicca and xerostomia developed
enlarged lacrimal, parotid and cervical lymph nodes.
Biopsy of a cervical lymph node from this patient
showed changes consistent with "panarteritis". The
evidence, therefore, in this patient described by
Shearn of polyarthritis nodosa is tenuous. Two
patients with polyarteritis nodosa are included in the
139 Sjogren patients described by Stoltze, et al (i960)
but no details are given.
Bloch and his colleagues (1965) reported that four
of their 62 patients with Sjogren's syndrome had
polymyositis. The patients were carefully examined for
evidence of rheumatoid arthritis and only one of them
might have had it in the past. The only other report
of the association of Sjogren's syndrome and polymyositis
concerns a 45-year old female patient who had
polymyositis and rheumatoid arthritis and who developed
lacrimal and parotid adenitis (Fox, 1966).
Fig.1,1 von Mikulicz
Fig.1,2 von Mikulicz*s patient.
Lacrimal and salivary gland enlargement,
(a) indicates sublingual glands.
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In 1888, von Mikulicz (Fig.1,1) recorded the case
history of a U2-year old Prussian fanner who developed
enlargement of the lacrimal and salivary glands without
any evidence of diminished secretion (Fig.1,2),
Biopsy of the lacrimal and salivary glands revealed
atrophy of the aciner parenchyma and gross round cell
infiltration which led Mikulicz to deduce that the
patient suffered from a low grade infection. The
patient died 13 months after his initial symptoms but
no autopsy was performed. Thereafter patients
presenting with lacrimal and salivary gland enlargement
were diagnosed as having Mikulicz's disease. However,
Schaeffer and Jacobsen (1927) considered that Mikulicz's
disease was not a single entity but many which could be
described under two main headings, idiopathic benign
Mikulicz's disease or "Mikulicz's syndrome" which may
be caused by a variety of disorders (Table 1,1).
Bearing in mind this classification, Morgan and
Castlemen (1953» ^95*0 considered that the histology
in Sjogren's syndrome and in chronic benign enlargement
of the salivary and lacrimal glands hitherto called
Mikulicz's disease, were identical. They concluded
that Mikulicz's disease was a "variant of a larger
symptom complex, Sjogren's syndrome".
The confusion in the literature concerning the
relationship of Mikulicz's disease and Sjogren's
syndrome has a close parallel with Reidel's thyroiditis
and Hashimoto's thyroiditis. Reidel described a "hard"
goitre in a patient and the brevity of the histological
RELATIONSHIP OF MIKULICZ'S DISEASE AND SJOGREN'S SYNDROMB
MIKULICZ (1888)
42 year old farmer with bilateral enlargement of lacrimal and
salivary glands, but no impairment of secretion. Biopsies of lacrimal
and submaxillary glands showed massive round-cell Infiltration and
atrophy of acinar parenchyma.
SCHAFFER AND JACOBS EN (1927)
Classification :
1. Mikulicz's disease proper.
2. Mikulicz's syndrome (Leukaemia, lymphosarcoma,
tuberculosis, sarcoidosis, lead and iodine poisoning)
SJOGREN ( 1933)
Nineteen women with keratoconjunctivitis sicca, xerostomia and
salivary gland enlargement. Thirteen had arthritis.
MORGAN AND CASTLEMAN (1953, 1954)





report is uncannily like that of Mikulicz's report on
the salivary glands of his patient. In neither
instance was there sufficient clinical or pathological
evidence to adequately define the disease. Hashimoto,
like Sjogren, on the other hand described his h cases
of goitre with considerable attention to clinical and
histological detail, and noted that failure of the
thyroid gland may lead to hypothyroidism. As with the
Mikulicz/Sjogren controversy the Reidel/Hashimoto
controversy continued for many years until finally












SJOGREN'S SYNDROME consists of the triad of
keratoconjunctivitis sicca, xerostomia and rheumatoid
arthritis though only two of these three components are
necessary for the diagnosis to be made. There is
growing evidence that other connective tissue diseases
may on occasion replace rheumatoid arthritis in the
syndrome. However, the incidence of these diseases
in Sjogren's syndrome is much lower than that of
rheumatoid arthritis and the converse is also true.
Systemic lupus erythematosus, progressive systemic
sclerosis, polyarteritis nodosa and polymyositis have
each been implicated in order of decreasing frequency.
There is now incontrovertible evidence that
Sjogren*s syndrome and Mikulicz's disease are variants
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The dry eye of Sjogren*s syndrome is the result
primarily of reduced secretion from the lacrimal and
accessory lacrimal glands. Hypofunction of the tear
forming glands may be measured by means of Schirtner
tear tests. However, before a diagnosis of
keratoconjunctivitis sicca can be made, the eye must
be seen to have suffered as a result of reduced tear
secretion as expressed in the form of specific staining
patterns with the vital dye rose bengal (Sjogren, 1933)•
This chapter deals with factors influencing
Schirmer's tear tests, the value of symptoms and signs
tabulated by the physician, the range of biomicroscopic
Changes commensurate with a diagnosis of




Patients attending the Centre for Rheumatic
Diseases, Glasgow, between June 1965 and January 1970
were examined by the author at eye clinics held
specifically for this purpose at the Ophthalmic
Institute, Glasgow (1965-1966) and the University
Department of Ophthalmology, Western Infirmary,
Glasgow (1966-1970)* la addition, all of the patients
admitted to the rheumatic hospital were screened under
inpatient conditions and referred to the outpatient
clinics as required. The diagnosis, clinical and
laboratory details were extracted by the author and
recorded on computer punch cards. The result, of this
exercise is the subject of Chapter V which deals with
keratoconjunctivitis sicca in rheumatoid arthritis.
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OPHTHALMOLOGICAL EXAMINATIONS
The first eye examination included recording of
visual acuity, refractive errors, evaluation of ocular
adnexa, pupil reactions and eye movements. The
conjunctivae, corneae and anterior segment of the eye
were examined without and with the aid of a slit lamp
and the lens, vitreous and fundus were viewed through
dilated pupils.
Schirraer Tear Tests
In 1903» Schirmer devised a simple test for
measuring tear secretion. He utilised strips of
filter paper 5 ram* wide by 15 mm. long which he folded
at a right angle 5 mm. from the end to be inserted into
the un-anaesthetized conjunctival sac, at the outer
third of the lower lid. Both eyes were tested
simultaneously and at the end of 5 minutes, the length
of paper moistened by tears was measured. Patients
normally moisten more than 15 mm. j less than 15 mm.
wetting requires investigation. This test is referred
to as the Schirmer I tear test or unforced test to
distinguish it from the Schirmer II or forced tear test
in which there is an added stimulus to tear secretion.
To obviate the tedious task of cutting hundreds of
filter papers to the correct size, I used standardised
Schirraer Tear Test Kits as devised by Iso-Sol Company,
26
Lindenhurst, New York (Halberg and Berens, 1961 ) •
The unforced test is a useful screening procedure
for evidence of reduced tear secretion but as first
noted by Schirmer in 1903 and later confirmed by others
(Sjogren, 1933; de Roetth, 19^1 I Henderson and Prough,
1950, Wright and Meger, 1962) less than 15 mm. of
wetting may be recorded by this method in a proportion
of normal subjects. In particular, caution has to be
exercised in interpreting the results of Schirmer I
tear tests in rheumatoid arthritic patients living in a
warm dry atmostphere.
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The Effect of Temperature and Humidity
on the Schirmer I Tear Test
All of the inpatients at the Centre for Rheumatic
Diseases in Glasgow have Schirmer I tear tests a few days
after admission to the hospital. Early in 1966, I noted
that the frequency of positive unforced tear tests was
very high. Those patients with Schirmer I tests of less
than 15 mm. wetting were re-examined one week later at
the ophthalmic outpatient department. The majority on
this second occasion gave normal readings; the
remainder were shown later to be suffering from
keratoconjunctivitis sicca, A third unforced Schirmer
test was carried out the following week in the rheumatic
hospital. Once again, the same patients demonstrated
lower than 15 mm. wetting of the filter paper strips in
5 minutes when no added stimulus was used.
Material and Methods
At the time this phenomenon came under scrutiny,
338 inpatients comprising 250 females and 88 males had
been examined (age range 18-72 years, mean age 56
years). Apart from those later shown to have
keratoconjunctivitis sicca, 65 patients (20%) had
positive Schirmer I tear tests. 123 eyes were suspect,
78 of them reading less than 5 mm. in 5 minutes (60$).































39 42 41 38 39 41 40 37 42 40 39 40 41 40
Humidity
41 40









54 50 54 50 52 54
0
52 58 60 54 56 50
Humidity
Fig.II,2 Temperature and humidity in eye
outpatient department
28
ophthalmic outpatient department. In every case, the
Schirmer I tear test was normal and there was no evidence
of keratoconjunctivitis sicca. The suspect patients
were returned to the rheumatic centre where another
week elapsed before the third tear test was carried out.
Again reduced unforced tear test readings were obtained,
this time from 110 of the eyes, 75 of them reading less
than 5 mm. in 5 minutes (68$>).
Thermographic and humidity records (self recording
barometer and whirling string hydrometer) were made
simultaneously in both hospitals over a period of 20
days. Pig.11,1 shows part of the tracing from the
rheumatic hospital, where the mean temperature was
72.3°F. (22.3°C.) and the humidity 40.5. Fig.II,2
shows part of the tracing from the ophthalmic
outpatient department, where the mean temperature over
the same period was 57*4°F. (14.1°C.) and the humidity
48. While these recordings were being made, 12 of the
rheumatic centre patients who had demonstrated positive
Schirmer I tear tests were given a further six unforced
tear tests, three in the ophthalmic hospital, three in
the rheumatic hospital.
Results
Six recordings of the unforced tear test were thus
available for 12 patients, none of whom was suffering
from keratoconjunctivitis sicca. The results show that
Case No. Sex
Three Recordings (average of two eyes)
At Rheumatic Hospital At Ophthalmic Hospital
1 F 11, 12, 11 15, 18, 18
2 F 8, 7, 7 20, 20, 19
3 M 4, 8, 7 16, 18, 17
4 F 3, 7, 5 20, 18, 20
5 F 8, 12, 11 20, 20, 20
6 M 12, 11, 12 22, C.W., C.W.
7 M 14, 15, 10 18, 18, 20
8 M 15, 11, 14 19, 20, 20
9 M 14, 12, 13 22, C.W., C.W.
10 F 12, 9, 8 20, 18, 16
11 M 7, 6, 4 20, 16, 20
12 F 3,2,0 20, C.W., 20
(C.W. «= completely wet)
Table 11,1 Recordings of unforced Schirmer
tear test in rheumatoid arthritic patients
related to temperature and humidity. None
of the patients had keratoconjunctivitis sicca.
29
the test was consistent for either hospital, and
readings were consistently lower in the higher
temperature and lower humidity of the rheumatic wards
(Table 11,1). It must be noted that reduction of
measurable tear secretion by the unforced Schirmer test
occurred after the patients had been in the rheumatic
hospital for 12 hours or more. When the patients were
tested just after their return to the wards normal
readings were recorded.
The Schirmer I test was repeated every second night
in each of these 12 patients for the next 20 days.
There was no tendency for the patients to compensate by
increased production of tears, i.e. the results remained
consistently low. Furthermore, within three days of
hospitalization, 10 of the patients complained that
their eyes felt hot and dry towards early afternoon and
within seven days of entering hospital all 12 had
uncomfortable eyes.
Discussion
Sixty-five of 338 patients (20$) admitted to the
Centre for Rheumatic Diseases, tested 12 hours or more
after entering the hospital, had less than 15 ram. of
wetting of Schirmer papers after 5 minutes. All of
these patients */ere re-examined a week later at an
ophthalmic outpatient department and were found to have
normal Schirmer I tear tests. They did not have
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keratoconjunctivitis sicca. The findings appear to be
related to the differences in temperature and humidity
between the two hospitals, the readings being
consistently lower in the warmer and dryer atmosphere
of the rheumatic centre. 12 patients were examined
repeatedly over a period of 20 days. The results were
reproducible. There was no improvement in the low
readings during this time and symptoms of dry, hot or
irritable eyes developed in all of the 12 patients
within a week of entering the rheumatic hospital.
If the reduction in wetting of the filter paper,
observed in 20 per cent of the ward patients, was due
merely to increased evaporation in a warm, dry
atmosphere, then would 12 hours have elapsed before the
phenomenon was apparent? Furthermore, why should there
be a selection of patients if the explanation lies in
the purely physical process of evaporation? Emotional
factors could have been responsible for an increased
lacrimal secretion in these suspect patients until they
settled down in the wards and began to produce their
normal basal level of tears. If this explanation is
correct then there must be a poor response to dry heat
in some patients suffering from rheumatoid arthritis.
If an equivalent number of normal control patients were
subjected to the conditions that prevail in the rheumatic
wards, then the incidence of reduced Schirmer I tear
tests could be obtained. To date this experiment has
proved to be impractical because of the cost and number
of volunteers that would be necessary. It may be that
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the paucity of lacrimal response to temperature and
humidity occurs in rheumatoid arthritic patients who have
some infiltration of the lacrimal glands but enough
functioning tissue to prevent the development of
keratoconjunctivitis sicca. Whatever the cause of
this observation, the effect of temperatures over 72°F.
and humidities below 40.5 is to produce 20 per cent
false positive Schirmer I tear tests in rheumatoid
arthritic patients.
The Forced Schirmer Tear Test
From what has been demonstrated above, it can be
seen that some form of augmented Schirmer tear test is
necessary when the diagnosis of keratoconjunctivitis
sicca is suspected.
Schirmer (1903) anaesthetized the surface of the
eye by instilling 4 per cent solution of cocaine in
order to eliminate the stimulus caused by the insertion
of the blotting paper, inserted a camel hair brush into
the nostril and by rotating it caused reflex lacrimal
gland secretion. He demonstrated that most normal
patients wetted the stripe of filter paper to 15 mm. in
2 minutes. Sjogren (1935) substituted red litmus paper
and ammonia fumes finding them to be as good as the nasal
brush and less troublesome to the patient. Stock (1924),
Isakowitz (1928) and Betch (1930) had also used ammonia
but in none of their reports nor in Sjogren's was the
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strength of the solution stated. Ammonia solutions
are normally at a strength of five per cent. However,
it was noted during the first 6 months of this project
that Schirmer tests augmented with a five per cent
concentration of ammonia did not produce better results
than those recorded by the Schirmer I method.
Consequently, 25 patients who had produced less than
15 mm. of wetting in two minutes with five per cent
ammonia and who did not have keratoconjunctivitis sicca
were recalled and tested with a ten per cent solution
over 5 minutes. Only three of the 25 patients had
false positive tests with this method. Ten per cent
ammonia solution held 6 inches from the patient's nose
for 5 minutes was adopted, therefore, as the standard
method for a Schirmer II tear test. In an attempt to
further reduce error, reduced tear secretion was
diagnosed only when the forced test was positive on
two separate occasions.
Summary
Schirraer I tear tests are unreliable particularly
when carried out in a warm, dry atmosphere. Forced
Schirrner tests using ten per cent ammonia are
satisfactory, reduced tear secretion being diagnosed
when the test is positive on two separate occasions.
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Symptoms and Signs in
Keratoconjunctivitis Sicca
The diagnostic signs of keratoconjunctivitis sicca
defined by Sjogren (1933) are relatively simple to
detect with a corneal microscope. However, the slit
lamp is a piece of equipment that requires some expertise
not normally acquired by a physician. Furthermore, not
all rheumatology units are fortunate enough to have all
of their patients examined by an ophthalmologist.
Therefore, it seemed important to design a diagnostic
index for keratoconjunctivitis sicca which might be of
some use to the rheumatologist.
Pig-. 11,3 Lacrimal gland enlargement in Sjogren1
syndrome - patient No.^6, appendix IX.
Fig.11,4 Salivary gland enlargement in Sjogren*s
syndrome - patient No.50, appendix IX.
Pig.11,5 Lacrimal and salivary gland enlargement
in Sjogren*s syndrome. Injection of
conjunctival vessels and perilimbal injection
readily detected - patient No.80t appendix IX.
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The Keratoconjunctivitis Sicca Index
This section deals with the evolution and trial
of* a diagnostic index for keratoconjunctivitis sicca.
The study was conducted in two phases.
Phase One
The symptoms, gross signs and slit lamp appearances
of 40 patients not known to have Sjogren*s syndrome
before examination, and 40 age and sex matched
rheumatoid arthritic patients with no evidence of
external ocular disease were tabulated. The patients
had either received no topical treatment or none for at
least 8 weeks before examination. Thus an attempt was
made to exclude patients who may have benefited from
topical therapy. Furthermore, patients like those
depicted in Figures 11,3,4 and 5 showing lacrimal and
salivary gland enlargement were excluded from the study.
Their appearances would have immediately drawn the
V
physician*s attention to the possibility of Sjogren's
syndrome and the idea of this investigation is to
develop a system that will enable unsuspected cases to
be diagnosed.
The list of the patients* symptoms was compiled by
noting voluntary statements and by completing a
questionnaire based on the prevalence of ocular complaints
detected by Henderson (1950)» Gross signs and slit lamp
Table
SIGNS IN KERATOCONJUNCTIVITIS SICCA ON NAKBD EYB EXAMINATIONS
( 40 patients)
Percentages
1. Dilated bulbar conjunctival vessels,
usually interpalpebral 77.5
2. Mild pericorneal injection 52.5
3. Photophobia 27.5
4. Irregularity of corneal image 27.5
5. Discharge - white and frothy, or
yellowish and tenacious 25.0
6. Dullness of conjunctiva and/or cornea 25.0
7. Ptosis 15.0
TBN SYMPTOMS IN KERATOCONJUNCTIVITIS SICCA
Percentage
SYMPTOMS Present
1. Foreign body sensation 88.0
2. Burning 75.0
3. Tiredness with or without difficulty in opening the eyes 70.0
4. Dry feeling with or without a poor response to physical
or chemical irritants and emotion 65.0
5. Redness 47.0
6. Difficulty in seeing 40.0
7. Itch 37.5
8. Aches, soreness or pain 37.5
9. Photosensitivity 25.0
10. Excess of secretion, watery, ropy or film 22.5
II. 2
Table 11,3
Fig.11,6 showing macroscopic signs, discharge
white, yellow and tenacious, dullness of
conjunctiva, ptosis - patient No.5i appendix II.
Fig.IIf7 Macroscopic sign - irregularity of the
corneal image. This photograph was taken
¥
following instillation of adrenaline 1it000 and
homatropine one per cent. The camera was focused
on the anterior lens capsule and the cornea
retro-illuminated - patient No.6# appendix II.
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examinations were recorded where possible in the
terminology used by Sjogren (1933)•
Phase Two
A prospective study of 100 rheumatoid arthritic
patients who had not been examined previously by the
author was carried out using the Index developed as a
result of Phase One. The diagnosis was confirmed by
the usual tear tests and slit lamp examinations.
Results
Tables 11,2,3 and 5 show the results of the
ophthalmological examinations in the 40 rheumatoid
arthritic patients diagnosed as cases of Sjogren's
syndrome. Examples of some of the macroscopic signs
listed in Table 11,3 are shown in Figures 11,6 and 7*
The prevalence of 10 symptoms and 7 gross signs
in the Sjogren group of patients can be compared with
that in the control series of arthritic patients who
did not have keratoconjunctivitis sicca. By weighting
each of the 17 factors involved a "Keratoconjunctivitis
Sicca Index" is produced (Table 11,4 - see Appendix to
Chapter II, page 251). A score of 24.4 .+ 4.23
Standard Error was recorded in the Sjogren group
whereas a score of only 1.18 0,71 Standard Error was
SYMPTOMS AND PRESENT ABSENT






















Table 11,1* Example of scoring system fox*
diagnostic index. Patient No.1 total score
43» diagnosis keratoconjunctivitis sicca.
Fig.11,8 Histogram showing the dramatic difference
between the control group of rheumatoid arthritic
patients who had low index scores and those with
keratoconjunctivitis sicca (K.C.S.) who had high
scores. A score of 10 or more indicates K.C.S.
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observed in the control series (Fig.II,8). Only two
of the patients suffering from keratoconjunctivitis sicca
had a score of less than 10.
Application of the Index to the 100 rheumatoid
arthritic patients in phase two of the investigation
resulted in a correct diagnosis of keratoconjunctivitis
sicca in 8 patients (8'jo). Another patient who had
Sjogren's syndrome was missed by the diagnostic Index
but no false positive diagnoses were made.
Discussion
Sjogren (1933) described in detail all of the
clinical criteria necessary for a diagnosis of
keratoconjunctivitis sicca. However, there have been
considerable variations in the reported prevalence of
both subjective and objective phenomena in the disease
partly as a result of selection of cases, natural
remissions and treatment (Gifford, Puntenney and
Bellows, 19^3; Henderson, 1950? Bloch, Buchanan,
Wohl and Bunim, 1965)* The data analysed in this
study was collected from new and untreated cases of
Sjogren*s syndrome with a view to composing a system
whereby the physician could diagnose
keratoconjunctivitis sicca.
The prevalence of 10 symptoms and 7 gross signs in
Sjogren's syndrome, confirmed by forced tear tests and
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slit lamp examination, were recorded. When the 17
factors were weighted to favour a diagnosis of
keratoconjunctivitis sicca and applied to kO control
patients, it was seen that a highly effective
diagnostic index had been developed. Thus a score of
10 or more almost certainly indicates that the patient
has keratoconjunctivitis sicca. Conversely, only two
patients with a score of less than 10 had dry eyes.
The value of this "Keratoconjunctivitis Sicca Index"
was tested in a prospective study of 100 rheumatoid
arthritic patients who, in addition, were examined by
Schirmer II tear tests and the corneal microscope.
Nine patients (9$) had keratoconjunctivitis sicca, 8
being diagnosed initially by the Index. Furthermore,
the diagnostic Index did not result in any false
diagnoses of keratoconjunctivitis sicca.
In conclusion, the "Keratoconjunctivitis Sicca
Index" is a useful screening technique that can be
applied by the physician. At present no erroneous
diagnoses of keratoconjunctivitis sicca have been made
and only one patient in 100 rheumatoid arthritics has
been missed.
BIOMICROSCOPY ^ KEaATOCOHJUKGTIYITIS SICCA. (40 p«tl«nt»)
Before bengal rose dye
Conjunctiva Percentage
Dilated interpalpebral vessels 77*5
Mild pericorneal injeotion 52.5
Mucus in conjunctival sao 25-0
Cornea
Viscous tear fila 50*0
Mucous threads in tear film 25*0
Filaments attached to cornea 10.0
Large mucous threads attached to cornea 5«0
After bengal rose dye
Conjunctiva




Mucous attached to conjunctiva 20.0
Cornea
Punctate staining - including staining of
pits 40.0
Mucous threads in tear film 25*0
Filaments attached to cornea 20.0
Large mucous threads attaohed to cornea 5«0
Fluorescein staining
Cornea 30«0
Table IIy5 Microscopic examination of UO
patients with keratoconjunctivitis sicca.
Fig.II,9 Scattered staining of conjunctiva and
cornea with bengal rose dye. Adrenaline 1|1000
instilled before photography to enhance
appearance of vital staining - patient No.22,
appendix II.
Fig.IIf10 Intermediate staining of conjunctiva and
cornea - patient No.20f appendix II,
Fig»II,11 Marked staining of conjunctiva and cornea.
Photographic technique as in Fig.11,7.
Fig.11,12 Mild pericorneal injection and viscous
r
tear film. This patient also had ptosis. No.12,
appendix II.
Fig.II,13 Mucus in the tear film. Patient No.19,
appendix II.
.XT11 '• Slit lamp photograph of large mucous
shreds attached to cornea* Patient Mo,11,
appendix II.
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Slit Lamp Examinations in
Keratoconjunctivitis Sicca
Results
Table II,5 shows the frequency of ocular signs in
the 40 patients suffering from untreated
keratoconjunctivitis sicca. The results of the
examinations were recorded before and after the
instillation of one per cent bengal rose and two per
cent fluorescein. Interpalpebral staining of the
conjunctiva with bengal rose was present to some extent
in every case (Figs.II, 9 ,10 and 11 ) and dilated
interpalpebral conjunctival vessels in 77•5 P©r cent.
Mild pericorneal injection and a viscous tear film were
the next commonest features present in some 50 per cent
of cases (Fig.11,12). Punctate staining usually of the
lower third to two thirds of the cornea with bengal rose
and fluorescein was a feature of 30 to UO per cent and
was rather more common than mucus in the tear film
(Fig.IX,13) or attached to the surface of the cornea
(Fig.II, 14 ). Large mucous threads were distinguished
from small corneal filaments for the purposes of this
study although it is recognised that filaments are
largely mucus (v.l.). Thus tiny corneal filaments
were observed in 20 per cent of cases following
instillation of bengal rose dye whereas large mucous
threads were present in about 30 per cent. Moreover,
corneal filaments were never present in the absence of
bO
mucus in the tear film or punctate staining of the cornea
with rose bengal,
Sjogren (1933) recognised tiny circular grey facets
and pits especially in the lower two thirds of the
cornea, These have been designated "pits" in Table 11,5*
Occasionally the lesions extend through Bowman's
membrane into the anterior stroma, When the pits have
been resurfaced with epithelium dye is not taken up and
they are more difficult to distinguish.
Fluorescein patterns of staining varied
considerably, isolated punctate erosions, linear confluent
erosions, widespread punctate erosions and punctate
keratitis. Some of these patterns suggested the
possibility of adenovirus or early herpetic infections
and stimulated some of the investigations described in
Chapter VIII,
Discussion
The possible causes of the ocular signs in Sjogren's
syndrome require careful consideration. Conjunctival
hyperaemia, particularly of the interpalpebral vessels,
was a prominent feature of 77*5 per cent of the patients
described in this series (Table 11,5)• Although this
is constantly referred to in series of patients
suffering from Sjogren's syndrome, Holm (19^9) considers
that it is not pathognomonic of the disease but rather
indicative of superimposed infection. Certainly the
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prevalence of pathogenic bacteria in the conjunctival
sacs of untreated keratoconjunctivitis sicca patients is
higher than in arthritics with no evidence of external
eye disease (Cahpter VIIl). On the other hand, the
overlying conjunctiva always shows evidence of
dessication and cell necrosis in that rose bengal stain
is constantly present. It seems likely that some
degree of hyperaemia is typical of the disease but that
it may be enhanced by bacterial infection.
As a result of reduced tear secretion and increased
goblet cell formation in the conjunctiva (Sjogren, 1933f
Klein, 1949) mucus accumulates in the eyes of patients
suffering from keratoconjunctivitis sicca. Thus the
tear film increases in viscosity (Klein, 1949) and its
normal firm adherence to the cornea (Fischer, 1928) is
increased. Mucous shreds may be detected either lying
on the surface of the cornea and conjunctiva or attached
to their surfaces (Table 11,5). There is convincing
evidence that a proportion of the corneal changes in
keratoconjunctivitis sicca is brought about by the
interaction of the abnormally tenacious mucus and the
already diseased cornea. Sjogren, 1933» examined
autopsy material from two of his 19 cases and detected
fine threads of superficial corneal "fibrillae"
attached to the superficial part of an epithelial cell
or several cells. He did not examine the material in
any greater detail. However, Hess (1892) and Nuel
(1892, 1893) Had stated that the filaments in filamentary
keratitis arise from a triangular elevation of epithelium
h2
which is elongated into a spiral containing a core of*
mucus. Nuel (1892) suggested that the cell-like
structures sometimes seen in the terminal expansion of
a filament are conjunctival squames picked up by the
aggregation of mucus. Weskamp (1956) observed what he
regarded as an eruption of gelatenous degenerated stromal
material carrying epithelial cells with it.
The introduction for clinical use of one per cent
alcian blue by Norn (1962, 1963) helped to clarify the
nature of the shreds and filaments. Alcian blue stains
choroidoitin - and mucotin — sulphate complexes in mucin.
Norn detected intense staining of the cornea in
keratoconjunctivitis sicca indicating that the filaments
consisted largely of mucin. The central core of the
filament stains densely with this vital dye and Jones and
Coop (1965) could not detect any cells or cell-like
structures except at its base. Furthermore, Nora (1969)
was able to demonstrate that the rate of flow of mucus
towards the medial canthus was reduced in
keratoconjunctivitis sicca. Thus, it is postulated
that the abnormal quantities of mucus, produced by the
goblet cells in the conjunctiva of keratoconjunctivitis
sicca patients, are deposited on the surface of the
cornea, possibly on cells already damaged by dessication.
As the mucus builds up it may form filaments or may tear
off corneal cells either singly or in strands. In this
context it is important to recall that none of the
patients described in the preceding pages had filaments
in the absence of mucus shreds or bengal rose staining
of the corneal epithelium.
Summary
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The prevalence of symptoms, macroscopic and
microscopic signs in 40 new cases of Sjogren's syndrome
are described. Consideration of the symptoms and gross
signs in relation to a control series of 40 arthritic
patients with no evidence of keratoconjunctivitis sicca
led to the development of a "Keratoconjunctivitis Sicca
Index" for use by the physician. A score of 10 or more
indicates that the patient has keratoconjunctivitis sicca.
The Index was evaluated in a series of 100 rheumatoid
arthritics and found to be a highly successful screening
procedure.
The possible causes of some of the microscopic
changes in keratoconjunctivitis sicca, conjunctival
hyperaeinia, excess mucus, corneal filaments and corneal




Various methods for measuring the protein content
of tears have been in use for several years. Using
a viscometric technique, Meyer (19^8) shoved that the
lysozytne concentration was reduced in keratoconjunctivitis
sicca. His observation vas confirmed by others using
electrophoresis (Regan, 1950} McEwen and Kimura, 1955)
and by Erickson (1955) who also demonstrated reduced
lysozyxae content in other ocular conditions such as
paralimbal ring keratitis in systemic lupus
erythematosus. Furthermore, Minton (19^5) observed
less lysozyme in the tears of patients living in
polluted atmospheres than in those living in clean air
conditions and Erickson, Matlcn and Berg (1959)» Sapse,
Bonavida, Stone and Sercarz (1968) in older age groups
with eye complaints. It appears, therefore, that many
factors must be considered before a diagnosis of
keratoconjunctivitis sicca can be made on the basis of
reduced lysozyme concentration. However, Thygeson and
Kimura (1963) showed that a decrease in concentration
of lysozyme may precede all other evidence of
keratoconjunctivitis sicca. The advent of a new
technique - the agar diffusion lysozyme test (Bonavida
and Sapse, 1968) with its increased degree of accuracy
presents exciting prospects for the future. Lysozyme
acts selectively on the cell walls of the micrococcus
h 5
Lysodeikticus. The effect of this action can be
measured by the zone of lysis produced round an
antibiotic disc in an agarose plate. Van Bijsterveld
(1969) applied this method to patients suffering from
keratoconjunctivitis sicca and claimed that it was more
accurate than the Schirmer I tear test or staining with
rose bengal dye. However, he did not compare it with
a combination of the Schirmer II test and rose bengal
staining. Nevertheless, the agar diffusion lysozyme
test must be thoroughly evaluated by future observers.
In this context it will be interesting to examine the
lysozyme content in the tears of those rheumatoid
arthritic patients who consistently produce very few
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CHAPTER XXX
0B8KRVATX0H8 OH LACRZNAL GLAND HISTOLOGY
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The histology of Sjogren's syndrome has been studied
at post mortem either in single cases or in series of
fewer than 8 patients (Sjogren, 1933; Bruce, 19^1?
Holin, 19^9} Allington, 1950? Bohm, 1950; Ellraan,
Weber and Goodier, 1951; Hass, 1951; Reader, Whyte
and Rimes, 1951; Morgan and Raven, 1952; Cardell
and Gurling, 195^; Szanto, Farkas and Gyulai, 1957;
Funatsu and Eguchi, 1957; Bucher and Reid, 1959;
Bain, I96O; Bloch, Buchanan, Wohl and Bunim, 19^5)#
Lacrimal and salivary glands, mucous glands of the
respiratory tract, mouth and upper oesophagus are
typically involved. However, most of the
observations on lacrimal gland structure were recorded
in severe cases of keratoconjunctivitis sicca (K.C.S.)
and in patients who had died as a result of the severe
complications of arthritis or another connective tissue
disease. The primary purpose of this study was to
investigate the histology of the lacrimal gland in
patients currently suffering from K.C.S.
Patients with K.C.S. and xerostomia but no
evidence of connective tissue disease may be
classified as suffering from the * sicca syndrome'
(Chapter X). Lacrimal gland tissue from 'sicca
syndrome* patients was also studied to determine any
features that may differentiate the disease from
Sjogren's syndrome.
Reduced Schirmer XI tear tests (Chapter II) may
be demonstrated in a number of rheumatoid arthritic
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patients who have no evidence of punctate or filamentary
keratitis. For study purposes, these patients may be
regarded as "possible* K.C.S. and they are the subject
of extensive clinical and serological examination
reported in Chapters V and VI. Lacrimal gland
biopsies were obtained from a sample of patients with
'possible* K.C.S. in an attempt to elucidate the
validity of this classification.
Systemic corticosteroid or adrenocorticotropic
hormone therapy may be effective in controlling acute
exacerbations of Sj^gren*s syndrome (Manschot, 1961)
and, therefore, may be expected to modify the
histological appearances of the lacrimal gland. Thus






























Biopsies of the lacrimal gland were obtained from
29 female patients suffering from definite (23) or
possible (6) keratoconjunctivitis sicca. In addition,
the lacrimal glands of 10 age matched patients, who had
died from a variety of medical disorders not related
to rheumatoid arthritis or connective tissue disease and
who had no history of ocular disease, were examined post
mortem.
The diagnosis of rheumatoid arthritis, the clinical
and laboratory methods referred to in the results and
discussion are detailed in Chapters V and VI.
Lacrimal Gland Biopsy Technique
Since removal of part of the palpebral portion of
the lacrimal gland would entail disruption of the
excretory ducts, the orbital segment was chosen for
biopsy. Each patient understood the reason for the
operation and that it was to be carried out on a
voluntary basis. Following infiltration with local
anaesthesia, two per cent lignocaine without adrenaline,
the skin was incised for a distance of 1.5 cm. from the
lateral orbital tubercle towards the medial canthus,
0.5 cm. below and parallel to the superior orbital margin.
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Underlying fascia and muscle were separated by blunt
dissection until the smokey blue periorbital membrane
was identified closely attached to the rim of the
orbit. Incision of the periorbital membrane resulted
in protrusion of periorbital fat which was easily
replaced with a probe. Two into three toothed forceps
were inserted into the superior lateral angle of the
orbital roof and a piece of lacrimal gland tissue
extracted through the gap in the periorbital membrane,
severed with scissors and placed in formal saline.
The skin wound was closed with three interrupted black
silk sutures, no haemostatic or subcuticular stitches
being necessary. Eyelid appearances returned to
normal within 1k days and no complications were
encountered. Histology was studied on 6 p, thick
paraffin sections stained by haematoxylin and eosin.
Considerable care was taken to present the pathologist
with no information regarding the source of the
lacrimal tissue.
Results
Table 111,1 shows the range of disorders from
which the patients were suffering. Two of the 2k
rheumatoid arthritic patients also had systemic lupus
erythematosus and three of the four 'sicca syndrome'
group had osteoarthritis. All of the 6 patients with
'possible' K.C.S. were suffering from rheumatoid arthritis.
Fig.111,1 Lacrimal gland from a post mortem
specimen of a 55 year old male patient who died
of coronary disease. The normal architecture
of the lobules, ducts and acini should be
compared with those in Fig.Ill,6 where lobular
destruction is evident.
(X^ magnification)
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Fig.Ill,2 X10 magnification of section of the normal
lacrimal gland shown in Fig-.1X1,1. Fat spaces are
interspersed among acinar tissue.
Fig.111,3 Normal lacrimal gland From a post mortem
specimen of a 7^ year old female patient who died
as a result of secondaries from breast cancer.
Plasma cells (arrowed) are frequently noted in
normal specimens (X10 magnification).
Fig.III,^ Biopsy specimen showing mild chronic
inflammation. Early intralobular fibrosis is
present but the main feature is the abnormal
arrangements of the ducts (arrowed).
Fig.Ill95 Mild chronic inflammation showing
abnormal duct arrangement and infiltration with
lymphocytes (arrowed). There does not appear to
be any damage to the acinar epithelium.
Fig.Ill,6 X4 magnification of an example of severe
chronic inflammation. Themain feature is the
destruction of the normal lobular pattern compared




Dense aggregates of lymphocytes are
in severe chronic inflammation and acinar
is evident in selected fields.
Fig.XI.C,8 Severe chronic inflammation showing the
moat severe degree of acinar atrophy acceptable
for this grade of specimen.
Pig.111,9 Lymphocytic infiltrations may reach a
peak in severe chronic inflammation with the
formation of lymph follicles and germinal centres
(arrowed).
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There was no significant difference in the mean age and
age rang© of the groups studied.
Four distinct histological stages were recognised
in this study.
Stage 0 - normal lacrimal gland.
The lacrimal gland consists of tubulo racemose
tissue with short branched tubules and masses of
lobules interspersed with fat (Figures 111,1 and 2).
Plasma cells are a normal feature of the interacinous
and interlobular connective tissue (Figure 111,3)5
lymphocytes are less frequently detected.
Stage I — mild chronic inflammation
The salient features in these cases are abnormal
arrangement of the ducts, mild lymphocytic infiltration
and slight intralobular fibrosis (Figures III,** and 5)*
Stage IX - severe chronic inflammation
Total destruction of the normal lobular pattern
(Figure 111,6), dense infiltration with lymphocytes,
aggregating into lymph follicles (Figures III, 7 and 9)
and progressive acinar atrophy (Figures III, 7 and 8)
are the features of this grade.
Fig.XII,10 Late stage of lacrimal gland involvement
in K.C.S. (x4 uigui ~icu.ti> n) . The total
destruction of lobular pat toon is evident but there
is a reduction in the cellular infiltrate (compare
Figs,111,1 ant} 6) and an increase in the acollular
fibrous tissue.
Fig.Ill,11 X10 magnification of the section shown
in Fig.XIX,10. The dense fibrous tissue, few
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Stage III - late results of inflammation
The cellular infiltrate is reduced and acellular
fibrotic tissue is increased. Few acinar cells
remain (Figures 111,10 and 11).
All of the post mortem specimens and the 6 biopsies
from patients suffering from "possible" K.C.S. had normal
lacrimal glands. Only one patient suffering from
definite K.C.S. had a normal tissue biopsy. This
patient was a 50 year old female with a two year
history of sero positive rheumatoid arthritis, xerostomia
and dry eyes. Her white blood count, serum globulin
and liver function tests were normal, the erythrocyte
sedimentation rate being slightly raised to 25 mm. in
the first hour. Tests for antinuclear factor and
salivary duct antibody were negative and x-ray and
functional grades were zero. The patient's eyes had
responded to artificial tear therapy (Chapter IX).
All of the evidence, therefore, indicated that the
patient had mild chronic rheumatoid arthritis and
K.C.S. at the time the biopsy was carried out.
None of the remaining 23 patients with definite
K.C.S. had lacrimal gland biopsies that showed
entirely normal tissue (Table 111,2). Mild chronic
inflamination was detected in he one patient with
primary biliary cirrhosis and K.C.S. This was a 67
year old female patient with a six year history of liver
disease without arthropathy and a six months' history
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of* dry eyes. Salivary duct autoantibodies were present
but there was no clinical, serological or x-ray evidence
of rheumatoid arthritis. The patient's eyes had
responded to artific al tear therapy. The remaining
patient with mild chronic inflammation (Stage I) was
a 75 year old female with osteoarthritis and
xerostomia of six years' duration - sicca syndrome -.
Eleven patients, 9 with Sjogren's syndrome and two with
the sicca syndrome had severe chronic inflammatory
changes (Stage III) and the late results of inflammation
(Stage III) were recorded in the remaining 9 patients,
8 with Sjogren's syndrome and one sicca syndrome
(Table 111,2). No histological features distinguished
the lacrimal glands of patients with Sjogren's syndrome
from those with K.C.S. and no rheumatoid arthritis.
Severity of lacrimal gland destruction tended to
be greater with increased duration of ocular disease
(Table 111,3)« Thus none of the 8 patients who had
suffered from K.C.S. for less than three years had
Stage III changes. On the other hand, three patients
with a three to five year history showed late changes
(Stage III) whereas four patients with a five to seven
year history showed only mild or severe chronic
infiltration (Stages I and II). The groups are too
small to compare with respect to severity of arthritis.
However, it is interesting to note that Sjogren's
syndrome is more likely to develop in severe rheumatoid
arthritis of long duration (Chapter V) and more severe
destruction of lacrimal gland might be expected to
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correlate with advanced forms of arthritis.
Five of the Sjogren patients had received systemic
steroid therapy for periods varying from 2 to 10 years
in an average daily dose of 5 mgm. of prednisolone or
its equivalent per day. Stage XII (late) changes
were described in four and Stage II (Severe chronic)
in one case. Steroid therapy had not prevented
marked involvement of the lacrimal glands in these
patients. All five patients had suffered from
K.C.S. for more than five years and had received
systemic steroids during that time. Nevertheless,
no difference in histology could be determined between
these patients and the remaining group who had never
received systemic steroids and who had also suffered
from K.C.S. for more than five years.
Discussion
Biopsy of the orbital portion of the lacrimal
gland in patients suffering from K.C.S. had not been
recorded in a series of patients until this study was
conducted. From my perusal of the literature, it
appears that no series of greater than 8 patients have
been examined post mortem and in most instances only a
single case has been reported (Sjogren, 1933? and others
listed in the introduction). Investigation of the
recorded work further suggests that most specimens
were obtained from extreme cases who had died as a
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result of the complications of associated systemic
disease and that lacrimal histology could be expected
to show advanced changes. For these reasons, a series
of 29 female patients depicting a range of involvement
with K.C.S. were selected for lacrimal gland biopsy.
The specimens could be classified into four stages?
normal tissue, mild chronic, severe chronic inflammation,
and a late fibrotic phase. In general, the severity
of destruction paralleled the duration of ocular
disease. The groups, however, were too small for
definite conclusions regarding relationship with
severity and duration of arthritis. Nevertheless, in a
parallel clinical study reported in Chapter V, Sjogren's
syndrome was more prevalent in severe arthritis and
severe lacrimal gland destruction might be expected to
correlate with advanced arthritis. A future study of
interest would be to extend the present series to
include a wide range of arthritic patients who had
suffered from K.C.S. for the same duration. Neither
the 10 age matched patients examined post mortem, nor
the 6 patients with "possible" K.C.S. had abnormal
lacrimal gland tissue. This would suggest that the
definition of Sjogren's syndrome as a chronic
inflammatory disease is valid. However, Radnot
recorded over 30 years ago that patients over the age
of 50 years undergo progressive atrophy of the lacrimal
glands and that infiltration with lymphocytes is a normal
occurrence in this and older age groups (Radnot, 1939)*
The mean age of the control group in this series was
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6h years, somewhat older than the Sjogren patients,
61.k years, yet no abnormalities of the lacrimal glands
were detected. However, another future study
suggested is the extension of 'normal* lacrimal gland
histology in older age groups. In this context, it is
interesting to note that the prevalence of K.C.S. in
hospital patients is less than in rheumatoid arthritis,
except in geriatric patients of over 80 years of age
(Chapter IV).
There were no specific features in the lacrimal
gland that distinguished Sjogren's syndrome from the
sicca syndrome. Further comparison of these groups
is studied in Chapter VI.
Systemic corticosteroid or adrenocorticotruphic
hormone therapy may be effective in controlling acute
exacerbations of Sjogren's syndrome particularly when
accompanied by swelling of the lacrimal and salivary
glands (Manscbot, 1961) but has little place in the
treatment of the disease in its chronic form (Chapter IX).
*he latter view has been strengthened by the absence of
any difference in lacrimal gland histology in steroid
and non steroid treated patients who had experienced
K.C.S. for similar periods.
Summary
Biopsies of the orbital portion of the lacrimal
gland were carried out in 29 female patients, 18 Sjogren's
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syndrome, 4 sicca syndrome, one biliary cirrhosis and
6 with rheumatoid arthritis and "possible"
keratoconjunctivitis sicca (K.C.S.). In addition
10 post mortem specimens were obtained from patients
who had no history of ocular disease and who had died
from diseases unrelated to rheumatoid arthritis or other
connective tissue diseases. The biopsies were
classified according to severity into normal, mild
chronic inflammation, severe chronic inflammation and
late fibrosis (Stages 0, I, II and III). All of the
post mortem specimens and the 6 from patients with
"possible" K.C.S. had normal lacrimal glands. The
degree of infiltration with lymphocytes disruption of
normal glandular tissue and eventual replacement with
acellular fibrotic tissue was related to the duration
of the K.C.S, There were no specific features in
K.C.S. associated with rheumatoid arthritis (Sjogren's
syndrome) not seen in the sicca syndrome. Systemic
steroid therapy did not appear to have influenced the
microscopic features in the lacrimal glands of five
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KERATOCONJUNCTIVITIS SICCA IN NON^RIIBUMATIC
SUBJECTS, INCLUDING THE ELDERLT
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Sjogren (1933) noted that keratoconjunctivitis
sicca was recorded as a diagnosis in only 19 of 36,000
patients (0.05%) at the Sabbatsberg Hospital in Sweden,
and Beetham (1935) could trace only one case in 20,000
attending the Massachusetts Eye and Ear Infirmary
(0.0005%)• However, de Roetth (19**5) observed that
one in 620 of his ophthalmic outpatients (0.16%) had
keratoconjunctivitis sicca. Conversely, it took
Gifford, Puntenney and Bellows (19**3) four years to
collect 33 keratoconjunctivitis sicca patients from a
very busy practice and they suggested that more cases
were being recognised each year. Furthermore, in 1950,
Henderson reported that he was examining 13-1** new cases
of Sjogren*s syndrome per year over a 9 year period.
In none of these series however, was the age and sex
distribution of all the patients described. Despite
this, the influence of age and sex factors on the
incidence of keratoconjunctivitis sicca, has been
discussed by many authors. Earlier reports suggested
the disease was exclusive to women at the menopause
although by 19**0, Sjogren no longer considered the
menopause was a significant factor.
There followed a series of publications citing
examples of the disorder in patients younger than bO
years and in males (Bruce, 19**1} Gifford and colleagues,
1 9**3; Lutman and Favata, 1 9**6 $ Stenstam, 1 9**7 5 Holm,
19495 Henderson, 1950). Bloch, Buchanan, Wohl and
Bunim in 1965 studied 39 patients with Sjogren's
syndrome and 23 with the sicca syndrome and found that
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50 per cent of their female patients developed symptoms
before the menopause. Although the commonest decades
of onset were the fourth, fifth and sixth, there was no
clear cut relationship with the menopause itself.
Reduction in tear secretion with age has been
observed by some investigators (de Roetth, 19^1;
Henderson and Prough, 1950; Wright and Meger, 1962;
Norn, 1965)* Conversely, Holm (19^9) concluded after
examining the literature on histology of the lacrimal
gland and a group of non—rheumatic patients, that there
was no indication of reduced tear secretion with age.
Faced with such conflicting and incomplete surveys,
I considered it of interest to study the prevalence of
keratoconjunctivitis sicca in non-rheumatic male and
female subjects of widely differing age groups. This
study was all the more relevant since I had determined
to examine the prevalence of Sjogren's disease in organ
specific autoimmune disorders and required a knowledge
of the prevalence of keratoconjunctivitis sicca in the
non-rheumatic patient for purposes of comparison.
Examination of a geriatric group of patients for
keratoconjunctivitis sicca presents its own particular
set of problems and interests. The prevalence of
rheumatoid factors and antinuclear factors is high in
Sjogren's syndrome with and without rheumatoid arthritis
(Bloch, Wohl, Ship, Oglesby and Bunim, i960; Bunim,
1961; Crews and Whitfield, 1963; Bech, 1963; Bloch,
Buchanan, Wohl and Bunim, 1965; Beck, Anderson, Bloch,
Buchanan and Bunim, 1965) and also in the elderly patient
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especially females (Laurence, 1961; Beck, 1963)* It
is therefore clearly of interest to examine the elderly
patient for evidence of Sjogren's syndrome in relation
to rheumatoid and antinuclear factors. Mitochondrial
antibodies are found in the serum of patients with
primary biliary cirrhosis (Walker, Doniach, Roitt and
Sherlock, 1965; Doniach, Roitt, Walker and Sherlock,
1966; Goudie, HacSween and Goldberg, 1966), cryptogenic
cirrhosis or active chronic hepatitis (Doniach and
colleagues, 1966) and occasionally in patients who give
no clinical impression of liver disease; for example,
low titre mitochondrial antibody has been described in
Sjogren's syndrome (Doniach and colleagues, 19665
Doniach and Walker, 1969)* Conversely, clinical and/or
biochemical evidence of liver disease was found in 6 per
cent of patients with S.j/gren's syndrome without
rheumatoid arthritis, 1.5 per cent of patients with
Sjogren*s syndrome and rheumatoid arthritis and 0.66 per
cent with rheumatoid arthritis alone (Whaley, Goudie,
Williamson, Nuki, Dick and Buchanan, 1970). Clinical,
biochemical and immunological evidence of liver disease





Pour hospital sources were utilized.
Group t Orthoptic Patients (25)
These were children aged 5-15 years, mean 9*8,
12 girls and 13 boys, who were attending the Orthoptic
Departments of the Ophthalmic Institute and Southern
General Hospital for treatment of strabismus. None of
the children had had acute rheumatism, Still's disease
or congenital alacrima.
Group 2 Orthopaedic and Accident Outpatients ()
These are young adults aged 16-30, mean age 21.3
years, 23 female and 17 male, who were attending the
Accident and Orthopaedic Outpatient Department of the
Royal Infirmary, as a result of a variety of arm and
leg fractures and lacerations. None of the patients
was known to be suffering from a systemic disease.
Group 3 Miscellaneous Medical Clinics (120)
These were adult patients aged 31-79* mean 56.4,
58 male and 72 female patients, attending clinics
associated with the Western and Royal Infirmaries. They
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had a variety of general medical conditions, none of
which had any known association with rheumatic disease
or autoimmune disorders.
Group k Geriatric patients (1^5)
These were inpatients in Cowglen and Shieldhall
Hospitals and were all over the age of 80 years (57 males,
88 females, mean age 83.8 years). The variety of
medical disorders for which they had been admitted to
hospital is shown in Table IV,2. None of the patients
was acutely ill or dehydrated.
The diagnosis of keratoconjunctivitis sicca was made
in accordance with the criteria set out in Chapter II.
All patients were examined for clinical evidence of
xerostomia and sialograms were carried out in 36 of the
patients in Group 3 (Park and Mason, 1966). Sialograms
were not performed on the geriatric patients who were in
the main too infirm to withstand the ambulance journeys
and outpatient waiting entailed.
Laboratory Investigations
Laboratory investigations in the over 80 year old
patients included serum alkaline phosphatase, total
protein, serum albumin and globulin, total bilirubin and
serum glutamic oxalacetic transaminase estimations carried
PREVALENCE OF KERATOCONJUNCTIVITIS SICCA (KCS)
in
NON-RHEUMATIC HOSPITAL PATIENTS
No. of patients Age (yrs) Schirmer's test 11 of 5 minutes Keratoconjunctivitis
Clinical Groups Mean Range 5 5-9 10-14 sicca
No. per cent No. per cent No. per cent No. per cent
Orthoptic patients 25 9. 9 5-15
Orthopaedic and
Accident out-patients 40 21.3 16 - 30
Miscellaneous Medical
Clinics 120 56.4 31 - 79 7 6.2 3 2.5 1 0.6 8 6.5






5-15 16-30 31-79 80 +
AGE GROUPS (years)
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out in accordance with the methods in current use in the
Biochemistry Department of the Southern General Hospital,
Glasgow. Additional data included antinuclear factors
(by the Indirect irnrnunofluorescent technique) (Beck,
1961), latex fixation test (Singer and Plotz, 1966),
sheep red cell agglutination test (Ziff, Brown,
Lospallato, Baden and McEwan, 1956), mitochondrial
antibodies to rat kidney (Goudie and others, 1966) and
smooth muscle antibodies (Johnson, Holborow and Glynn,
1965).
Results
The results of the ophthalmological examinations
are summarized in Table IV, 1 and in Figure IV,1. None
of the patients in Groups 1 or 2 had keratoconJunetivitis
sicca. A small number, 6.5 per cent in Group 3 had dry
eyes. Two of the patients were under 50 years of age,
the other six were between 51 and 65 years old. A
significantly higher prevalence of keratoconjunctivitis
sicca, 23 patients, 16 per cent, was detected in the
Geriatric Hospital population (P > 0. 02)?» The
prevalence of dry eyes was no higher in the female group
than the male (15 of 87 female, 8 of 58 male). Neither
the four patients with pernicious anaemia nor the one
with hypothyroidism had keratoconjunctivitis or
xerostomia (Table IV,2).
No instances of xerostomia were observed in the
DIAGNOSIS IN PATIENTS OVER 80 YEARS OF AGE
Clinical Group Number Per cent
Cerebrovascular disease 101 69.6
Ischaemic heart disease 8 5.5
Orthopaedic casualties 9 6.2
Diabetes mellitus 5 3.4
Pernicious anaemia 5 3.4
Nutritional anaemia 5 3.4
Hypertension 4 2.7
Parkinson's disease 2 1.3
Rodent ulcer 1 0.6
Hypothyroidism 1 0.6





LABORATORY DATA Patients with Patients without
keratoconjuncticitis keratoconjunctivitis
sicca (23) sicca (122)
Latex Fixation test 7 (30. 6 per cent) 40 (33. 3 per cent)
Anti-nuclear factor 8 (34. 3 per cent) 35 (29.1 per cent)
Mitochondrical Antibodies - -
Smooth Muscle Antibodies - 2(1.6 per cent)
Total protein gm. per 100 ml 7.2 ± 2.1 7.3 ± 3.0
Serum Albumin gm. per 100 nil 4.9 ±0.8 4.1 ±0.75
Serum Globulin gm. per 100 mi 3.4 ±0.8 3.6 ±0.75
Serum Alkaline Phosphate
(King Armstrong Unit)
(mgm per 100 ml) 8.0 ±3/TOO ml. 8.4 ±3. 2/100 ml.
Total Bilirubin mgm/100 ml 0.48 ±1.1 0.48 ±1.0
Serum Glutamic Oxalacetic
Transaminase. Units/ml. 28 ± 4 27 ± 4
Table IV,3 Laboratory data in the Geriatric
Group of patients.
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younger age groups. However, a dry mouth was noted in
7 of 36 (19$ of patients) with miscellaneous medical
disorders and abnormal sialograms were recorded in 6 of
them (16$). Xerostomia was detected in 22 of the 1*15
(15$ geriatric patients). Two female patients in Group
3 (1.6$) and k in the Geriatric Group (2.7$) had both
xerostomia and keratoconjunctivitis sicca (the sicca
syndrome)• None of the patients had a history or
clinical evidence of salivary or lacrimal gland
enlargement. The results of the biochemical tests in
the Geriatric Group of patients are shown in Table IV,3»
There were no significant differences between those with
keratoconjunctivitis sicca and those with normal tear
secretion. A slightly raised Y globulin fraction was
observed in 10 per cent of the sera, but this was not
related to Sjogren's syndrome in this group of patients.
The latex fixation test for rheumatoid factor was
positive in 30-33 P©n cent of the geriatric patients
although in weak titre in over two thirds of cases. In
only 8 patients (17$) was the presence of rheumatoid
factor confirmed by sheep red cell agglutination.
Furthermore, of the 9 patients with strongly positive
latex fixation test, 7 also had positive sheep red cell
agglutination. None of the patients with both tests for
rheumatoid factor however, had keratoconjunctivitis sicca
or xerostomia.
Antinuclear factors were observed in 29-3*1 per cent
of the geriatric sera, the prevalence being significantly
higher in the female group (37 of 85 females, 6 of 58
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male, P > 0.02). Fifteen patients had positive latex
fixation tests and antinuclear factors and 5 of them
were suffering from keratoconjunctivitis sicca - a
finding which is of no statistical significance.
Although none of the geriatric patients had
mitochondrial antibodies, four of them had antibodies
to smooth muscle. None of these patients had
keratoconjunctivitis sicca or xerostomia, clinical or
biochemical evidence of liver disease.
Discussion
This study shows no evidence of keratoconjunctivitis
sicca in patients aged 5 to 30. Only 6.5 per cent of
non-rheumatic hospital patients aged 3* to 7^ years had
dry eyes; two were under 50 years and 6 between 50 and
65 years of age. However, the prevalence of
keratoconjunctivitis sicca in the over 80 year old group
of patients (16%) was significantly higher than in the
younger age groups. The distribution of
keratoconjunctivitis sicca between male and female
elderly patients was equal. On the other hand,
xerostomia occurred with equal frequency in groups 3 and
k, furthermore, the co-existence of keratoconjunctivitis
sicca and xerostomia (sicca syndrome) was observed in very
few instances in both groups (1.6$ and 2.7$).
The significance of autoantibodies in apparently
non-diseased patients is not always immediately apparent,
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e.g. it had been shown that euthyroid non-goitrous
individuals may have thyroid autoantibodies, usually in
low titre, and that these antibodies may increase with
age, especially in females (Goudie, Anderson and Gray,
1959)* Furthermore, thyroid autoantibodies may reflect
a symptomatic focal Hashimoto*s thyroiditis (Goudie and
colleagues, 1959)* In female patients these antibodies
may be associated with abnormalities in iodine metabolism
which are consistent with a mild Hashimoto's thyroiditis
(Buchanan, Harden, Koutras and Gray, 1965). Gastric
parietal cell autoantibodies also increase with age,
especially females, and correlate with chronic asymptomatic
atrophic gastritis (Irvine, 1956).
In contrast to these organ specific autoantibodies,
the situation regarding non-organ specific autoantibodies
such as rheumatoid and antinuclear factors is less clear.
Certainly, rheumatoid factors (Laurence, 1961) and
antinuclear factor (Beck, 1963) increase in prevalence
with age especially in females, and are frequently found,
albeit in usually low titre, in apparently healthy
individuals. Indeed they may be found even in young
persons although again in low titre (Buchanan, Boyle,
Greig, McAndrew, Barr, Anderson and Goudie, 1966;
Buchanan, Boyle, Gj-eig, McAndrew, Barr, Gray, Anderson
and Goudie, 1967)» Since rheumatoid factor and antinuclear
factor are frequently found in patients with Sjogren's
syndrome, even in the absence of rheumatoid arthritis or
other connective tissue disease (Bloch and colleagues,
1965) and others quoted in the introduction, and since
lh
keratoconjunctivitis sicca is found as is shown by this
study in a proportion of healthy individuals, especially
in the elderly, it might be thought that rheumatoid
factor and antinuclear factor could be a reflection of
keratoconjunctivitis sicca. However, in this geriatric
series, this does not appear to be the case although one
cannot exclude the possibility except by pathological
studies, that is to say histological studies in the
negative "keratoconjunctivitis sicca cases" with
rheumatoid factor or antinuclear factor in their sera.
It is possible that these patients could have histological
subclinical keratoconjunctivitis sicca, and it is also
possible that the diagnosis of keratoconjunctivitis sicca
in the elderly, i.e. those over the age of 80, could be
due to lacrimal gland failure sine inflammation.
Evidence of liver disease was sought in the geriatric
group because patients with Sjogren's syndrome exhibit
evidence of liver disease (Whaley and colleagues, 1970)
and patients with various liver diseases have
mitochondrial antibodies as do patients with Sjogren's
syndrome (Walker and colleagues, 1965? Doniach and
colleagues, 1966; Doniach and Walker, 1969)* Clinical
and biochemical evidence of liver disease was not present
in any of the geriatric group although a slightly raised
y globulin fraction was observed in 10 per cent of cases.
Four patients had antibodies to smooth muscle but no
other abnormalities and no mitochondrial antibodies
using rat kidney sections were detected. There appears,
therefore, to be no evidence for an association between
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Sjogren's syndrome and a generalised active inflammatory
process in the elderly patient.
Summary
Keratoconjunctivitis sicca is present in a number
of "healthy" non-rheumatic patients. No evidence of
the disease was found in 25 children or 40 young adults.
A prevalence of 6.5 per cent of 120 outpatients whose
mean age was 56.4 increased to 16 per cent of 145
geriatric patients whose mean age was 83.8. The
difference is statistically significant. There was no
indication in the geriatric group that the ocular
disease was related to rheumatoid factors or antinuclear
factors, to clinical, biochemical or immunological
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CHAPTER V
KERATOCONJUNCTIVITIS SICCA IN RHEUMATOID ARTHRITIS
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Although keratoconjunctivitis sicca (KCS) has
been reported with varying prevalence (Chapter X, page 7)
in rheumatoid arthritis, no systematized study of the
relationship of K.C.S. to the various clinical and
laboratory features of rheumatoid arthritis has been
reported.
This chapter is a record of such a study in 893





Eight hundred and ninety-three consecutive patients
with definite or classical rheumatoid arthritis as
defined by the diagnostic criteria of the American
Rheumatism Association (Ropes, Bennett, Cobb, Jacox
and Jessar, 1958) formed the basis of the study.
Each patient had a detailed ophthalmological
examination as described in Chapter II. For the
purposes of this study three groups were defined!
patients with rheumatoid arthritis and no evidence of
K.C.S., patients with rheumatoid arthritis and
doubtful K.C.S., Patients with rheumatoid arthritis
and definite K.C.S. Doubtful or possible K.C.S. was
diagnosed when on two or more occasions the Schirraer II
test was below 15 mm. of wetting and at the most only
scattered staining of the conjunctivae with bengal
rose was detected.
In addition to age and sex, the following clinical
features were recorded in each patient! age of onset
of arthritis, duration of arthritis, history of drug
allergy, xerostomia and salivary gland enlargement,
superficial and deep venous thrombosis, Raynaud's
phenomenon, thyroid disease and skin ulcers.
On physical examination the following features
were recorded! subcutaneous nodules, lymphadenopathy,
splenomegaly, peripheral neuropathy, functional grade
8^
and a clinical index of joint tenderness (Ritchie,
Boyle, Mclnnes, Jasani, Dalakos, Grieveson and
Buchanan, 1968)*
X-ray joint surveys were interpreted according to
the stages of Steinbrocker, Traeger and Batterman (19^9)«
Laboratory Investigations
Each patient had a full blood count including:
haemoglobin estimation, total and differential white
cell count, platelet count and erythrocyte sedimentation
rate (Westergren), The serum ix*on, iron binding
capacity, per cent saturation and Coombs test were also
performed.
Biochemical tests included: total serum protein,
serum albumin (Roberts, 1967)* serum globulin (Storiko,
1968), thymol turbidity estimations.
Immunological tests included: rheumatoid factor
by the sheep cell agglutination method (Ziff, Brown,
Lospallato, Baden and McEwan, 1956), antinuclear
factor (Beck, 1961), lupus erythematosus cell
(Zinkham and Conley, 1956) and lupus erythematosus
Latex tests (Dubois, Drexler and Arterberry, 1961),
thyroglobulin autoantibody by precipitin (Anderson,
Buchanan, Goudie and Gray, 1962) and tanned red cell
haemagglutination (Pulthorpe, Roitt, Doniach and
Couchraan, 1961), thyroid antimicrosomal (Holborrow,
Brown, Roitt and Doniach, 1959)» gastric parietal cell
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autoantibody (Adams, Glen, Kennedy, Mackenzie, Morrow,
Anderson, Gray and Middleton, 1964), indirect
immunofluorescence tests for salivary duct autoantibody
(MacSween, Goudie, Anderson, Armstrong, Murray, Mason,
Jasani, Boyle, Buchanan and Williamson, 1967)* non-
tissue specific precipitins (Anderson, Gray, Beck and
Kinnear, 1961) and "enereal Diseases Reference Laboratory
tests. Details of the immunological tests and the
significance of salivary duct autoantibodies are
recorded in Chapter VI.
The results of the examinations \irore recorded by
the author on computer punch cards and subsequently
transcribed on to magnetic computer tape. In order
to go more deeply into the study of K.C.S. and its
relationship %vith the clinical and laboratory features
of rheumatoid arthritis, a multivariate analysis of
all the data collected was carried out by calculating
the discriminant function between the group of
*
patients with R.A. and K.C.S. and those with R.A. and
no evidence of K.C.S. (Kendall, 1961). Discriminant
function was performed by the method described by
Goulden (1952). Since this technique requires that
all data on each variable be present, any case with
missing observations was discarded. The occurrence
of missing data in the patients' records was quite
random, so omission of incomplete records does not
appear to introduce any bias. Since many of the
variables are inter-correlated the impact of all



























































































































































































































































































































R.A.withdoub fulefinite K.C.S.. .
No.MeanSt.Dev. 47.50 572.65 596.85 593.15 593.70 70.14 606.62 592.98 20.00 490.02 10.00 601 .00 600.38 600.20
3.69715 1.88570 0.60373 0.69873 0.62573 0.3786 3.17376 6.06173 0.0001 0.16359 0.0002 2.97273 0.69073 0.60373
13.071.166 2.76.662 6.960.675 3.260 627 3.690.673 0.00.00 5.663 17 2.583 135 0.00. 00 0.00. 00 0.00.00 0.822 697 O.230.6 6 0.23.6 6
TABLEV,4
DISCRIMINANTANALYSISBETWEENR.A.A DWI HDEFINITK.C.S ..T-TeatfarContributiont






































T-TsstforContributiont Discrimination 823Deg.Fre dom
DrugAllergy Xerostomia SalivaryGland Enlargement Raynaud*sPhenomenon
0.0002316364 -O.OO32543173 -0.0038977556 -0.0006768900
0.V739801470 -10,5196059303 -2.92800711178 -2.5313081
N.S.mnotsignificant
TableYt5
PValue N.S. <0.001 <0.01 <0.02
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Therefore, discriminant analyses with several different
sets of variables were performed to determine whether
the two groups could be more clearly differentiated on
the basis of optimally weighting the clinical
variables which had been recorded. The advantage of
using a discriminant score is that several clinical
variables and their complex interrelations are reduced
to a single, easily understood number.
Results
Hie calculations were carried out with an l.Q.M.
JOhO Computer by means of a programme prepared at the
Department of Biometrics and Medical Statistics,
Standford University, California. The results of the
computer print out are shown in Tables V, 1 to 5»
Seventy-four of the 893 patients in this study
(8.3$) had keratoconjunctivitis sicca. No significant
difference in age, sex, or age of onset of arthritis
could be determined in the three groups (Table V, 1 and
4). Although the duration of arthritis was about
twice as long in patients with definite K.C.S. as in
those with R.A. and no K.C.S. the difference is short
of significant (Table Vtk) because of the large
standard deviation in duration of the disease (Table V,1).
Xerostomia and a history of salivary gland enlargement
not surprisingly, were more frequent in the Sjogren
patients than in the rheumatoid arthritic series
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(Tables V, 1 and 5)» The significance of salivary-
duct autoantibody is the subject of Chapter VI.
Other clinical features of importance are Raynaud's
phenomenon, rheumatoid nodules, x-ray stage and
functional grade, all of which are more severe in
patients with R.A. and K.C.S. (Tables V, 1,4 and 5)»
There was no difference in the results of the laboratory
investigations carried out in the groups studied
(Table V,2).
Separate examination of the group with "doubtful
K.C.S." was not useful. There were no clinical or
laboratory features to distinguish them from the R.A.
patients with no K.C.S. It is interesting to note
that biopsies of lacrimal gland from six patients in
this group showed normal tissue (Chapter III).
Nevertheless, because it is not certain to which group
these patients may belong their results were not used
in the final statistical analyses.
Discussion
Although there was no significant difference in
the age of onset in the K.C.S. group with R.A. and
those with no K.C.S., the results are inconclusive.
There was a relative paucity of patients whose disease
began at the extremes of the spectrum. That is to say,
the number of patients whose arthritis began in the
second and third decade or in the eighth and over was
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small. It is difficult to determine at which point
a diagnosis of Still's disease (Juvenile rheumatoid
arthritis) should be replaced by one of adult rheumatoid
arthritis. One may use 15 years as the definitive age.
Children with Still's disease have a low incidence of
rheumatoid factors (under 6 years the tests are
consistently negative), the prevalence increasing
until at 15 years it approaches adult levels (Bywaters,
Carter and Scott, 19591 Tourabis, Franklin, McEwen
and Kuttner, 1963$ Sievers, Ahvonen, Ahok and Wager,
19631 Cassidy and Walkenburg, 1967)* Very rarely do
adults develop rheumatoid arthritis over the age of 65
years. Nevertheless, the two extremes should be
examined. Although the standard deviation of age of
onset and duration of arthritis are quite high in this
study (Table V,1), the wide range does not encompass
sufficient numbers at the two extremes,
Sjogren's syndrome occurs predominantly in
females. Nevertheless, in rheumatoid arthritis,
K.C.S. appears to be equally distributed between the
sexes (Tables V,1 and k)• There are, of course, many
more females with K.C.S. and R.A., since rheumatoid
arthritis is more frequent in women. The result of
this investigation indicates that rheumatoid arthritis
predisposes both sexes equally to the development of
K.C.S. A parallel might be drawn with thyrotoxicosis
where the disease is also more common in the female but
where affected males and females are equally prone to
developing thyroid antibodies (Buchanan, Alexander,
89
Koutras, Crooks, Macdonald, Richmond and Wayne, 1962).
A high incidence of drug allergy in patients
suffering from florid Sjogren's syndrome has been
reported (Bunim, Buchanan, Wertlake, Sokoloff, Bloch,
Beck and Alepa, 1964) and early symptoms of Sjogren*s
syndrome may be attributed to hay fever or similar
allergies (Bloch, Buchanan, Wohl and Bunim, 1965)*
Nevertheless, in this study there was no evidence of a
higher prevalence of drug allergy in patients with
K.C.S. and R.A. over those with R.A. and no K.C.S.
(Table V,5).
As expected xerostomia and salivary gland
enlargement correlates closely with K.C.S. and R.A.
The significance of salivary duct antibody and the
result of labial gland biopsies are examined in the
following Chapter.
Raynaud's phenomenon appears to be a feature of
Sjogren's syndrome irrespective of whether R.A. is
present or not (Bloch and colleagues, 1965)* In
this study, of 74 patients with K.C.S. and R.A.,
Raynaud's phenomenon was significantly more frequent
than in the R.A. patients without K.C.S. (Table V,5)»
The correlation between subcutaneous nodules,
severity of x-ray stage, functional grade and K.C.S.
is high in this series of 893 patients. It is
surprising that the sheep cell agglutination titre
for rheumatoid factor (S.C.A.T. titre — Table V,4)
does not correlate with K.C.S. since its correlation
with rheumatoid nodules, advanced x-ray stage and
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functional incapacity is high (Kellgren and Ball, 1959)*
Thus patients with a high titre of rheumatoid factor
have severe joint disease (Vaughan, 1959J Ziff, 1957)
and a poor prognosis (Duthie, Drown, Truelove, Baragar
and Lawrie, 1964). In addition a high incidence of
rheumatoid factor is found in patients with subcutaneous
nodules (Ball, 1952; Kellgren and Ball, 1959). The
poor correlation between R.A. with K.C.S. and the
S.C.A.T. titre in this study cannot be explained at
present. The articular index (Ritchie and Colleagues,
1968) is not significantly related but is slightly
higher in those patients with K.C.S. and R.A. This
result is not so surprising since, although there is a
general trend for those with high index scores to have
poor functional grades, the correlation is not
particularly good (Ritchie and Colleagues, 1968).
Summary
The results of this study show that K.C.S. is more
likely to occur in rheumatoid arthritic patients who
have severe joint disease as judged by their x-ray
stage and functional incapacity and in those with
rheumatoid nodules. There is also a tendency for K.C.S.
to occur with increasing duration of R.A. and in those
with active joint inflammation, Hoi^ever, in this study
age, age of onset, sex and sheep cell agglutination titre
do not appear to be important factors in relation to the
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development of K.C.S.
K.C.S. in rheumatoid arthritis correlates highly
with the oral manifestations of Sjogren1s syndrome
and with Raynaud's phenomenon. It does not correlate
with the presence of drug allergy.
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CHAPTER VI
ASSOCIATION OP SJOGREN•S SYNDROME AND SALIVARY
DUCT AUTOANTIBODY
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In Sjogren's disease, even in the absence of
rheumatoid arthritis or other connective tissue disease
(i.e. the sicca syndrome), there is hypergarnmaglobulinaemia
and a high incidence of abnormal immunological reactions,
such as antinuclear factors, rheumatoid factors,
precipitating antibodies to tissue constituents,
autoimmune complement-fixation tests, and passive
cutaneous anaphylaxis in guinea-pigs (Jones, 1958;
Stoltze, Hanlon, Pease and Henderson, 1960; Anderson,
Gray, Beck and Kinnear, 1961; Anderson, Gray, Beck,
Buchanan and McElhinney, 1962; Bunim, Buchanan, Wertlake,
Sokoloff, Bloch, Beck and Alepa, 1964| Beck, Anderson,
Bloch, Buchanan and Bunim, 1965? Bloch, Buchanan, Wohl
and Bunim, 1965)* In addition to these non-organ
specific reactions, the prevalence of low titre thyroid
auto-antibodies is slightly higher than expected
(Anderson, Goudie, Gray and Buchanan, 1961; Bloch and
others, 1965) and gastric parietal cell auto-antibodies
with chronic atrophic gastritis show a higher prevalence,
at least in patients studied in Glasgow (Buchanan, Cox,
Harden, Glen, Anderson and Gray, 1966). These serum
factors indirectly favour the view that Sjogren's
disease may have an autoimmune basis.
Bertram and Halberg (1964) and Halberg, Bertram,
S^borg, and Nerup (1965) reported the demonstration by
immunofluorescence of antibody against salivary duct
epithelium in eleven of nineteen patients with Sjogren's
disease, and they considered that the antigen might be
organ specific, i.e. peculiar to salivary tissue.
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The incidence of this salivary duct antibody (SDA) in
groups of patients with the sicca syndrome (Sc), patients
with Sjogren's disease complicated by rheumatoid
arthritis (Sj-RA), patients with rheumatoid arthritis
alone (RA) and patients with various other arthritides
is recorded in the first part of this chapter.
Waterhouse and Doniach (1966) demonstrated focal
lymphocytic sialadenitis in 16 of 17 patients with
rheumatoid arthritis examined at post mortem. The
possibility, therefore, exists that any salivary duct
auto-antibody found in uncomplicated rheumatoid
arthritis may reflect a subclinical form of Sjogren1s
syndrome. Since biopsy of the major salivary glands
is not without risks, and since the labial mucosal
glands are frequently involved in Sjogren's syndrome
(Bloch and colleagues, 19^5} Chisholm and Mason, 1968)
it is of interest to study the association between focal
lymphocytic sialadenitis of the labial glands and
salivary duct auto-antibody in the serum of patients
with Sjogren's syndrome, rheumatoid arthritis or other
arthritides and connective tissue diseases. The
results of this investigation are recorded in the
second part of this chapter.
INCIDENCE OF SALIVARY DUCT ANTIBODY IN VARIOUS CONDITIONS




Male Female Mean Range No. Per cent.
Sicca Syndrome 13 1 12 64 53-78 2 15
Sjogren's Disease with Rheumatoid Arthritis. . 17 4 13 55 29-81 11 65
Rheumatoid Arthritis 129 54 75 48 6-73 34 26
Systemic Lupus Erythematosus 4 4 35 20-60 1 25
Psoriatic Arthritis 9 i 8 49 20-65 - --
Reitcr's Syndrome 9 9 — 35 19-45 2 22
Ankylosing Spondylitis 1 1 - 43 - - -
Gout 6 4 2 58 36-83 - -
Osteo-arthritis 43 12 31 58 23-78 — —
Table VI, 1
PilT. VI, 1(a)
Pl^# VI,1(b) Salivary duct autoantibodyt





OCCURRENCE OF ANTIBODY TO SALIVARY DUCT EPITHELIUM




231 patients were studied. The clinical diagnosis,
sex distribution, mean age, and age range are shown in
Table VI,1. The diagnosis of Sjogren's disease was ,
based on the criteria described in Chapter I and
patients were required to show at least two of the three
major components of the syndrome. The diagnosis of
rheumatoid arthritis was based on the criteria of the
American Rheumatism Association (Ropes, Bennett, Cobb,
Jacox and Jessar, 1958).
Ophthalmological Examination
This was performed by the method described in
Chapter II. For the purposes of this study a diagnosis
of "definite" keratoconjunctivitis sicca was made when
on two occasions the Schirmer II test showed wetting
less than 15 mm. and the Rose Bengal dye test showed
at least scattered staining of the conjunctivae and
corneae. Patients with "possible" keratoconjunctivitis
sicca had a Schirmer II of less than 15 mm. of wetting
but no evidence of punctate or filamentary keratitis.
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Each patient was carefully questioned regarding a
history of xerostomia and of associated oral and
pharyngeal symptoms of Sjogren's disease (Bloch and
others, 196f>)« Salivary flow studies were performed
using a modified Carlson-Crittenden cup with an outer
chamber diameter of 20 ram. and an inner chamber diameter
of 10 ram. Parotid saliva was collected from each
patient under resting condition and after stimulation
with fruit gums and lemon juice.
Many patients admitted to having a dry mouth
(symptomatic xerostomia) but without experiencing
insufficiency of saliva and/or difficulty in mastication,
or requiring increased fluid intake. Their mouths
appeared to be moist and salivary flow studies on a
sample of them were within the normal range.
Sialography was performed on all the 231 patients,
using the hydrostatic technique described by Park and
Mason (1966). The criteria of abnormality in the
sialograms were based on those described by Bloch and
others (1965)*
Other Clinical and Laboratory Data
In addition to the age and sex of the patient and
the ophthalmological and oral examinations described,
the following clinical facts were recorded:
Duration of arthritis, presence of subcutaneous
nodules, functional grade, and x-ray classification
(Steinbrocker, Traeger and Batterman, 19^9)*
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Laboratory investigations includedi
Haemoglobin concentration, erythrocyte sedimentation
rate (westergren), white cell count, and assay of serum
globulin.
Serological Methods
Salivary Duct Antibody (SDA) - Blocks of human
submandibular gland obtained at autopsy not more than
10 hours after death were frozen on to metal chucks
with CO^ snow and 6\i sections were cut in a cryostat.
The sera were applied undiluted to the unfixed section
for 30 minutes at room temperature. After washing in
normal saline buffered with veronal (pH 7*2) for 10
minutes, fluorescein-conjugated goat anti-human globulin
serum was applied for 30 minutes. After a final 10
minutes wash in buffered saline the sections were
mounted in buffered glycerol and examined with a Oillett
and Sibert conference microscope using blue light. To
reduce non-specific fluorescent staining, the fluorescein-
conjugated anti-human globulin serum was absorbed twice
with dried rat liver powdcnr.
Antinuclear Factor (ANF) was detected using the
indirect fluorescence method described by Beck (1961)
with rat liver as substrate. The sera were initially
tested at a dilution of 1 in 16 and positive sera were
then titrated in quadrupling dilutions till an end point
of nuclear staining was obtained.
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Anti-thyroglobulin was detected by the tanned red
cell haemagglutination test described by Fulthorpe,
Roitt, Doniach and Couchman (1961)» using thyroglobulin-
coated formolized tanned sheep red cells (Burroughs
Wellcome). The sera were initially tested at a dilution
of 1 in 16 and positive sera were titrated in quadrupling
dilutions*
Thyroid "Microsomal* Antibody was detected by the
indirect immunofluorescence technique described by
Holborow, Brown, Roitt and Doniach (1959)» using unfixed
thyrotoxic thyroid tissue as substrate and with the test
sera diluted 1 in 4.
Gastric Parietal Cell Antibodies were demonstrated
by an indirect immunofluorescence technique (Adams, Glen,
Kennedy, Mackenzie, Morrow, Anderson, Gray and Middleton,
1964), using unfixed human gastric mucosa as substrate
and testing the sera undiluted.
In the tests for SDA a highly reactive fluorescein-
conjugated goat anti-human globulin provided by Dr. J.S.
Beck was used, while in the other immunofluorescent tests
eommerically available fluorescein-conjugated rabbit
anti-human globulin (Burroughs Wellcome) was used.
Rheumatoid Factor was determined by the Hyland
latex (RA) test technique (Hyland Laboratories,
(California). All sera were screened at a dilution of
1 in 32 and the presence of agglutination was recorded
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15 and ^5 seconds after mixing the reagents.
Agglutination at either 15 or h5 seconds was recorded
as positive. Positive sera were then titrated in
doubling dilutions.
Non-specific Tissue Precipitin Tests were performed,
using the method described by Anderson, Gray and others
(1961) with human thyroid tissue as antigen. All
specimens were tested undiluted and at a dilution of 1
in 8.
Results
Figure VI,1 shows positive and negative staining of
salivary duct epithelium. Positive imrnunofluorescent
staining varied in intensity, but even with the brightest
staining pattern it was found that the antibody was
present in low titre, none exceeding 1 in JZ»
2
In the following statistical analysis X has been
calculated (when appropriate) using Yates's correction
for small numbers. Comparisons which do not yield
statistically significant differences are not discussed.
Whole Series 1 Incidence of SDA in Various
Conditions (Table VI,1)
In patients with Sc, the antibody was found in only
two of thirteen (15 por cent). In contrast, the
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Subcutaneou Nodules — — 3 3
± Standard deviation
Table VI,2
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Rheumatoid Factor Positive 1 6 8 6
Antinuclear Factor Positive 1 3 2 6
Non-specific Tissue Precipitin Positive 0 4 2 1
Thyroglobulin Antibody 0 3 3 1
Thyroid Microsomal Antibody 1 5 3 2




antibody was present in eleven of seventeen patients (65
per cent) with Sj-RA. In the RA group 34 of 129 patients
(26 per cent) had SDA in their serum, an incidence not
differing significantly from that found in the Sc group,
p
but lower than that in the Sj-RA group (X-^ = 12,23;
P < 0.001).
Of the various other groups examined, one of the
four patients with systemic lupus erythematosus and two
of nine males with Reiter's syndrome had SDA.
The patient with systemic lupus had definite
keratoconjunctivitis sicca, severe xerostomia with
objective evidence of reduced salivary flow rate,
punctate sialectasio and intermediate duct changes on
sialography, and a history of intermittent parotid
swelling. Of the two patients with Reiter's syndrome,
one had definite keratoconjunctivitis sicca, but no
other stigmata of Sjogren's disease were found.
None of the 43 patients with osteoarthritis was
found to have SDA.
Sc and Sj-RA Groups (Tables VI,2 and 3)
Patients with Sj-RA had SDA more often than did
those with Sc (X^ = 5*43; P < 0.02). The two groups
also differed in that the Sc patients were older (t = 3*89?
P < 0.001), and had more sialographic abnormalities
2
(X = 12.6; P < 0.001) and a lower erythrocyte
sedimentation rate (t = 3*47, P < 0.001). In Sj-RA
there was a negative correlation between SDA and ANF
(X2 « 8.24; P < 0.01).













Sex I6F, I8M 57F, 38M
—
"Possible" Keratoconjunctivitis Sicca 15(44%) 20 (21 %) X, = 6-67PCO-01
Symptomatic Xerostomia 14(41%) 9(9%) *• = 1718P<0 001

























Subcutaneous Nodules 7 (21 %) 12(13%)
± Standard deviation
Table VI,4
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P<0 001














Rheumatoid Factor Positive 29 (85 -3%) 43 (45 2%) x'= 16-27
P<0-00I
Anti-nuclear Factor Positive 13(38%) 20 (21%) —
Non-specific Tissue Precipitins Positive 1 (3%) 4(4%) —
Thyroglobulin 3(9%) 7(7%) —
Thyroid Microsomal Autoantibody 8(23%) 17(18%) —
















S D A positive
S D A negative
<32 32 64 128 256 512 1024 2048
Reciprocal of titre of rheumatoid factor
Histogram showing percentage of cases positive for rheuma¬
toid factor in patients with rheumatoid arthritis with or without
salivary duct antibody
Fig. VI,2
"POSSIBLE" KERATOCONJUNCTIVITIS SICCA, SYMPTOMATIC XEROSTOMIA. AND ABNORMAL SIALOGRAMS IN






No. of Patients .. 129 34 95 67
"Possible" Kerato-Conjunctivitis Sicca 35 (27%) 15(44%) 20 (21%) 20 (30%)
Symptomatic Xerostomia 23 (27%) 14 (41 %) 9(9%) 12(18%)
Abnormal Sialogram 7(5%) 4(12%) 3(3%) 4(6%)
•Other ardiritides psoriatic arthritis, Reiter's syndrome, ankylosing spondylitis, gout, and osteo-arthritis.
Table VI,6
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RA Group (Tables VI,4 and 5 j Fig. VI,2)
SDA was found significantly more frequently in
older rheumatoid patients and in those with more severe
rheumatoid disease as judged by functional grade, x—ray
stage, erythrocyte sedimentation rate, and the
prevalence of rheumatoid factor. As shown in Fig. VI,2,
the prevalence of rheumatoid factor for all titres
except 1 in as well as the highest titres were seen
in SDA positive patients.
A higher incidence of "possible" keratoconJunetivitis
sicca and of symptomatic xerostomia was found in those
with SDA. Table VI,6 compares the frequency of
"possible" keratoconjunctivitis sicca, symptomatic
xerostomia, and abnormal sialograms in rheumatoid
patients and in those with other rheumatic diseases —
psoriatic arthritis, Heiter's syndrome, ankylosing
spondylitis, gout, and osteoarthritis. There is no
significant difference. The sub—group of rheumatoid
patients with SDA had symptomatic xerostomia more
frequently than other patients (X = 6.4; P < 0.01).
Comparison of Sj—RA and RA Groups
Among all the patients with rheumatoid arthritis,
Sj—RA was found in those who were older (t = 2.1$
P < 0.05), had had their arthritis for a longer period
(t = 1.98; P < 0.05), and had more severe rheumatoid
disease as judged by the erythrocyte sedimentation rate
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(t » 3*5| P < 0.02) and the presence of subcutaneous
2
nodules (X » 4.5; P < 0.05). The Sj-RA group also
had a higher prevalence of SDA (X^ * 12.23; P < 0.001)
2
and of rheumatoid factor (X « 4.37; P < 0.05).
Similarly, when Sj-RA patients were compared with
SDA-positive RA patients, the former were shown to have
had their arthritis longer (t * 1.73; P < 0.05) and to
have a higher erythrocyte sedimentation rate (t = 2.4;
P < 0.02). No age difference was, however, found.
Discussion
Bertram and Halberg (1964) first described the
occurrence in Sjogren*s disease of an antibody against
salivary duct epithelium. Since sera containing the
antibody did not give immunofluorescent staining of
salivary gland acini or of thyroid, they considered
that the antibody might be specific for an antigen
peculiar to salivary duct epithelium. Feltkamp (1967)
has shown that the antibody could be absorbed from the
serum with extracts of salivary gland, but extracts of
a number of other tissues, including thyroid, liver,
and kidney, failed to do so.
This study shows that the antibody reacts with the
individual's own tissues (i.e. it is an auto-antibody)
and also causes immunofluorescent staining of small
lacrimal ducts, but not of gastric, thyroid, or
prostatic epithelium. The mitochondral antibody found
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in a high percentage of patients with primary biliary
cirrhosis (Walker, Doniach, Roitt and Sherlock, 19*>5f
Goudie, MacSween and Goldberg, 1966) gives an
immunofluorescent staining pattern with salivary gland
similar to that seen with SDA positive sera.
Preliminary experiments, however, have shown that the
SDA differs from the mitochondrial antibody in that
only the latter can be absorbed from sera with rat
liver mitochondria. The SDA thus shows some organ-
specificity, but final confirmation must await further
experimental investigation.
The present studies have found SDA in 15 per cent
of patients with Sc, but in 65 per cent of patients with
Sj—RA. In RA the incidence of the antibody was 26 per
cent. In none of the large series of patients with
osteoarthritis was the antibody present. The antibody
is thus not peculiar to Sjogren*s disease. It is most
commonly found in Sj-RA, and in one in seven of Sc
patients. These observations suggest that the antibody
is in some way related to the rheumatoid disease process,
whether or not there be clinical evidence of salivary
gland involvement. This is further emphasized in that,
among RA patients, SDA was found significantly more
frequently in older patients and those with more severe
rheumatoid disease. Furthermore, Sj-RA also occurred
in patients who were older, had had their arthritis
longer, and had more severe rheumatoid disease.
Circumstantial evidence of lacrimal and salivary gland
involvement by the rheumatoid process was provided by
COMPARISON OF SICCA SYNDROME (Sc) WITH SJOGREN'S DISEASE WITH RHEUMATOID ARTHRITIS (Sj-RA)
Bloch and others (1965) and Bunim and others (1964)
Diagnosis Sc Sj-RA Reference
Serum Globulin (g./lOO ml.) Mean 4 4 3 6 Bloch and others (1965)
Range 2-8-68 2-0-5-7
Antinuclear Factor 14/16(88%) 14/25 (56%) Bloch and others (1965)
Pattern of Nuclear Fluorescence Staining . . Homogeneous 7/16 8/18 Bloch and others (1965)
Speckled 5/16 2/18
Nucleolar 5/16 0/18
Auto-immune Complement-Fixation Test 15/19 5/26 Bloch and others (1965)
Precipitating Autoantibodies 13/16 1/18 Bloch and others (1965)
Anti-Gm Factors 4/20 14/27 Bunim and others (1964)
Reticulum Cell Sarcoma 4/23 0/32 Bloch and others (1965)
Numerator -- number of patients with positive teats
Denominator -number of patients tested
Table VI,7 Resume of previous studies.
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the significantly higher incidence of "possible"
keratoconjunctivitis sicca and of symptomatic xerostomia
noted in the SDA positive RA patients as compared with
the RA patients without the antibody. This might
suggest that a subclinical form of Sjogren's disease
was present in the SDA positive RA patients.
Histological evidence of salivary gland involvement
in rheumatoid arthritis was provided by Waterhouse and
Doniach (1966), who found focal lymphocytic sialadenitis
in all of twelve females and in four of five males with
rheumatoid arthritis. They considered the salivary
lesion regularly found in rheumatoid arthritis to be
Sjogren's disease in miniature. It is thus perhaps not
entirely surprising that, in rheumatoid arthritis,
without clinical evidence of salivary or lacrimal gland
involvement, there should be a high incidence of
salivary duct antibodies.
The finding of a significantly lower incidence of
SDA in the Sc patients than in the Sj—RA patients is of
considerable interest. The previous detailed studies
of Bloch and others (1965)* Beck and others (l965)t and
Bunim and others (1964) — summarized in Table VI,7 —
have shown differences between these two sub-groups of
Sjogren's disease. Furthermore, Talal, Leventhal and
Waldorf (1966) found that lymphocytic transformation in
response to phytohaemagglutinin and streptolysin was less
in Sj-RA than in Sc. However, with dinitrochlorobenzene
skin sensitization, these workers found that differences
between the two groups were not apparent. Reference to
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Table VI,7 shows that, with the exception of anti-Gra
factors, non—organ-specific autoantibodies have been
found to be consistently more prevalent in the Sc
patients* It is therefore surprising that in this study
in patients with Sc, which clinically appears to be an
organ-specific disease, the possibly organ-specific SDA
should be significantly less common than in the Sj-RA
patients. The number of Sc patients is small in this
series, but the findings, taken in conjunction with the
observations of other workers, clearly indicate the need
for a more detailed comparison of Sc patients and
patients with salivary and lacrimal gland involvement
accompanied by a connective tissue disorder.
Summary
(1) An immunofluorescent autoantibody to salivary duct
epithelium has been found in two of thirteen patients
with sicca syndrome, in eleven of seventeen patients with
Sjogren*s disease and rheumatoid arthritis, and in 3b
of 129 patients with uncomplicated rheumatoid arthritis.
(2) In patients with rheumatoid arthritis, the antibody
was found significantly more frequently in older patients
and in those with more severe rheumatoid disease.
(3) The antibody appears to be a manifestation of the
rheumatoid disease process, in which other workers have
shown a high incidence of chronic focal sialadenitis.
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Salivary duct autoantibody is found in approximately
15$ of patients with the sicca syndrome
(keratoconjunctivitis sicca, xerostomia with or without
salivary gland enlargement, but not rheumatoid arthritis
or other connective tissue disease), 65$ of patients with
rheumatoid arthritis and Sjogren's syndrome, and in 26%
of patients with rheumatoid arthritis alone (vide
supra). Feltkamp and Van Rossum (1968), however, found
the salivary duct autoantibody in the sera of
approximately 50$ of patients with the sicca syndrome
and also in the same number of patients with Sjogren's
syndrome with rheumatoid arthritis. The reason why
patients with rheumatoid arthritis who have Sjogren's
syndrome develop this autoantibody is unknown. However,
Waterhouse and Doniach (l966) demonstrated focal
lymphocytic sialadenitis in sixteen of seventeen
patients with rheumatoid arthritis examined at post¬
mortem. The possibility, therefore, exists that the
salivary duct autoantibody found in uncomplicated
rheumatoid arthritis may reflect a subclinical form of
Sjogren's syndrome (vide supra).
Since biopsy of the major salivary glands is not
without risks, and since the labial mucosal glands are
frequently involved in Sjogren's syndrome (Bloch et al,
1965f Chisholm and Mason, 1968), it was thought to be
of interest to study the association between focal
lymphocytic sialadenitis of the labial glands and
salivary duct autoantibody in the serum of patients with
Sjogren's syndrome, rheumatoid arthritis or other
arthritides and connective tissue diseases.
Labial mucosal lymphocytic sialadenitis and salivary duct antibody in the clinical groups studied




Sex Age (years) sialadenitis duct antibody
Male Female Mean Range No. % No. %
Sicca syndrome 10 2 8 55-9 27-66 6 600 1 100
Rheumatoid arthritis and
Sjogren's syndrome
27 6 21 60-3 48-78 17 630 19 70-4
Rheumatoid arthritis alone 47 13 34 53-2 20-73 13 27-7 21 44-6
Psoriatic arthritis 11 4 7 49-3 19-88 2 18-2 _ _
Ankylosing spondylitis 10 5 5 47-8 23-73 2 200 1 100
Reiter's syndrome 6 6 — 34-5 18-52 — — —
Still's disease 1 — 1 290
Systemic lupus
erythematosus
1 — 1 21 0
Progressive systemic
sclerosis
4 — 4 320 1OA0 1 200 — —
Gout 2 1 1 61 0 60-62 — — — —
Osteoarthritis 11 3 8 64-9 53-74 1 91 — —
Table VI,8 Occurrence of labial mucosa
sialadenitis and salivary duct antibody in
various clinical groups.
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SALIVARY DUCT AUTOANTIBODY IN SJOGREN'S SYNDROME
AND FOCAL SIALADENITIS IN THE LABIAL MUCOSA
Material and Methods
One hundred and thirty patients were included in
the study. The clinical diagnosis, age and sex
distribution are shown in Table VI,8,
Labial Mucous Membrane Biopsy
The biopsy was taken from the lower lip under
local anaesthesia (Chisholm and Mason, 1968),
Results
The histological appearances of the buccal mucous
membrane were divided into three types, (a) normal;
Fig.VI,3* (b) diffuse lymphocytic infiltration;
Fig.VI,4, and (c) a focal lymphocytic sialadenitis;
Fig.VI,5. Both diffuse and focal infiltrations could
be further subdivided into two stages, based on the
severity of the infiltrate (Chisholm and Mason, 1968).
In this way five stages of lymphocytic infiltration in
the buccal mucous membrane biopsy were identified.
Stage 0 - Normal biopsy appearance.
Fig.VI,3 Normal buccal membrane.
Fig.VI,k Diffuse lymphocytic infiltration
 
1 12
Stage I - Fine diffuse lymphocytic -infiltrate.
Stage II - Marked diffuse lymphocytic infiltrate.
Stage III - Focal infiltration of lymphocyte.
Stage IV - Very heavy focal infiltration of
lymphocytes.
Both Stage III and IV, in addition to foci of
lymphocytes showed a diffuse infiltration of lymphocytes.
In post-mortem studies, stages I and II were quite
common (Chisholm and Mason, 1968) and so these were not
included as positive in this series.
Table VI,8 shows the prevalence of salivary duct
autoantibody and focal lymphocytic sialadenitis in the
clinical groupd studied.
Salivary duct autoantibody was present in 10# of
patients with the sicca syndrome, in 70*^# of patients
with Sjogren*s syndrome and rheumatoid arthritis^ and
44.6# of patients with rheumatoid arthritis
uncomplicated by Sjogren*s syndrome. The prevalence
of salivary duct autoantibody in patients with the
sicca syndrome and Sjogren's syndrome and rheumatoid
arthritis is similar to that found in the study reported
in part one of this chapter but the prevalence of
salivary duct autoantibody in patients with rheumatoid
arthritis alone is higher (thirty-four of 129 patients,
26#).
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Of the forty-six patients with other arthritides
and connective tissue diseases only one had salivary
duct autoantibody present. This was a 63-year old
woman with definite ankylosing spondylitis and a
positive sheep cell agglutination test for rheumatoid
factor at a titre of I1256, but without clinical
evidence of Sjogren's syndrome or rheumatoid arthritis.
The prevalence of labial focal lymphocytic
sialadenitis was the same in patients with sicca syndrome
and Sjogren's syndrome and rheumatoid arthritis (60 and
63$, respectively). The prevalence in rheumatoid
arthritis alone was 27.7$*
Two patients with psoriatic arthropathy had focal
lymphocytic sialadenitis, but neither had salivary duct
autoantibody. One of these patients had 'possible*
keratoconjunctivitis sicca.
Two patients with ankylosing spondylitis had focal
lymphocytic sialadenitis, and one of these, mentioned
above, had salivary duct autoantibody present. Neither
of these two patients had any evidence of Sjogren's
syndrome.
Of the four patients with progressive systemic
sclerosis one had focal lymphocytic sialadenitis, but
no evidence of Sjogren's syndrome.
One patient with osteoarthritis had a positive
buccal mucosal biopsy and had evidence of 'possible'
keratoconjunctivitis sicca. No salivary duct
autoantibody was detected in this patient's serum.
The relationship of the salivary duct autoantibody









































































































Laboratory and immunological features of patients with rheumatoid arthritis
Present Absent Significance































Salivary duct antibody 5 (38 5%) 16 (47-1%) —
Rheumatoid factor 13(100%) 29 (85-3%) —
Antinuclear factor 7 (53 8%) 6(17-6%) P < 0-02
Non-tissue specific precipitating
autoantibody
3 (231%) 2 (5-9%) —
Thyroglobulin autoantibody 5 (38 5%) 6 (17-6%) —
Thyroid microsomal autoantibody 4 (30 8%) 7 (20-6%) -
Gastric parietal cell autoantibody 2(15-4%) 9 (26-5%)
Table VI, 11
m
and other autoantibodies and laboratory data in patients
with the sicca syndrome, Sjogren's syndrome and rheumatoid
arthritis, and rheumatoid arthritis alone is shown in
Tables V.I,9-11» It can be seen that in none of these
three groups did the salivary duct autoantibody
correlate with focal lymphocytic sialadenitis. None
of the other autoantibodies including rheumatoid and
antinuclear factors, non—tissue specific precipitins,
anti-thyroglobulin, anti-thyroid 'microsomes' and
gastric parietal coll autoantibodies correlated with
focal lymphocytic sialadenitis in any of the three
clinical groups, with the exception of the antinuclear
factor in patients with rheumatoid arthritis (Table VI,1l)
(P < 0.02). None of the other laboratory features
correlated with the finding of focal lymphocytic
sialadenitis in patients with Sjogren's syndrome whether
associated with rheumatoid arthritis or not. In
patients with rheumatoid arthritis alone the
haemoglobin (P < 0.001) and white cell count (P < 0.02)
were significantly lower in patients with focal
lymphocytic sialadenitis and the erythrocyte
sedimentation rate was significantly higher (P < 0.001).
Discussion
Sjogren's syndrome is a chronic benign disorder
which is characterized by chronic inflammatory changes,
not only in the lacrimal and major salivary glands, but
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also in the small mucus—secreting glands of" the
conjunctiva, mouth, nasal passages, pharynx, trachea
and bronchi and also in the sweat glands (Bloch et al,
1965)* In this study biopsy of the labial mucous
membrane has been used to investigate the relationship
of salivary duct autoantibody to focal lymphocytic
sialadenitis of the oral mucosa in patients with
Sjogren*s syndrome with or without rheumatoid arthritis,
rheumatoid arthritis alone, and other arthritides and
connective tissue disorders.
Salivary duct autoantibody was present in only one
of ten patients with the sicca syndrome (Sjogren*s
syndrome uncomplicated by rheumatoid arthritis or other
connective tissue disease), although six had focal
lymphocytic sialadenitis on labial mucosal biopsy. In
contrast, nineteen of the twenty-seven patients (70,*t$)
with rheumatoid arthritis and Sjogren's syndrome had
salivary duct autoantibody, although the prevalence
of focal lymphocytic sialadenitis in this group was the
same as in patients with the sicca syndrome. This
suggests that dalivary duct autoantibody may be a
manifestation of Sjogren's syndrome associated with
rheumatoid arthritis rather than a reflection of
Sjogren*s syndrome per se. This conclusion is
supported by the finding of a very high prevalence of
salivary duct autoantibody in patients with rheumatoid
arthritis alone (twenty-one of forty-seven, bh,6$>) and
the comparatively low prevalence of focal lymphocytic
sialadenitis in this group (thirteen of forty-seven,
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27.7*). Ibis high incidence of the salivary duct
autoantibody probably represents a selection bias.
Fux-thermore, there was a complete lack of correlation
between salivary duct autoantibody and focal lymphocytic
sialadenitis in patients with the sicca syndrome,
Sj/£gren*s syndrome with rheumatoid arthritis, and
rheumatoid arthritis alone. These findings are in
agreement with those of Bertram (19&7) who performed
palatal biopsies on eight patients with Sjogren's syndrome,
six (75*) of whom had heavy lymphocytic and plasmacytic
infiltrates and occasional myoepithelial cell islands.
Of these six patients only two had salivary duct
autoantibody present in their serum.
It may be argued that the lack of correlation
between the salivary duct antibody and lymphocytic
sialadenitis may have been due to a sampling error, the
changes in the labial mucosa being patchy rather than
generalized. However, in twelve post-mortem specimens,
identical changes were found when biopsies were taken
from both sides of the mouth. It is also possible that
biopsy of the major salivary glands may have shown a
correlation, but it is not feasible to carry out biopsy
of these glands during life since the procedure carries
definite risk of injury to the facial nerve, and of
salivary fistulae, as well as leaving the patient with
a scar. However, in post—mortem studies performed by
Chisholm and Waterbouse (1968) a positive correlation
between the findings in the submandibular and labial
minor salivary glands could be made (P < 0.01).
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The salivary duct antibody reacts with the
epithelial cytoplasm of* the lacrimal and salivary glands
and has been shown to have autoreactivity in one case
above (page 103) and in a further two cases in this
series. It has been shown by Feltkamp and Van Rossum
(1968) to be absorbed by extracts of salivary tissue but
not by extracts of human pancreas, liver, thyroid,
adrenal or muscle. The apparent organ-specificity of
the antibody, therefore, corresponds to the occurrence
of inflammatory lesions in lacrimal and salivary gland
in Sjogren's syndrome. Nevertheless, from the present
findings, salivary duct antibody appears to be an
epiphenomenon associated with the pathological changes
of Sjogren's syndrome complicating rheumatoid arthritis
rather than with Sjogren's syndrome occurring alone.
Summary
No correlation between the occurrence of the
salivary duct antibody and focal lymphocytic sialadenitis
in the labial mucosa was found in ten patients with the
sicca syndrome, twenty-seven patients with Sjogren's
syndrome and rheumatoid arthritis, and forty-seven
patients with rheumatoid arthritis alone. No correlation
between the variables was found in any of the groups
examined. Post-mortem studies on the labial mucosal
biopsy show that the results of biopsy are reproducible,
and so the lack of correlation is not due to sampling
118
error when the biopsy is taken. It is suggested that
the salivary duct antibody is an epiphenomenon of
rheumatoid arthritis rather than a manifestation of
Sjogren's syndrome per se.
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CHAPTER VII
ASSOCIATION OF SJOGREN'S SYNDROME AND
AUTO-IMMUNE THYROID DISEASE, PERNICIOUS
ANAEMIA AND IDIOPATHIC ADDISON*S DISEASE
Fig. VII,1 Xk Magnification of section of thyroid
gland in Hashimoto's thyroiditis
Fig. VII,2 X10 Magnification, Hashimoto's
thyroiditis.
Compare with Figs.III, Chapter III
lymphocytic infiltration, destruction of acini,
irregularity of duct system similar to that seen
in severe chronic inflammation (Stage II) of the
lacrimal gland in Sjogren's syndrome.
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ASSOCIATION OF SJOGREN*S SYNDROME AND
AUTO-IMMUNE THYROID DISEASE
Anderson, Gray, Beck and Kinnear (1961); Bunim
(1961); Bloch and Bunira (1963)? Anderson, Beck, Bloch,
Buchanan and Bunim (1965)* have shown that the
prevalence of thyroglobulln autoantibodies is increased
in patients with Sjogren's syndrome, but the
corresponding prevalence of Sjjfgren*s syndrome in
patients with auto-immune thyroid disease has not been
evaluated. The histological features of auto-immune
thyroiditis (Hashimoto*s thyroiditis, and spontaneous
myxoedema) and those of the lacrimal and salivary
glands in Sjogren's syndrome are, however, very similar,
as first noted by Hashimoto (1912) Fig,VII, 1 and 2.
For these reasons it appeared to be important to
determine whether the two conditions occur together
with significant frequency. Since thyroid
autoantibodies are also found in patients with
thyrotoxicosis (Roitt and Doniach, 1958} Buchanan,
Alexander, Crooks, Koutras, Wayne, Anderson and Goudie,
1961; Buchanan, Koutras, Crooks, Alexander, Brass,
Anderson, Goudie and Gray, 1962; Anderson, Gray,
Middleton and Young, 196*0, incidence of Sjogren's
syndrome in this disorder was also determined. In
each group of patients the incidence of Sjogren's
syndrome was compared with that in a group with simple





339 female patients comprising five groups were
examined for keratoconjunctivitis sicca; mean age and
age range are shown in Table VII,1.
Group 1 Hashimoto's Thyroiditis (83)
In five patients the diagnosis was based on
histological examination of the gland using the
criteria of Joll (1939) and in the remaining 78 on the
presence of a positive precipitin test for
antithyroglobulin autoantibodies in patients with a
euthyroid or hypothyroid state (Buchanan and others,
1961). Three of these patients were hypothyroid,
but the remaining eighty were receiving 0,2 mg. sodium
thyroxine and were euthyroid when studied. Pour had
"definite" rheumatoid arthritis by the American
Rheumatism Association criteria (Ropes, Bennett, Cobb,
Jacox and Jessar, 1958).
Group 2 Spontaneous Primary Hypothyroidism (69)
(hypothyroidism without a goitre)
The diagnosis was based on the clinical and
laboratory criteria described by Wayne (i960) and
Wayne, Koutras and Alexander (196*1). Ten patients
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were hypothyroid when examined and the remaining 59
were receiving 0,2-0.3 nig. sodium thyroxine and were
euthyroid. Four had "definite" rheumatoid arthritis
by the American Rheumatism Association criteria (Ropes
and others, 1958).
Group 3 Thyrotoxicosis (68)
21 patients had become hypothyroid following
131
radioactive iodine ( i) therapy; twenty of them were
euthyroid at the time of examination and were receiving
0.2-0.3 mg. sodium thyroxine per day and the other was
hypothyroid. The remaining 1*7 were euthyroid
following antithyroid drug therapy, subtotal
131
thyroidectomy, or I therapy.
Group 4 Simple Goitre (46)
All these were euthyroid, and none had systemic
disease.
Group 5 Hospital Controls (72)
These were all women attending as outpatients at
the clinics associated with the Western and Royal
Infirmaries, Glasgow. They had a variety of general
medical conditions, none of which, however, had any




Autoantibodies to thyroglobulin were tested by a
precipitin test using the Ouchterlony-Elekplate
technique (Anderson, Buchanan, Goudie and Gray, 1962)
and by the tanned red cell haemagglutination test
using thyroglobulin-coated formalized tanned sheep red
cells (Burroughs Wellcome), (Fulthorpe, Roitt, Doniach
and Couchman, 1961). The lowest serum dilution used
in the tanned red cell haeraagglutination test was 1 in
16. Autoantibody to thyroid "microsomes" was measured
by an immunofluorescence technique on unfixed frozen
sections of thyroid slices (Holborow, Brown, Roitt and
Doniach, 1959)» using test serum diluted one in four in
the first layer.
Sialography
This was performed in 109 patients, 41 with
Hashimoto's thyroiditis, 32 with primary hypothyroidism,
and 36 control subjects. A hydrostatic technique was
employed, using Triosil "45" (sodium roetrizoate) as a
contrast medium. Apparatus consisting of a 20 ml.
glass syringe, polythene tubing, and a tapered catheter
was used to convey the contrast medium to the duct and
gland. The glass syringe was set at a fixed height
above the patient's head (70-90 cm.). The contrast
medium flowed into the gland using only the force of
gravity and therefore a relatively constant pressure
Fig. VII,3(a) Sialogram showing normal pattern during
injection phase
Fig. VII,3(b) Punctate sialectasis













was obtained (Park and Mason, 1966). This method
rarely led to over—filling and was less painful for the
patient. The water-soluble contrast medium is rapidly
expelled from the gland and therefore a secretory phase
film was exposed 5 minutes after the filling phase was
complete. Between the two phases, the patient was
asked to suck a slice of lemon to stimulate salivary
flow (Pig.VII,3).
Results
The results of the ophthalmological examination
are summarized in Table VII,1 and in histogram form in
Fig.VII,4. Only a small minority in each group had
definite keratoconjunctivitis sLcca. The highest
prevalence was found in Group 3» treated
thyrotoxicosis (8.6 per cent), but this was not
significantly different from that in Group 5» hospital
controls (6.9 per cent). The 43 patients treated
131
with I therapy were reassessed separately
(Table VII,2). Six of those with keratoconjunctivitis
sicca came from this group and none of the remaining
25 treated by drugs and/or surgery had
keratoconjunctivitis sicca. No correlation was,
however, found between the presence of
keratoconjunctivitis sicca and the number of doses,
1 31














































































































































None of the 83 patients with Hashimoto*s
thyroiditis and none of the four with primary
hypothyroidism plus rheumatoid arthritis had
keratoconjunctivitis sicca. None of the five patients
with Hashimoto's thyroiditis in whom the diagnosis was
confirmed by biopsy had keratoconjunctivitis sicca.
Abnormal sialograms were found in eighteen casest
seven (t6 per cent) of the 41 patients with Hashimoto's
thyroiditis, five (16 per cent) of the 32 with primary
hypothyroidism, and in six (16 per cent) of the 36 in
the hospital control group (Table VII,3)• Only two
patients with Hashimoto's thyroiditis showed globular
sialectasis, the remaining patients having only minor
abnormalities consisting of punctate sialectasis with
or without intermediate duct changes. Mild xerostomia
was found in sixteen of these eighteen patients. None
had a history or clinical evidence of salivary gland
enlargement. Two of the hospital control subjects
had unexplained xerostomia but normal sialograms. None
of the patients with Hashimoto's thyroiditis or with
primary myxoederaa who had rheumatoid arthritis had
xerostomia or abnormal sialograms.
Discussion
This study shows no increased prevalence of
keratoconjunctivitis sicca in patients with proven
auto-immune thyroid disease (Table VIX,1). The
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prevalence is higher than in Sjogren*s original series
of 19 cases which were distributed among 36,000 hospital
patients (Sjogren, 1933) and de Roetth's group of
ophthalmic control patients where there was 0.2 per
cent of cases in 6,200 patients (de Roetth, 19^5).
However, in neither series was the age and sex
distribution of the patients recorded.
The number of patients with xerostomia and
sialographic abnormalities consistent with Sjogren*s
disease affecting the parotid glands was also no
higher in the groups with Hashimoto's thyroiditis and
primary hypothyroidism respectively than in the hospital
control group (Table VII,3).
The prevalence of keratoconjunctivitis sicca in
patients with thyrotoxicosis (8.6 per cent) was higher,
but not significantly higher, than in the patients
with simple goitre (h.3 per cent) and the hospital
controls (6.9 per cent). 6U per cent of the patients
1 31
with thyrotoxicosis received treatment with I
therapy, but no correlation was found between the
number of doses or the total amount given. It does
not appear, therefore, that radioactive iodine results
in subsequent irradiation damage to the lacrimal and
accessory lacrimal glands of the eye. It is of
interest to note, however, that irradiation parotitis
and xerostomia have been noted in patients receiving
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similar doses of I therapy for thyrotoxicosis
(Chapman and Maloof, 1955).
The prevalence of thyroglobulin autoantibodies in
131
patients with Sjogren*s syndrome is, however, increased
(Anderson and others, 1961; Bunim, 1961$ Bloch and
Bunim, 1963, Anderson and others, 1965)» and
thyroglobulin autoantibodies have also been reported
to occur with increased frequency in the connective
tissue diseases, rheumatoid arthritis (Anderson and
others, I96I; Bloch and others, 1965)» an<3 systemic
lupus erythematosus (Anderson and others, 1961; Hijmans,
Doniach, Roitt and Holborow, 1961), all of which may be
associated with established keratoconjunctivitis sicca.
The absence of an increased prevalence of
keratoconjunctivitis sicca in auto-immune thyroid
disorders in contrast to that in auto—immune systemic
disorders is consistent with the concept that auto-iraraune
thyroiditis is an organ specific disorder.
Summary
83 patients with Hashimoto*s thyroiditis, 69 with
primary hypothyroidism, and 68 with thyrotoxicosis were
examined for keratoconjunctivitis sicca. The prevalence
of keratoconjunctivitis sicca in these patients was no
higher than in, h6 patients with simple goitre and in
72 hospital controls matched for age and sex.
Sialography was performed in ^1 patients with
Hashimoto's thyroiditis, 23 with primary hypothyroidism,
and 36 of the hospital controls. Sialographic
abnormalities suggestive of Sjogren's syndrome were
132
found as frequently in the hospital controls as in
the patients with Hashimoto*s thyroiditis and primary
hypothyroidism.
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Association of* Sjogren's Syndrome with Pernicious
Anaemia and Idiopathic Addison's Disease
Lymphocytic infiltration of the gastric mucosa in
chronic gastritis is associated with the development of
pernicious anaemia in a proportion of cases (Anderson,
Buchanan and Goudie, 1967)* More than bO per cent of
patients suffering from pernicious anaemia can be shown
to have antibodies to gastric parietal cells (Irvine,
Davies, Delamore and Williams, 1962; Markson and Moore,
1962; Taylor, Roitt, Doniach, Couchman and Shapland,
1962; Irvine, 19^3)• It occurred to the writer that
the lymphocytic infiltration in chronic gastritis might
be similar to that found in the lacrimal and salivary
glands in Sjogren's syndrome and it is noted that a
series of patients suffering from this disease was
found to have a high incidence of autoantibodies to
gastric parietal cells (Buchanan, Cox, Harden, Glen,
Anderson and Gray, 1966). Further, patients suffering
from pernicious anaemia have a high incidence of
thyroglobulin antibodies (Irvine and others, 1962}
Markson and Moore, 1962} Taylor and others, 1962}
Doniach, Roitt and Taylor, 1963) as do patients with
Sjogren's syndrome (Anderson, Goudie, Gray and
Buchanan, 19615 Bloch, Buchanan, Wohl and Bunim, 1965).
It was, therefore, important to determine the
incidence of Sjogren's syndrome in patients suffering
from proven pernicious anaemia.
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In idiopathic Addison's disease there is atrophy of
both adrenal cortices with loss of most of the cortical
cells, lymphocytic and plasma cell infiltration and
minimal fibrosis. Chronic thyroiditis, which
demonstrates similar histological changes, is present
in approximately 50 per cent of patients with idiopathic
Addison's disease examined at post mortem (Wells, 1930;
Sloper, 1953; Bloodworth, Kirkendall and Carr, 195*0#
Primary myxoederaa has occurred with idiopathic Addison's
disease with sufficient frequency to warrant the term
Schmidt's syndrome (Schmidt, 1926). In addition, the
chronic thyroiditis found in idiopathic Addison's
disease is associated with thyroid microsomal antibodies
in about 30 per cent of the patients studied (Blizzard
and Kyle, 1963; Irvine, 1963) and thus is probably of
the auto-immune type. Pernicious anaemia has been
reported in idiopathic Addison's disease (Blizzard and
Kyle, 1963; Irvine, 1963; Kra and Barile, 1964).
Gastric mucosa biopsies reveal a high incidence of
chronic gastritis in patients with idiopathic Addison's
disease (Peyrter and Klima, 1952; Smith, Delamore, Wynn
and Williams, 1961). Furthermore, gastric parietal
cell antibodies are more prevalent in idiopathic
Addison's disease than in tuberculous cases (Irvine,
1963)* There is, therefore, strong evidence, clinical,
histological and immunological, pointing to an association
between idiopathic Addison's disease, chronic thyroiditis
and chronic gastritis (which of course predisposes to
pernicious anaemia).
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Antibodies to salivary duct epithelium have been
reported in patients with idiopathic Addison's disease
(Blizzard and Kyle, 1963) and similar antibodies have
been detected in Sjogren patients (Bertram and Halberg,
1964} Halberg, Bertram, S^borg and Nerup, 1965?
MacSween, Goudie, Anderson, Armstrong, Murray, Mason,
Jasani, Boyle, Buchanan and Williamson, 1967)*
The second purpose of this investigation, therefore,
was to determine the prevalence of Sjogren's syndrome
in patients suffering from idiopathic Addison's disease.
Materials and Methods
Patients
169 patients (120 female, 49 male) comprising
three groups, pernicious anaemia, idiopathic Addison's
disease and hospital controls, were included in the
survey (the mean age and age range are shown in
Table VII,4). All of the patients were examined for
evidence of keratoconjunctivitis sicca. The patients
in the first two groups had been investigated as
Inpatients. Together with the help of the original
case records and further specific examinations, evidence
of rheumatoid arthritis, thyroid disease and salivary
duct atrophy was collected. Most of the hospital
control patients were attending as outpatients and were




77 patients (UO female, 37 male) had pernicious
anaemia. Pour of these had rheumatoid arthritis by
the American Rheumatism Association criteria (Ropes,
Bennett, Cobb, Jacox and Jessar, 1958). Two patients
had Hashimoto's thyroiditis (Buchanan, Alexander, Crooks,
Koutras, Wayne, Anderson and Goudie, 1961) and one
idiopathic Addison's disease (Anderson, Buchanan and
Goudie, 1967)« One patient had thyrotoxicosis as well
as rheumatoid arthritis and another had thyrotoxicosis.
Group 2
Idiopathic Addison's Disease, (primary adrenal
atrophy) (20 patients, 15 male, 5 female). The
diagnosis was based on the exclusion of obvious causes,
e.g. tuberculosis for extensive and irreversible
destruction of the cortex of the adrenal glands
(Anderson, and others, 1967) and on the detection of
antibodies to adrenal cortical cells (Anderson, Goudie,
Gray and Timbury, 1957; Blizzard and Kyle, 1963;
Goudie, Anderson, Gray and Whyte, 1966).
Group 3
Hospital Controls (72). These were female patients
attending clinics associated with the Western and Royal
Infirmaries, Glasgow. None cf the variety of general
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medical conditions from which they suffered had any
known association with pernicious anaemia, thyroid
disease or auto-iramune disorders.
Methods
Antibodies to Parietal Cells were tested using
the indirect immunofluorescence technique for the
detection of gastric autoantibodies. Antigen was
prepared from frozen unfixed sections of normal gastric
fundal mucosa (Taylor and others, 1962).
Autoantibodies to Thyroglobulin were tested by a
precipitin test using the Ouchterlony-Elekplate
technique (Anderson, Buchanan, Goudie and Gray, 1962)
and by tanned red cell haemagglutination test using
thyroglobulin-coated formalized tanned sheep red cells
(Burroughs Wellcome), (Fulthorpe, Roitt, Doniach and
Couchman, 1961). Autoantibody to thyroid microsomes
was measured by an immunofluorescence technique on
unfixed frozen sections of thyroid slices (Holborow,
Brown, Roitt and Doniach, 1959)*
Other Laboratory Data
Rose Waaler, Latex particle and haemoglobin tests
were recorded in the patients suffering from pernicious
anaemia.
Sialography was performed on four patients who gave
a history of dryness of the mouth and throat and who had







Fig*VII,5Keratoconjunctivitissiccaiper i iousanaemiad Addison'sdisease
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Results
The results of the examination for
keratoconjunctivitis sicca are summarised in Table VII,k
and in histogram form, Fig.VII,5. A small number of
patients in Group 1, pernicious anaemia, and Group 3»
hospital controls, were suffering from
keratoconjunctivitis sicca. Although the incidence
of the ocular disease was higher in Group 1 than Group
3 the difference was not significant.
None of the patients with idiopathic Addison's
disease had keratoconjunctivitis sicca.
Four of the patients with pernicious anaemia had
xerostomia but normal sialograms.
Table VII,5 summarises the principal findings in
those patients who had pernicious anaemia and evidence
of Sjogren's syndrome. Four of the patients had
evidence of involvement in other diseases. Patient one
had rheumatoid arthritis, patient two xerostomia and
Hashimoto's thyroiditis, patient three Hashimoto's
thyroiditis and idiopathic Addison's disease and
patient four xerostomia. Three other patients had
pernicious anaemia and rheumatoid arthritis but no
evidence of keratoconjunctivitis sicca. One of the
patients with pernicious anaemia and rheumatoid
arthritis also suffered from thyrotoxicosis.
Age(yrs)
Schirmer'stest(m .at5minutes)


















































































































TableVII,5Summaryofcoexistingdiseaseinth8pati ntssuf eringfr perniciousa aemiandkeratoconjunctivitissi
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Other Investigations
A family history of pernicious anaemia was obtained
from 14 of the 77 patients (18.2 per cent) suffering
from this disease and a history of thyroid disorders in
8 (10.4 per cent). There was no history of pernicious
anaemia or thyroid disease in the families of those
suffering from idiopathic Addison's disease.
25 of the 77 pernicious anaemia patients (32.4 per
cent) had palpable thyroid glands. In 20 patients the
glands were soft, in 5 firm. Five of the patients with
pernicious anaemia had proven thyroid disease; two had
Hashimoto's thyroiditis, two thyrotoxicosis and one
primary tnyxoedema.
Laboratory Data
All of the patients with pernicious anaemia were
receiving Cytamen injections, the current mean
haemoglobin being 11.5 ± 2.1 gm./lOO ml. Antibodies
to gastric parietal cells were detected in the sera of
35 of 46 patients (77 per cent), antibodies to thyroid
microsomes in 18 of 46 patients (39 per cent) and anti-
thyroglobulin antibodies were observed in 13 of 46
patients (28 per cent) suffering from pernicious anaemia.
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Discussion
This study, like the previous one concerning
Sjogren*s syndrome and thyroid disease, shows no
increased prevalence of keratoconjunctivitis sicca in
patients suffering from pernicious anaemia (Table VII,4),
Once again the incidence is higher than in Sjogren*s
(1933) and de Roetth's (1945) series but in neither of
these was the age and sex distribution recorded. Some
authorities believe that a patient with any one organ
specific disease has a higher than normal tendency to
develop another organ specific disorder (Anderson, and
others, 1967)* In this series it is interesting to
observe that two of the 3ix patients with pernicious
anaemia and keratoconjunctivitis sicca also had
auto-immune thyroiditis - Hashimoto*s disease
(Table VII,5) and one of them in addition had
idiopathic Addison's disease.
However, the inability of the present investigation
to show an increased prevalence of keratoconjunctivitis
sicca in pernicious anaemia or thyroid disease (v.s.)
would tend to contradict this concept. Furthermore,
the number of patients with xerostomia was no higher
than in the hospital control group. One of the
pernicious anaemia patients who had keratoconjunctivitis
sicca was also suffering from rheumatoid arthritis.
The remaining three patients with rheumatoid arthritis
and pernicious anaemia did not have Sjogren's syndrome.
No instances of Sjogren's syndrome were detected
HI
in the 20 patients who had a primary diagnosis of
idiopathic Addison's disease. Their mean age, 36.6
years, is much younger than either the pernicious
anaemia group or the hospital control patients.
However, as described above, one patient in the
pernicious anaemia series had idiopathic Addison's
disease and keratoconjunctivitis sicca.
Nevertheless, the prevalence of gastric parietal
cell antibodies and thyroglobulin antibodies is increased
in Sjogren's syndrome (Buchanan, Cox and others, 1966;
Anderson and others, 1961; Bloch and others, 19^5) and
both of these antibodies occur with increased frequency
in pernicious anaemia (Irvine and others, 19^2; Markson
and Moore, 1962; Taylor and others, 1962; Irvine,
19635 Doniach and others, 1963) and in idiopathic
Addison's disease (Blizzard and Kyle, 1963; Irvine,
1963)* Thyroglobulin antibodies are more frequent in
the connective tissue diseases, rheumatoid arthritis
(Anderson and others, 1961; Bloch and others, 1965) and
systemic lupus erythematosus (Anderson and others, 1961;
Ilijmans, Doniach, Roitt and Ilolborow, 1961) both of
which may be associated with established
keratoconjunctivitis sicca. The absence of an
increased prevalence of keratoconjunctivitis sicca in
pernicious anaemia or in idiopathic Addison's disease in
contrast to that in auto—immune systemic disorders is
consistent with the concept that pernicious anaemia and
idiopathic Addison's disease are organ specific disorders.
1 k2
Summary
77 patients suffering from pernicious anaemia
and 20 patients with idiopathic Addison's disease were
examined for keratoconjunctivitis sicca. The
prevalence of keratoconjunctivitis sicca in these
patients was no higher than in 72 hospital control
patients. Sialography was performed on k patients who
had xerostomia but no abnormalities were detected.
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SUMMARY
The histological features of the lacrimal and
salivary glands in Sjogren1s syndrome are reminiscent
of those in the thyroid gland in Hashimoto's
thyroiditis and primary myxoederaa. Furthermore, the
prevalence of thyroglobulin autoantibodies is high in
patients suffering from Sjogren's syndrome, Hashimoto's
thyroiditis, primary myxoedema and thyrotoxicosis.
However, this study has failed to demonstrate any
increased prevalence of Sjogren's syndrome in patients
suffering from thyroid disease.
Similarly, it may be argued that the lymphocytic
infiltration of the gastric mucosa in chronic gastritis
is not unlike that in the lacrimal and salivary glands
in Sjogren's syndrome. Patients with chronic gastritis
have a higher than normal tendency to develop pernicious
anaemia and conversely patients with pernicious anaemia
nearly always suffer from chronic gastritis. The
prevalence of gastric parietal cell antibodies is high
in pernicious anaemia and according to some authorities
in Sjogren's syndrome. In addition, patients suffering
from pernicious anaemia have, like Sjogren patients, a
high incidence of thyroglobulin autoantibodies. However,
when a series of patients suffering from pernicious
anaemia was examined for Sjogren's syndrome no increased
prevalence was detected.
Patients suffering from idiopathic Addison's
disease appear to have an increased susceptibility to
1 kh
chronic thyroiditis associated with thyroid microsomal
antibodies. Pernicious anaemia has also been reported
in this disease and the prevalence of gastric parietal
cell antibodies is higher than in tuberculous cases.
Salivary duct antibodies have been reported in
idiopathic Addison's disease and Sjogren's syndrome.
On the other hand, a series of patients suffering from
idiopathic Addison's disease was examined for increased
prevalence to Sjogren's syndrome without success.
The results of these studies are consistent with
the concept that auto—immune thyroiditis, pernicious
anaemia and idiopathic Addison's disease are organ
specific disorders. If keratoconjunctivitis sicca
and/or xerostomia is diagnosed in the absence of a
generalised connective tissue disease then it may be
regarded as an organ specific auto-immune disorder and
the belief exists that patients suffering from one
organ specific disease are more susceptible to the
development of another organ specific disease. The
failure of these investigations to demonstrate any
increased prevalence of Sjogren's syndrome in auto-immune
thyroid disease, pernicious anaemia or idiopathic
Addison's disease tends to contradict this thesis.
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CHAPTER VIII
STUDIES OP THE BACTERIAL, FUNGAL
AND VIRAL FLORA IN KERATOCONJUNCTIVITIS SICCA
1 52
Keratoconjunctivitis sicca is a chronic disorder,
that behaves erratically, being non-progressive in
some patients whilst proceeding in extreme cases,
sometimes with alarming speed, to perforation of the
cornea and blindness.
In this chapter the frequency and identity of
bacteria, fungi and viruses in the dry eye are
recorded and their possible significance in relation
to the ocular complications of Sjogren's syndrome is
examined•
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STUDIES OP THE BACTERIAL FLORA IN
KERATOCONJUNCTIVITIS SICCA
A great deal of attention has been given to the
bacterial flora of the conjunctival sac in health and
disease and lengthy investigations have been carried out
in many centres including the United Kingdom (Smith,
195^} Soudakoff, 195^ 5 Orfila and Courden, 1961).
Views vary as to how often the healthy sac is devoid of
organisms and what effect climate, hygiene, coincidental
disease and the use of topical antibiotics may have on
the range of bacteria detected. Nevertheless, there
is general agreement about the commonest bacterial
organisms found in the healthy sac, the inhibitory
effect of lysozyme and the mechanical effect of the
lacrimal secretions (Duke Elder, 1965)* Since both
lysozyme content (Thygeson and Kimura, 19^3) and tear
secretion (Sjogren, 1933) are reduced in
keratoconjunctivitis sicca, it is important to
investigate the nature of the bacterial flora in the
conjunctival sac of the dry eye.
During the process of collection data for the
diagnosis of keratoconjunctivitis sicca, I noticed that
quite a number of the patients had evidence of blepharitis.
For this reason the prevalence of bacteria on the lid
margins was also examined. Nasal carriers of bacteria,
particularly of staphylococcus coagulase positive
organisms are regarded as potentially infectious and a
great deal of energy has been expended in determining
I5h
the incidence of carriers in hospital and non-hospital
patients (Rogers, Duffy and Mou, 19^5? Polakoff,
Richards, Parker and Lidwell, 19*>7; Noble, Valkenburg
and Wolters, 1967)* It is generally accepted that the
nose if the most frequent site of carriage for
staphylococcus coagulase positive bacteria in man
(Polakoff, Richards, Parker and Lidwell, 1967) and
nasal carriers of pathogenic staphylococci have a
higher isolation rate for the organism on their hands
than do non-carriers (Noble, Valkenburg and Wolters,
1967)* Consequently, the bacterial flora in the
anterior nares of the patients suffering from
keratoconjunctivitis sicca were also examined.
Material and Methods
Patients
1. Clinically healthy conjunctival sacs, lid margins
and anterior nares. Sixty (60) arthritic patients
comprising 5 males and 55 females, without clinical
evidence of external ocular inflammation, were selected
for the investigation of bacterial flora in the healthy
conjunctival sac, lid margins and anterior nares. All
of them were suffering from rheumatoid arthritis and
had been referred over a period of 2 years for routine
ophthalmological examination. Their mean age was
55.2 years (_+ 11.1 standard deviation).
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2 Untreated Keratoconjunctivitis Sicca
(a) The association of bacterial colonisation and the
dry eye was studied in 65 patients diagnosed over a
period of three years. The group consisted of 8 males
and 57 females whose mean age was 57*7 years (standard
deviation _+ 9,8), 8 patients had been treated by
their general practitioners for chronic conjunctivitis
and 10 patients had been in the habit of bathing their
eyes with a variety of commercially obtainable
solutions, such as Optrex and Ocusol, However, none
of the patients had received any topical therapy for
at least 8 weeks before they were included in the
study.
All of the bacterial investigations were repeated
after one month of tear substitute therapy,
(b) When the diagnosis of keratoconjunctivitis sicca
was made, a record of objective evidence suggesting
bacterial infection of the external eye was compiled
with a view to relating bacterial isolates to the
clinical state of the patients* eyes.
Collection of Specimens
In all cases, specimens for culture were taken
from both conjunctival sacs using sterilised cotton
tipped sticks with which the lower fornices were
scraped. The same technique was applied to the lower





Staphylococcus (all types) 16 26.6 36.3
Staphylococcus coagulase
positive 6 10 13.6
Diphtheroids 14 22.5 31.8
Neisseria Catarrhalis 5 8.3 11.3
Pneumococcus 2 3-2 4-5
Haemolytic Streptococcus 1 1.6 2.2
Streptococcus viridans 4 6.6 9-1
Escherichia Coli 2 3.2 4.5
Sterile sacs 24 40
Table VIII,t
Bacterial flora from the lid margins of 60 patients with clinically healthy eyes.
Bacteria Isolated Patients Percentage of
total isolates
Number per cent
Staphylococcus (all types 25 41.6 41.5
Staphylococcus coagulase positive 9 15 14.7
Diphtheroids 10 16.6 16.4
Neisseria Catarrhalis 2 3.3 3-3
Pneumococcus 3 5 5
Haemolytic Streptococcus 3 5 5
Streptococcus Viridans 4 6.7 6.6
Escherichia Coli 2 3.3 3.3
Proteus 1 1.6 1.6





lid margins and to one anterial nasal vestibule.
Cultures were also taken at irregular intervals from
the mydriatics, miotics, vital dyes and tear
substitutes in current use at the Outpatient
Departments.
Cultivation of Bacteria
All specimens were inoculated within two hours on
to blood agar plates and incubated at 37°C. The filter
paper disc technique was used for testing sensitivity
employing dishes saturated in the variety of
antibiotics listed below.
Penicillin, ampicillin, cloxacillin, tetracycline,
Chloromycetin, erythromycin and latterly septrin,
neomycin.
Results
1 Clinically healthy conjunctivae, lid margins and
anterior nares. Tables VIII,1,2 and 3 show the
frequency and identity of bacterial isolates from the
conjunctival sacs, lid margins and anterior nares of
60 arthritic patients, none of whom had any evidence of
external ocular disease. Bacteria were isolated from
the conjunctival sacs of 36 patients (60 per cent) and
from the lid margins of b2 patients (70^o), a difference
which is not statistically significant. Staphylococci
Bacterial flora from the anterior nares of 60 patients with clinically healthy eyes.
Bacteria isolated Patients Percentage of total
Number Per cent isolates
Staphylococcus (all types) 51 51.6 64.5
Staphylococcus coagulase positive 14 ro V-H VX 29.1
Diphtheroids 9 15.0 18.7
Pneumococous 2 3.2 4.1
Haemolytic Streptococcus 5 5-0 4.1
Escherichia Coli 5 5.0
6.2
Sterile nares 20 33.3
Table VIII,3
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and diphtheroids were the commonest organisms detected
in both sites and staphylococcus coagulase positive
(staphylococcus aureus) was the commonest pathogen.
Thus, staphylococcus aureus was isolated from
conjunctival sac of 6 patients (10 per cent) and the
lid margins of 9 patients (15 per cent), isolation ratos
which were not significantly different from one another.
However, if all of the bactoria, normally regarded as
pathogens are sununated then their prevalence on lid
margins is higher than in conjunctival sacs, although
once again the probability of this being significant
is doubtful (9 of 60 patients with sac isolated, 17 of
O
60 patients with lid isolates, X = 2,691, P < 0.1).
Bacterial isolates were obtained from the anterior nares
of U0 patients (66.6 per cent) only two less than the
number of patients with lid isolates. Staphylococcus
aureus represented a larger percentage of the total
isolates from the nose than from the lid margins or the
conjunctival sacs but only in the case of the latter may
the difference have some significance (X = 2.75*8,
P < 0.1).
Coagulase positive staphylococci were isolated from
the conjunctival sacs of 6 patients (Table VIII,l) and,
in addition, from the lid margins and anterior nares of
one patients and the lid margins of two patients, A
fourth patient had the organisms on her lid margins and
anterior nares but not the conjunctival sac. The only
other pathogen found from more than one site in the same
patient was the pneumococcus which appeared in the sacs
Bacterial flora in the conjunctival sacs of 65 patients suffering from untreated
keratoconjunctivitis sicca.
Bacteria isolated Patients Per centage of total
Number Per cent isolates
Staphylococcus (all types) 35 53.9 50.0
Staphylococcus coagulase positive 29 44.6 41.3
Diphtheroids 18 27.9 25.7
Neisseria Catarrhalie 3 4.6 4.2
Pneumococcus 4 6.1 5.7
Haemolytic streptococcus 2 5.2 2.8
Streptococcus viridans 3 4.6 4-2
Escherichia coli 2 3.2 2.8
Haemophilus aegyptius (Koch
(Week's Bacillus) 1 1.6 1.4
Proteus 2 3.2
2.8
Sterile sacs 6 9.2
Table VIII,h
Bacterial flora on the lid margins of 65 patiente suffering from untreated keratoconjunctivitis
sicca.
Bacteria Isolated Patients Percentage of total
Number Per cent isolates
Staphylococcus (all types) 45 66.6 41.2
Staphylococcus
coagulase-positive 58 59.0 38.4
Diphtheroids 11 16.9 10.1
Pneumococcus 4 6.1 3.6
Haemolytic streptococcus 3 4.6 2.7
Streptococcus viridans 3 4.6 2.7
Escherichia coli 3 4.6 2.7































and lid margins of one patient.
2 Untreated Keratoconjunctivitis Sicca
(a) The bacterial flora in the conjunctival sacs, lid
margins and anterior nares of 65 patients suffering
from untreated keratoconjunctivitis sicca are shown in
Tables VIII,h95 and 6. Although the prevalence of
bacteria in the conjunctival sacs and lid margins of
these patients appears to be considerably higher than
in patients with healthy eyes (Figure VIII,1) the
O
differences are not in fact significant (X'~ = 2.2410 and
1.3327)» However, staphylococcus aureus was detected
in the conjunctival sacs of 29 patients (kk,6 per cent)
with untreated keratoconjunctivitis sicca, compared \tfith
only 6 (10 per cent) with clinically healthy eyes
(Figure VIII,2) a difference which is highly significant
2
(X = 10,7^32, P < 0.01). Similarly, coagulase positive
organisms were significantly more prevalent on the lids
of 38 patients (59 per cent) with keratoconjunctivitis
sicca than in 9 rheumatoid patients (15 per cent) with
healthy eyes (X2 = 11.8351, P < 0.001 ).
The identity and frequency of bacterial isolates
from the anterior nares of the two groups of patients
are not significantly different (Tables VIII,3 and 6,
Figures VIII,1 and 2). Coagulase positive
staphylococci were isolated more frequently from the
nose than from the conjunctival sacs or lid margins of
patients with healthy eyes. The reverse applies to the
BACTERIAL ISOLATES IN 60 PATIENTS WITH CLINICALLY HEALTHY
EYES AND IN 65 PATIENTS WITH UNTREATED KCS
o- SACS MARGINS NARES ONE SITE
Pig.VIII,1
COAGULASE POSITIVE STAPHYLOCOCCI IN 60 PATIENTS WITH


















Bacterial flora in conjunctival sacs of 65 patients with keratoconjunctivitis siooa
after one month of tear substitute therapy.
Bacteria isolated Patients Percentage of
Number Per cent total isolates
Staphylococcus (all types) 25 39.0 62.5
Staphylococcus coagulase-
positive 15 2J.0 37-5
Diphtheroids 10 15-3 25
Neisseria Catarrhalis 2 3.1 5
Streptococcus viridans 3 4.6 7.5
Sterile sacs 30 46.1 -
Table VIII,7
Bacterialflora on lid margins of 65 patients with keratoconjunctivitis sicca after one month



















Bacterial flora in the anterior nares of 65 patients with keratoconjunctivitis sicca
after one month of tear substitute therapy.
Bacteria isolated Patients Percentage of
Number Per cent total isolates
Staphylococcus (all types) 34 52.3 77.1
Streptococcus coagulase-
positive 15 25.I 34.1
Diphtheroids 6 9.2 13.6
Pneumococcus 1 1.5 2.2
Streptococcus viridans 3 4.6 6.8
Sterile nares 24 36.9 -
Table VIII,9
COAGULASE POSITIVE STAPHYLOCOCCI IN 65 PATIENTS WITH KCS









CONJUNCTIVAL LID ANTERIOR MORE THAN
SACS MARGINS NARES ONE SITE
1
Fig.VIII,k
BACTERIAL ISOLATES IN 65 PATIENTS WITH KCS, BEFORE AND
AFTER ONE MONTH OF TEAR SUBSTITUTE THERAPY
Pig.VIII,3
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group of patients suffering from untreated
keratoconjunctivitis sicca in that there are
significantly more patients with staphylococcus aureus
on the lid margins than in the nasal vestibule
p
(X = 6.4243» P < 0.02). However, the difference in
2
sac isolates is less striking (X = 2.8053» P < 0.1).
Staphylococcus aureus was isolated from more than
one source in 17 of the 65 patients (26.1 per cent)
suffering from untreated keratoconjunctivitis sicca,
significantly more than the four patients of 60 (6.6
per cent) in the control series (X = 4.8442, P < 0.05»
Figure VIII,2). It is interesting to note that 13 of
the 17 keratoconjunctivitis sicca patients were nasal
carriers. Coagulase positive bacteria were present
in the anterior nares of 16 patients and additionally,
on the lid margins and conjunctival sacs of 6, on the
lid margins of 4 and in the conjunctival sacs of 3*
Another 4 patients had staphylococcus aureus in their
sacs and lid margins but were not nasal carriers.
Tables VIII,7»8 and 9 show the frequency and
identity of bacterial isolates from the conjunctival
sacs, lid margins and anterior nares of 65 patients
with keratoconjunctivitis sicca iiamediately following
one month of tear substitute therapy. There was a
significant reduction in sac (X^ = 3*5975» P > 0.05) and
2
lid margin isolates (X =* 2.977°, P > 0,05) - presumably
as a result of the treatment (Figure VIII,3)• However,
although there was a lowered incidence of
staphylococcus aureus in the conjunctival sac (X « 3»3^97»
160
P > 0.05)t there was no difference in the lid margin
2
isolates of this organism (X « 2.5260). In other
words, staphylococcus aureus was still to be found more
frequently than in the control series (Figures VIII,2 and
<0.
(b) Clinical evidence of infection was recorded in 37
of the 65 patients (56.9 per cent) in whom the diagnosis
of keratoconjunctivitis sicca had been made (Table VIII,10).
Blepharitis, occasionally accompanied by other signs
suggesting possible bacterial infection, was diagnosed in
19 patients in the majority of whom staphylococcus
aureus was detected, both in the conjunctival sacs (13
patients) and on the lid margins (l6 patients). The
prevalence of staphylococcus coagulase positive organisms
is, therefore, higher in patients with superimposed
blepharitis than in the keratoconjunctivitis sicca
group as a whole but not significantly so.
Corneal lesions unassociated with objective evidence
of blepharitis were recorded in 13 of the 37 patients
with suspected clinical infection. Only four patients
had staphylococcus aureus in their conjunctival sacs
and 7 on their lid margins, isolation rates that are no
higher than for the rest of the keratoconjunctivitis
sicca group. Although the number of patients is too
small for definite conclusions to be drawn, the results
suggest that staphylococcus aureus is more likely to be
associated with the blepharitis sometimes present in
patients with keratoconjunctivitis sicca than with any
Coagulase positive Staphylococci in untreated keratoconjunctivitis sicca, related to clinical
evidence of infection.
Before one month tear substitute After one month tear substitute therapy.
therapy
Clinical group No.patients No. conj.Staph. No.lid margin No.nasal No.conj. No.lid margin No.nasal
aureus Staph.aureus isolates Staph.aureusi Staph.aureus Staph.aureus
Blepharitis 19 13 16 4 7 12 5
folliculitis 2 1 2 1 1 2 1
styes 2 2 1 - - 2 -
yellow con;}.
discharge 2 1 2 1 - 1 -
Marginal
corneal
infiltration 1 1 1 - 1 - 1
Oral, ragged
ulcerations
cornea 1 0 1 - - - -
Corneal lesions 13 4 7 3 2 2 1
Marginal corneal
infiltration 1 0 1 1 - - -
Superficial punctate
erosions, oval or
ragged ulceration 12 4 6 2 2 2 1
Styes 2 1 1 - - 1 -
Yellow conjunctival
discharge 3 2 1 1 1 - 1
Total 37 20 25 8 10 16 7
Table VIII,10
Antibiotic resistance 29 Staph.aureus isolates 85 Staph.aureus isolates in
in control group keratoconjunctivitis sicca group
Group Number Per cent Group Number Per cent
1. Penicillin 7 24 30 56
2. Ampicillin 1 3 5 6
3- Cloxacillin - -
4. Tetracycline - -
?• Chloromycetin - -
6. Erythromycin _ — ~ ~
Table VIII,11
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specific corneal lesions. On the other hand, the
presence of blepharitis in these patients may enhance
the chances of conjunctival and corneal infection.
Antibiotic Resistance
Resistance to penicillin was encountered in some of
the staphylococcus aureus strains (Table VIII,1l) but in
none of the other species. Twenty four per cent of
the staphylococcus aureus recovered from the control
series and thirty six per cent from the untreated
keratoconjunctivitis sicca group were penicillin
resistant. Of the 16 nasal carriers of staphylococcus
aureus who had keratoconjunctivitis sicca, 10 (62.6 per
cent) had penicillin resistant strains. A few
patients had ampicillin resistant forms but all the
bacteria were sensitive to cloxacillin, tetracycline,
Chloromycetin and erythromycin (Table VII1,11).
Discussion
The most recent surveys of bacterial flora in the
healthy conjunctival sac undertaken in various parts
of the world have indicated that staphylococcus albus
and diphtheroids (Coryne bacteria xeroses) are by far
the commonest organisms encountered (Duke Elder, 1965).
To date, the only large series that has been published
in this country concerns 5000 eye patients admitted to
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hospital for routine ocular surgery (Smith, 195*0.
Bacterial isolates were detected in 53 per cent of
Smith's patients, staphylococci of all types being
present in nearly 3** per cent and diphtheroids in 3*
per cent of cases. In the present study, 60 rheumatoid
arthritic outpatients with no evidence of external eye
disease were examined for conjunctival bacterial flora.
Isolates were present in 60 per cent of the patients,
staphylococci being identified in 26.6 per cent and
diphtheroids in 22.3 per cent* Furthermore,
staphylococcus coagulase positive organisms (Staph,
aureus) were isolated in nearly 8 per cent of the
patients in Smith's series and in 10 per cent of the
rheumatoid group. The identity of the remaining
organisms in the two series is also similar, more
varieties being present in the larger series. It would
appear, therefore, that the rheumatoid series of patients
with no evidence of external ocular inflammation can be
used as a control for comparison with the age and sex
matched patients suffering from untreated
keratoconjunctivitis sicca.
During the preliminary stages of these investigations,
it was observed that nearly one in three new cases of
keratoconjunctivitis sicca was suffering from blepharitis.
Consequently, it appeared important to have a knowledge
of lid margin as well as conjunctival flora in this group
and in the control series. Of the 65 patients
ultimately diagnosed 19 (29.2 per cent) had blepharitis
(Table VIII,7). There was no significant difference
163
between the frequency and identity of conjunctival and
lid margin bacteria in the control series. Similarly,
no difference existed between the isolates from sacs
and lid margins of untreated keratoconjunctivitis sicca
patients. However, the higher prevalence of bacteria
both in the conjunctival sacs and on the lid margins
of patients with untreated keratoconjunctivitis sicca
and the predominance of staphylococcus aureus were
undeniable (Figures VIII,1 and 2).
A dramatic reduction in the frequency of bacterial
isolates from the keratoconjunctivitis sicca patients
resulted from one month of tear substitute therapy.
The eye drops prescribed contained 0.005 per cent
chlorhexidene digluconate as a preservative and this
has some bacteriostatic effect. However, the
therapeutic regime included frequent irrigation with
dilute salt water and the mechanical effect of this
procedure in removing mucus and possibly bacteria may
have been considerable. Nevertheless, staphylococcus
aureus was still more frequently isolated than in the
control series (Figures VIII,2 and 4). Although the
difference was no longer statistically significant, it
appears to the author that a potentially dangerous
situation continued to exist, particularly since it is
well recognised that most strains of staphylococcus
aureus in the human subject are virulent pathogens
(Elik, 1959)• The effect of corticosteroids in
reducing resistance to a variety of bacterial and other
infections is also well documented (Zimmerman, 1950;
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Kligman, Baldridge, Rebell and Pillsbury, 1951; Selye,
1951» Symraers, 1965)* However, some authors advocate
the use of topical steroids in the treatment of the
"dry eye" (Jones and Coop, 1965)* The results of this
study indicate that topical steroids should be used
with extreme caution in the management of patients
suffering from lceratoconjunctivitis sicca.
Since the nose is generally regarded as the
commonest site for staphylococcus aureus in man
(Polakoff and colleagues, 1967) the nasal carrier states
of the control series and the keratoconjunctivitis sicca
patients were investigated. There was no difference in
the nasal bacterial flora of the two groups of patients
and staphylococcus aureus was more commonly detected in
the anterior nares of the control patients than on their
lid margins or conjunctival sacs. However, staphylococcus
aureus was more frequently detected from the conjunctival
sacs and lid margins of the untreated keratoconjunctivitis
sicca group than from the nose (statistically significant
in the case of lid margin isolates, Figure VIII,2,
X as 6.4243, P < 0.02). Moreover, significantly more
patients suffering from untreated keratoconjunctivitis
sicca exhibited staphylococcus aureus from more than
one site (X^ = 4.8442, P < 0.05). It is interesting
to note that most of the patients affected wore nasal
carriers (13 of 17) and conversely most of the nasal
carriers were simultaneously colonised by staphylococcus
aureus around the eye (13 of 16). This suggests that
the eyes of patients with untreated or inadequately
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supervised keratoconjunctivitis sicca, are readily-
infected with staphylococcus aureus when the patient
is a nasal carrier. Consequently, part of the
management of keratoconjunctivitis sicca patients must
entail the elimination of the nasal carrier state.
It was not possible to prove with certainty that
the signs of clinical infection recorded in Table VIII,10
were the result of staphylococcal infection.
Nevertheless, the prevalence of the staphylococcus
aureus was higher in patients with blepharitis both
before and after one month of tear substitute therapy
than in any other group. Blepharitis,
blepharoconjunctivitis, punctate kej-atitis, particularly
of the lower half of the cornea, and marginal corneal
infiltration, are all well recognised entities and all
have been described in association with staphylococcal
infection (Jones, Andrews, Henderson and Schofield, 1957}
Thygeson and Kimura, 1963). All of these conditions
were diagnosed in this study. However, staphylococcus
aureus was also isolated from untreated keratoconjunctivitis
sicca patients with no evidence of infection. It is
possible to conclude that some signs of infection were
not recorded as such but were interpreted as evidence
of keratoconjunctivitis sicca. This criticism may well
apply to "conjunctival injection" which the author
regarded primarily as an indication of the dry eye.
It is beyond the scope of this investigation to
study the reasons for variations in staphylococcal
resistance to penicillin. Nevertheless, it is important
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to record that in this area of the United Kingdom during
the years 1965-68, 36 per cent of the staphylococci
isolated from the external eye or the anterior nares of
untreated keratoconjunctivitis sicca patients v/ere
resistant to penicillin. When any ocular infection
develops in these patients, it seems logical to
conclude that penicillin should not be prescribed,
particularly if impairment of vision is likely to occur
as a result of delay in appropriate treatment. None
of the staphylococci were resistant to tetracycline or
Chloromycetin, therefore, these antibiotics should be
used in the first instance.
Summary
A comparison was made of the bacterial flora of
the lid margins, conjunctival sacs and anterior nares
of 65 newly diagnosed cases of keratoconjunctivitis
sicca and 60 age and sex matched rheumatoid arthritic
patients with no evidence of external, eye disease.
The results, which took three years to collect, showed
that significantly more bacterial organisms,
staphylococcus aureus in particular, were isolated from
the lid margins and sacs but not from the noses of
patients suffering from untreated keratoconjunctivitis
sicca. One month of tear substitute therapy was
sufficient to reduce the incidence of bacteria in the
keratoconjunctivitis sicca group, almost to that of the
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control series. Nevertheless, staphylococcus aureus
was still more frequently isolated from the
keratoconjunctivitis sicca patients than from the
control patients. Since coagulase positive
staphylococci are usually virulent pathogens, it is
suggested that topical corticosteroids should be
prescribed with extreme caution in this disease.
Generally, the nose is regarded as the commonest
carrier site for staphylococcus aureus. However,
prior to treatment with tear substitutes, more
staphylococci were found on the lid margins and sacs
than on the noses of the keratoconjunctivitis sicca
group. Moreover, most of the nasal carriers in the
keratoconjunctivitis sicca group were colonised by
staphylococcus aureus on the lid margins, the
conjunctival sacs or both, which suggests that the
nose may have been the origin of the infection.
Therefore, attempts should be made to eliminate nasal
carrier states in patients suffering from
keratoconjunctivitis sicca. 37 of the 65
keratoconjunctivitis sicca patients (56,9 per cent)
had clinical signs suggesting infection. Staphylococcus
aureus was no more readily isolated from this group than
from the keratoconjunctivitis sicca group, as a whole,
or the group of keratoconjunctivitis sicca patients
without clinical evidence of infection. However,
nearly 30 per cent had blepharitis and the prevalence
staphylococcus aureus in these patients was higher
before and after one month of tear substitute therapy
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than in any other group. In addition, the variety
of corneal lesions which were recorded have all been
associated with staphylococcal infection in series,
published by other authors. Thirty six per cent of
the coagulase positive staphylococci were resistant
to penicillin. None were resistant to Chloromycetin
or tetracycline, which are therefore recommended as
the antibiotics of first choice.
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STUDIES OF THE FUNGAL FLORA IN KERATOCONJUNCTIVITIS SICCA
Although the role of fungi as ocular pathogens has
become more widely recognised (Maddren, 19^1? Sykes,
1 9'46$ Mendleblatt, 1 953J Mitsui and Hanabusa, 19551
Roberts, 1957f Haggerty et al, 1958} Mikami, 1958}
Fine and Zimmermann, 1959} Chick et al, 1962} Currie,
1963} Ainley and Smith, 1965} Jelenkiewicz, 1965}
Dominiczak et al, 1965)» relatively little attention
has been given to the fungal flora of the healthy or
diseased eye. Previous lengthy investigations
conducted in Europe (Fazakas, 1935» 1953) a*"* in th©
U.S.A. (Hammeke and Ellis, i960) have shown some
disparity in the frequency of occurrence of fungi in
the healthy conjunctival sac, and studies of smaller
groups of patients (Mitsui and Hanabusa, 1955}
Azevedo, 1962) may not have been representative due to
the small size and selectivity of the samples.
Therefore, before attempting to demonstrate a high
incidence of fungi in the conjunctival sacs of
patients suffering from keratoconjunctivitis sicca,
the results from an investigation of clinically healthy
conjunctivae of a large and representative group of
subjects of various ages had to be analysed.
It is well documented that steroids reduce tissue
resistance to a wide variety of bacterial, viral and
fungal agents (Zimmermann, 1950} Kligman, 1951}
Selye, 1951)» and it would appear that the increase of
ocular mycoses within recent years may be associated
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with the extensive use of systemic and topical
corticosteroids and of broad-spectrum antibiotics
(Hogan et al, 195*1{ Suie et al, 19^3; McLean, 19^3)•
A number of patients with Sjogren*s syndrome are
treated with systemic steroids and topical steroid
therapy is advocated by some authorities dealing with
the ocular manifestations of the disease. Consequently
an investigation into the effects of topical steroids,
topical steroids and antibiotics and systemic steroids
on the conjunctival fungal flora of various groups of
patients was undertaken.
Materials and Methods
1 Clinically Healthy Conjunctivae
553 patients (1106 eyes), comprising ZB>h males and
269 females, without clinical evidence of external
ocular inflammation, were chosen for the investigation
of the fungal flora of the healthy conjunctiva. Each
decade was represented by at least hO patients, equally
divided between the sexes (Table VIII,12), The
children in the 0-9 year age group were obtained mainly
from an orthoptic department, and the 10-19 year olds
from a large comprehensive school. The remaining
subjects were drawn from an ophthalmic outpatient
department and from a mass radiography centre.
The association of conjunctival fungi with topical
PATIENTS WITH CLINICALLY NORMAL CONJUNCTIVAE. BY AGE GROUP AND SEX.
Ag* Group (yra) 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70+ Total
Mai* 39 105 21 20 27 28 34 20 284
Sax
Femal* 28 104 23 22 22 25 23 22 269
Total Patlenta 57 209 44 42 49 53 57 42 553
Table VIII,12 Haalthy conjunctiva*
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steroid therapy was examined in two series of patients.
2 Clinically Healthy Conjunctivae Subjected to
Topical Therapy
Adult patients with no clinical evidence of
external ocular disease selected from an ophthalmic
outpatient department, and from the Centre for Rheumatic
Diseases.
(a) Cultures were taken before and after a course of
Betamethasone disodium phosphate (0.1$ in water-miscible
base) in 86 patients (26 males and 60 females} 165
eyes), applied three times daily for one week. The age
range was 30 to 78 years (mean 62). J6 patients had
various forms of cataract, 35 had refractive errors,
and 15 had glaucoma.
(b) Cultures were taken from 52 patients (17 males and
35 females; 10U eyes) before and after a one week
course of Betamethasone disodium phosphate 0.1$ and
neomycin sulphate B.P. (0.5$) in water-miscible base
(Botnesol-N, Glaxo) three times daily for one week.
The age range was 28 to 75 years (mean age 60.5 years).
25 of the patients in this group had various forms of
cataract, three refractive errors, 23 rheumatoid
arthritis and one systemic lupus erythematosus.
Altogether 138 patients (269 eyes) with clinically
healthy conjunctivae were thus "treated" with the
Patients Receiving Topical Steroid Therapy
OCULAR DISEASE.
Disease under Treatment No. of Patients No. of Eyes
Conjunctivitis 15 25
B1epharo-Conjunc tivitis 10 20
Episcleritis 5 8












topical steroid or with the steroid/antibiotic drops
for one week, the fungal flora of the conjunctival sac
being determined before and after the course of eye
drops.
3 Diseased External Eyes Subjected to Topical
Steroid Therapy
The second main clinical category comprised
patients with various forms of external ocular disease,
for which either betamethasone disodium phosphate or
betamethasone disodium phosphate and neomycin sulphate
had been prescribed,
(a) 46 patients (10 males and 36 females; eyes;
age range 15—58 years, mean 53) had been receiving the
steroid preparations. Table VIII,13 shows the conditions
being treated and Table VIII,14 the duration of steroid
treatment. Mydriatics were being instilled into nine
eyes, miotics into three and methylcellulose drops into
one eye,
(b) 55 patients (10 males and 45 females; 75 eyes;
age range 23 to 61, mean 54.5) had been receiving the
steroid/antibiotic drops. The conditions under
treatment are shown in Table VIII,15 and the duration
of therapy in Table VIII,16, Mydriatics were being
instilled into six of these eyes.
Patients Receiving Topical Steroid/Antibiotic Therapy-
OCULAR DISEASE.









DURATION OF TREATMENT. /







4 Conjunctivas of Patients Receiving Systemic
Steroid Therapy
The association of conjunctival fungi and systemic
steroid therapy was examined in 30 randomly chosen ward
patients who were being treated in the Centre for
Rheumatic Diseases.
There were 8 males and 22 females; age range 18
t° 57 years (mean 52). Two of the patients had
recurrence of rheumatic fever, the remainder had
rheumatoid arthritis. The duration of therapy varied
from one month to more than 3 years and the daily
prednisolone intake from 5 to more than 15 mgm. The
total dosage of steroid ranged from 1.5 to over 99.0 G.
5 Conjunctivae of Patients with Sjogren*s Syndrome
Finally I was in a position to investigate and
evaluate the fungal flora of 37 patients suffering from
keratoconjunctivitis sicca (3 males and 3^ females;
74 eyes; age range 37 to 80 years, mean 55.2 years).
By the time the fungal surveys were underway the group
of Sjogren patients had been receiving tear substitute
therapy for varying periods of time. For 4 days before
the specimens were taken, the patients were asked to
discontinue this regime. It was felt that any lengthier
stoppage would be unfair to the patients who had
benefited so much by this time. Indeed many were
loathe to co-operate in the investigation when they
yjk
realised that they were to receive no treatment for a
few days* Positive cultures were obtained from 10
patients and 8 of them agreed to stop treatment for a
further k days after which a repeat culture was taken*
Collection of Specimens
In all cases, specimens for culture were taken
from both conjunctival sacs using a stiff nickel chrome
wire loop with which the lower fornices were vigorously
scraped. In the case of the patients with
keratoconjunctivitis sicca any ropy discharge was also
utilized for culture. Any cultures found to be
positive were repeated. 200 blank tubes inoculated
in the clinics under similar working conditions were
submitted to the laboratory interspersed in irregular
batches with the clinical samples. Cultures were
also taken at irregular intervals from the mydriatics,
miotics vital dyes and carboxymethylcellulose drops in
current use at the ophthalmic department.
Cultivation of Yeasts and Fungi
The mycological growth medium employed throughout
this investigation was 2# malt extract agar, containing
0.036$ potassium tellurite as a bacterial inhibitor.
Following inoculation and transmission to the laboratory
all tubes (including the blanks) were incubated at 25°C
and were examined for evidence of fungal growth at
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intervals of 10 days. Negative cultures were
reincubated, and no tube was discarded before the end
of k weeks incubation.
The yeasts and yeast-like fungi were identified
according to the taxonomic descriptions of Lodder and
Kreger—Van RIJ, (1952). In particular, the specific
identification of Candida species was based upon the
results of sugar fermentation and carbohydrate
assimilation tests (Lodder and Kreger-Van RIJ, 1952).
The identity of Candida albicans was confirmed by the
demonstration of characteristic germ tubes in human
serum (as described by Taschdjian et al, i960), and by
the demonstration of chlamydospore production on com
meal agar slide cultures. The identification of the
filamentous fungi was based upon their gross colonial
appearances on malt agar, and upon the nature and
arrangement of their spores on malt agar slide cultures.
The technique of slide culture was as described by
Riddell (1950). In order to reduce bias in this study,
the bacteriologist was not informed of the sources of
the cultures.
Results
Table VIII,17 shows the frequency and generic
identity of fungal isolates from the healthy conjunctival
sacs in the various age groups. The overall incidence
of fungi was 2.9 per cent, the lowest incidence, 0,8 per
ANALYSIS OF POSITIVE FUNGAL CULTURES FROM HEALTHY CONJUNCTIVAE. BY AGE GROUP.
Age Group (yrs) 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70+ Total
Penlcillium Sp. - - 1 1 3 1 1 - 7
Aspergillus Sp. - 1 - - 3 - - 4
Rhodotorula Sp. - - 2 - - 1 - 3
Scopulariopsis Sp. - 1 - - 1 - 1 3
Candida Sp. - 2 - - - - 1 - 3
Isaria Sp. 1 - - - - - 1 1 3
Geotrichum Sp. - - - - - 3 - 3
Papulospora Sp. - 1 - - -
- - - 1
Gliocladium Sp. - - 1 - — 1
Hormodendron Sp. - - - - - - 1 - 1
Saccharomyces Sp. - 1 - - - -
- - 1
Rhizopus Sp. - 1 - - -
- - — 1
Nigrospora Sp. - - — —

























































cent, being observed in the 0 to 9 year age group, and
the highest (7 per cent) in the 60 to 69 year age group.
Although there were more isolates from patients over
than from those under the age of 40 years, a progressive
increase of incidence of isolates with increasing age
was not demonstrated.
A comparison of the fungal flora of clinically
normal external eyes before and after the topical
application of steroid/antibiotic preparations for one
week is shown in Table VIII,18. No significant increase
in the frequency of isolation of fungi from the eyes of
86 patients treated with betamethasone disodium
phosphate was observed but the application of
betamethasone disodium phosphate/neomycin sulphate
preparation was associated, over the same period of time,
with a significant increase in incidence of fungi in the
conjunctival sacs of 52 patients (X Yates1 correction «*
8.2174; P < 0.01). On the other hand (Table VIII,19)
the conjunctival sacs of patients with external ocular
disease being treated with the steroid or steroid/
antibiotic preparation did not yield fungi any more
frequently than the healthy sacs. There was no
significant difference in the isolation rates between
patients subjected to topical steroids alone and those
subjected to topical steroids combined with an
antibiotic. Furthermore, repeats of the initially
positive fungal cultures were uniformly negative,
suggesting that fungal contamination was transitory.
Only one positive culture was obtained from the 30




































































patients receiving systemic steroid therapy.
Table VIII,20 shows the rate of occurrence of fungi
in the conjunctival sacs of the 37 patients with
Sjogren's syndrome after 4 days without their usual
ocular toilet. Four isolates were obtained from the 14
patients (28 eyes) receiving systemic prednisolone and
six isolates from the remaining 23 patients (46 eyes) -
an overall incidence of 13»3 per cent. This is a
significantly higher incidence than that obtained from
the clinically healthy conjunctival sacs investigated
2
above (X = 5»258j P < 0.05 comparing with age and sex
matched normals). Further specimens taken from those
patients following resumption of their replacement
therapy did not yield fungi. Eight of the 10 patients
in this group who had previously harboured conjunctival
fungi were sampled once again 4 days after ceasing
ocular treatment. Seven fungal isolates were obtained,
four of which were species of Candida.
Two of the 200 blank cultures yielded aerial
contaminants•
Discussion
Previous surveys of the fungal flora of the healthy
conjunctival sac have been undertaken by Fazakas (I935t
1955) in Central Europe, by Mitsui and Hanabusa (1955)
in Japan, by liaomieke and Ellis (i960) in the United
States, and by Azevedo (1962) in Brazil. Ainley and
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Smith (1965) are, to date, the only British workers who
have undertaken a study of the fungal flora of the
clinically normal conjunctiva. Hie latter was a small
series comprising only patients with no signs of
disease of the external eye. In comparison, the
present investigation has utilized material from 1106
healthy eyes, and is the largest series so far reported
in this country. Fazakas (1953) and Hanuneke and Ellis
(i960) conducted the two previously largest surveys, in
Europe and the U.S.A. respectively. In a study of 993
healthy eyes, Fazakas obtained 253 positive fungal
cultures (an incidence of 25.*i%). Hammeke and Ellis
investigated 520 healthy eyes of adults, children, and
neonates! 10.3% of 416 adults, 5% of 52 children, and
0.1% of 52 infants gave positive fungal isolates.
Ainley and Smith (1965) studied only ^3 healthy eyes,
and obtained 12 positives (27.^%)• X have obtained
32 positive cultures from 1106 healthy eyes, a much
lower incidence of 2.9%»
The clinical methods seem to be similar to those of
other investigators, and the lower incidence in this
series may partly be explained by the cultural
techniques employed. Thus, Ainley and Smith (1965)
used Sabouraud18 broth with subculture after one week
to Sabouraud's agar plates, and subsequent incubation
at 25°C for up to 6 weeks. Malt extract agar slants
for primary isolation, and an incubation period extending
to four weeks at 25°C was the technique used in this
study, Harameke and Ellis (i960) also employed Sabouraud*s
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glucose agar, but the length of incubation of their
cultures is not stated. In general, primary incubation
in broth might be expected to yield a higher isolation
rate than on solid medium.
Previous workers have indicated that variations in
the frequency of certain fungi occur, between various
geographical regions; e.g. Candida species (Urrets-
Zavalia, Reraonda and Rammacciotti, 1958) and
Sporotrichum sp. (Gordon, 19**7» McGrath and Singer,
1952). Despite a low overall incidence of fungi, the
results presented in this survey are in good qualitative
agreement with other investigators in other geographical
areas with regard to the genera of fungi and yeasts most
frequently found in the conjunctival sac. Thus,
Aspergillus spp., Rhodotorula spp., Candida spp., and
Penicilliura spp. appear to be common inhabitants of the
healthy external eye. (Pazakas, 1953? Mitsui and
Hanabusa, 1955? Hammeke and Bllis, i960? Ainley and
Smith, 1965)* These fungi collectively accounted for
5*1# of the total isolates in this series. Fazakas
(1953) found that the majority of his isolates from
healthy eyes were moulds, 28# of the isolates in his
series of 993 eyes belonging to the Penicillium group.
22 per cent of the positive cultures in the present
"healthy eye" group were Penicillium.
In contrast to the findings of Hammeke and Ellis
(i960), who reported distinct differences in the
frequency of positive fungal isolates from conjunctival
sacs in different age groups, progressive increase of
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incidence of fungi with increasing age, was not recorded
in this study, although the overall incidence of fungi
in the older-age groups was somewhat higher than in the
very young age groups.
One may question the significance of the presence
of fungi in the healthy conjunctival sac. In an
attempt to provide a partial answer to this question,
all of the 32 positive cultures were repeated within 4
weeks of their initial detection, but only 4 repeat
positives were obtained. Furthermore, in none of these
cases was the same species recovered. On the basis of
these findings, it is considered that the fungi
cultivable from healthy conjunctival sacs must be
regarded as transitory contaminants rather than resident
commensals. Although it would appear therefore that
little significance should normally be attached to the
presence of fungi in the healthy conjunctival sac,
nevertheless it is important to have accurate knowledge
of the fungal species most likely to be encountered
there even temporarily. Otherwise the significance of
those found in disease and in particular in
keratoconjunctivitis sicca could not be interpreted.
The role of fungi as pathogens in ocular infections is
becoming more widely recognised, and although an
increased awareness of the possibility of ocular mycoses
may be partly responsible, there is now well-documented
evidence of a real increase in the incidence of mycotic
infection of the eye (Haggerty and Zimmerraann, 1958}
Mikami and Stemmerman, 1958; Fine and Zimmermann, 1959}
181
Chick and Conant, 1962), especially as a sequel to
trauma or surgery of the eye (Fine and Zimmermann, 1959)»
where infection is believed to be exogenous in origin.
In the latter instance conjunctival saprophytes might
assume a pathogenic role in an "opportunistic" infection,
as recently discussed in the more general sphere of
microbial disease by Symmers (1965)*
The effect of corticosteroids in reducing
resistance to a variety of bacterial, fungal and viral
infections is well recognised (Zimmermann, 1950;
Kligman and others, 1951J Selye, 1951; Symmers, 1965)»
and it is believed that corticosteroids may permit fungi,
normally regarded as harmless commensals, to behave as
pathogens (Agarwal, Malik, Mohan and Khosla, 1963;
Suie and Havener, 1963)* There is evidence that the
extensive systemic and topical use of corticosteroids
and broad-spectrura antibiotics has largely contributed
to the increase of ocular mycoses (Hogan and others,
195^; Suie and Havener, 1963; McLean, 1963;
Manchester and Georg, 1959; Wolter, 1962} Currie,
1963)* There is also clear experimental evidence for
the enhancement of the effects of fungus infection by
corticosteroids (Mankowski and Littleton, 195^; Ley,
1956; Hirose, Yoshioka, Abe, Kanemitsus and Kiya, 1957;
Agarwal and others, 1963)* Although such experimental
conditions may have little counterpart in human ocular
infections, there are frequent reports at the clinical
level, of ocular mycoses complicating steroid therapy,
especially in relation to the recognised pathogens of
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the Candida species. Sykes (19*16), Mendleblatt (1953)»
Mitsui and Hanabusa (1955) and Roberts (1957) have all
reported corneal infections by Candida albicans.
Maddren (19**1) reported a case of severe angular
conjunctivitis occurring in the course of extensive
candidiasis in a woman, but Duke-Elder (i960) has stated
that fungus infections of the conjunctiva are very rare.
A case of ocular mycosis due to Candida parapsilosis was
reported by Manchester and Georg (1959)* Their patient
was thought to have received corticosteroid and
antibiotic drops for a long period before developing
keratomycosis, the initial lesion being a superficial
punctate keratitis. Currie (1963) described three
cases of mycotic keratitis associated with corneal
ulceration. Candida albicans was implicated, and he
considered that steroids had aggravated the condition,
Ainley and Smith (1965) have recently described a
probable case of secondary keratomycosis due to Candida
parapsilosis, which responded to the administration of
Nystatin.
It is of interest that both Candida albicans and
Candida parapsilosis were recovered in the isolates from
the clinically normal conjunctivae in this series and
that Candida albicans was represented in the isolates
from patients receiving topical steroid/antibiotic
preparations•
Previous studies have been undertaken of the effects
of corticosteroid therapy upon the incidence of fungi in
the eye. Mitsui and Hanabusa (1955) obtained h2
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positive cultures from 62 patients receiving topical
ocular steroids (67$), while a control group of
untreated patients had an incidence of 18.5$. The
majority of the isolates in their series were
Penicilliura, Candida, Saccharomyces, Aspergillus, or
Rhodotorula spp. In a second experiment, these
authors selected 18 cases, initially negative for
fungi by smear or culture. Following topical
application of hydrocortisone ointment for 3 weeks,
the eyes of 9 of the subjects were fungus positive,
Penicilliura and Rhodotorula spp. predominating. Ainley
and Smith (1965) Failed to demonstrate any striking
change in fungal flora following the application of a
corticosterold/antibiotic combination (Betnesol-N) to
the eyes. Thus, of 15 patients initially showing
negative cultures, only 3 became positive for fungi
after the administration of drops or ointment thrice
daily for not less than 2 weeks. They point out that
the number of patients studied was too small to give a
statistically significant result.
In the present Investigation, topical betamethasone
treatment of patients with clinically normal external
eyes and of patients with external ocular disease, did
not result in any significant changes in the mycotic
flora of the eye. Thus, 86 patients (165 eyes) with
clinically normal external eyes received betamethasone
disodium phosphate three times daily for 1 week; only
two pre-treatraent isolates and three post-treatment
isolates were obtained. Furthermore, no generally
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accepted fungal pathogens were represented. 46 patients
(74 eyes) with external ocular disease, who had been
receiving topical betamethasone disodium phosphate for
varying periods of time, yielded one fungal isolate, a
saprophytic Penicillium species and a further conjunctival
sac scraping from the same patient was negative.
Four fungal isolates, of no pathogenic significance,
were obtained from the eyes of 55 patients (75 eyes)
with various forms of external ocular inflammation, who
had been receiving the betamethasone disodium phosphate/
neomycin sulphate preparation for varying periods!
repeat cultures were uniformly negative. The combined
steroid/antibiotic preparation, therefore, produced no
significant changes in fungal flora in this group.
The effects of the topical administration of the
betamethasone/neomycin preparation to the patients with
clinically normal external eyes deserve comment. Thus,
there was one isolate from 104 eyes before the
commencement of therapy, and 11 isolates, including
three strains of Candida albicans, following its
completion. It is difficult to offer a simple
explanation of the comparatively large increase of
ocular fungi in this particular group of subjects, but
it is of interest that almost 50$ of the patients in
this category were hospital inpatients (23 rheumatoid
arthritis; 1 systemic lupus erythematosus). When the
cultural results are considered in relation to the
source of the patient, 10 of the 11 post-treatment
isolates xvere derived from the 24 ward patients, whereas
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only one post-treatment isolate was obtained from the
remaining 18 outpatients. The higher incidence of
fungi in the ward patients might possibly reflect a
high level of aerial fungal contamination of the ward
environment when the specimens were collected. On the
other hand, only one fungal species was recovered from
30 inpatients with rheumatoid arthritis receiving
systemic steroids in the same wards as the former group.
There is no evidence from the present investigation,
that the neomycin component of the combined topical
steroid/antibiotic preparation made any significant
contribution to the alteration of fungal flora in
patients so treated. Thus, there was no significant
difference in the frequency of isolation of fungi from
the eyes of patients with external ocular disease
treated with steroid/antibiotic and steroid alone
(Table VIII,12). It is, however, relevant to note
that numerous workers have shown that antibiotics,
especially the tetracyclines, can enhance the growth of
fungi, notably Candida albicans, and that subjects
treated with antibiotics are more often carriers of
Candida albicans than are untreated controls (McGovern,
Parrott, Emmons, Ross, Burke and Rice, 1953; Sharp,
195*0. There are relatively few reports to incriminate
neomycin in this respect, though Reiersol (1958)
observed a marked increase in the incidence of faecal
Candida albicans in patients given oral neomycin, and it
is possible that local neomycin therapy might give rise
to a similar situation in the conjunctiva.
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The Sjogren group of patients yielded some
interesting results. 10 primary isolates were obtained
from 7k eyes. The patients were instructed to use no
local treatment, not even saline washouts, for k days
prior to the first culture. Thereafter, they were
allowed to return to their usual routine of twice daily
irrigations with saline and instillations of
carboxymethylcellulose drops (0.5$ solution) at least
four times daily. The second cultures were taken
while the patients were receiving this irrigation regime,
and the totally negative cultural results could be
adequately explained on the basis of mechanical removal
of foreign material from the conjunctival sacs by the
irrigations. This thesis is supported by the fact
that seven fungal isolates were subsequently obtained
from the eyes of eight patients who consented to stop
all local treatment for four days before the collection
of further specimens. Any fungistatic effect of the
carboxymethylcellulose drops (which contains
chlorhexidine digluconate, 0.05$) was excluded by
failure to demonstrate inhibition of 20 strains of
Candida albicans, three strains of Rhodotorula, and
two Aspergillus strains, in simple plate diffusion tests
in agar.
The results indicate that the untreated dry eye of
the Sjogren patient is more susceptible to colonisation
with fungi than the healthy eye. As already stated some
patients suffering from Sjogren's syndrome may be
receiving systemic steroid therapy. This study shows
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that the isolation rate of fungi from rheumatoid
arthritic patients who do not have keratoconjunctivitis
sicca is unaffected by systemic steroid therapy and
similarly the isolation rate from Sjogren patients is
not influenced by systemic steroids. In view of the
more frequent isolation of fungi from the Sjogren
patients, including the potential intra-ocular pathogens
Candida albicans and Candida parapsilosis, it is
concluded that a constant watch must be kept on these
patients* eyes for evidence of mycotic infection.
Finally, particular caution must be exercised prior to
any surgical procedures since it is known that fungi may
be introduced as a result of trauma (Fine and Zimmermann,
1959).
Summary
Studies of the fungal flora of healthy and diseased
conjunctival sacs had to be undertaken before any
reliable comments could be passed on the incidence of
fungi in keratoconjunctivitis sicca.
Fungi were isolated from 2.9 per cent of 1106
healthy conjunctival sacs, a higher incidence being
observed in older age groups. Although the majority
of the species isolated were non-pathogenic transient
aerial contaminants, some potential intra-ocular
pathogens were also represented.
Because topical steroids are advocated for the
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treatment of keratoconjunctivitis sicca, the effects of
topical administration of betamethasone and of a
combined betamethasone/neomycin preparation of patients
with normal and diseased external ocular tissues was
observed. Topical betamethasone therapy did not
result in any significant changes in the fungal flora
of healthy eyes but a higher incidence was observed in
the eyes of hospital inpatients treated with betamethasone/
neomycin preparation. The outpatients who had external
ocular disease under treatment with steroid or steroid
and antibiotic applications had no more fungal
colonisation than the healthy subjects.
Fungi were obtained from 13*3 per cent of the 37
patients suffering from Sjogren's syndrome. This is
significantly higher than matched healthy eyes.
Whether the patients were receiving systemic steroids
or not made no difference. The isolates included
potential intra-ocular pathogens, Candida albicans and
Candida parapsilosis and the untreated dry eye may be
more susceptible to fungal colonisation than the eye
receiving simple "replacement" therapy.
189
STUDIES OF THE VIRAL FLORA IN
KERATOCONJUNCTIVITIS SICCA
Thirty per cent of kO newly diagnosed untreated
keratoconjunctivitis sicca patients had various corneal
staining patterns when fluoresceine was stilled
(Chapter II, page 4o)• Some of the lesions bore
features not unlike early herpes simplex or adenovirus
infections. In addition, two patients, while
receiving treatment, developed corneal ulceration that
spread out from a dendritic pattern to involve two-thirds
of the corneal surface and extend into the anterior
third of the stroma (Figs. VIII,5 and 6). Jones and
Coop (1965) recognised simplex corneal ulceration in
some of their keratoconjunctivitis sicca patients and
reported that some of them were carriers of the virus.
However, no analysis of virus infection in Sjogren's
syndrome has been recorded to date. Consequently,
corneal cells from patients suffering from
keratoconjunctivitis sicca were examined for evidence
of herpes simplex and adenovirus infection.
Two methods of detecting viruses in the cornea
are at present in use; tissue culture and
immuno-fluorescence.
Fig.VIII.5 showing spreading corneal ulceration
that began in a dendritic pattern. Large
mucous shred at 7 o'clock, Photograph taken
immediately after instillation of B.J.6, thus
highlighting the edges of the ulcer - patient
No.20, appendix VIII.
Fig,.VIIItt> Dendritiform pattern of corneal
ulceration photographed after instillation of
B.J.6 - patient No.18, appendix VIII.
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Patients
Between 1 9<>7 and 1968, 30 patients suffering from
Sjogren's syndrome and exhibiting fluorescein staining
of the cornea were examined for evidence of adenovirus,
herpes simplex and TRIC viruses by iramunofluorescence
techniques.
The investigations for corneal viruses were
repeated in 8 patients and in a further 20 cases
during 19&9» using standard tissue culture methods
for herpes simplex and adenoviruses.
Collection of Specimens, Techniques
Immuno fluo re s c enc e
Suspect corneal epithelial cells were removed with
a flattened aluminium spatula after instillation of a
one per cent solution of amethocaine. The cells were
spread over a clear glass slide, dried at room
temperature, fixed in 90 per cent acetone for 90
seconds and transported immediately to the laboratory.
According to the methods in current use at the
Department of Virology, Belvidere Hospital, Glasgow,
a polyvalent serum was developed in rabbits to herpes
simplex, adenoviruses 3»7»8 and 14 and the TRIC group.
This anti-serum was conjugated with fluorescein,
thereby rendering any reaction with appropriate virus
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antigen contained in the corneal cells visible under
ultra-violet light.
Tissue Culture
Specimens of corneal cells were obtained by-
scraping the corneal surface with sterile cotton
tipped sticks. The ends of the sticks were broken off
and immersed in screw topped bottles containing tissue
culture medium of He&a cells. The specimens were
transported immediately to the University Department of
Virology, Gardiner Institute, Glasgow, where they were
incubated for up to four weeks and examined by the
methods in current use in the department.
Results
No viruses were detected by either method.
Discussion
This study has failed to show any evidence of
herpes simplex, adenoviruses or TRIC viruses in the
corneal cells of patients suffering from Sjogren*s
syndrome.
The procedure for obtaining corneal specimens for
tissue culture is well established and gives a 90 per
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cent isolation rate for herpes simplex from dendritic
ulcere diagnosed at the University Department of
Ophthalmology, Glasgow. Figures VIII,5 and 6 are
certainly dendritic-like ulcers and it is difficult
to explain negative results in these cases. It is
possible that the patients had a form of corneal
ulceration akin to spontaneous corneal perforation.
However, reduced corneal sensitivity was not recorded
in either patient.
The collection of specimens in the imraunofluoresceine
study was also similar to that used in other series.
However, Richardson and his colleagues (Richardson,
Croiabie, Gardner and McQuillin, 19^9) deposited the
corneal cells in phosphate buffered saline and fixed
them in acetone for 10 minutes at k°C, An examination
of the value of immunofluorescence in diagnosing virus
infections is beyond the scope of this thesis. It is
sufficient to record at present that no viruses were
detected by this technique or by tissue culture in
patients suffering from Sjogren's syndrome.
Summary
Some of the staining patterns in Sjogren's syndrome
suggest early herpes simplex or adenovirus infections.
For this reason corneal cells of 30 patients were
examined by immunofluorescence methods and those of 28
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patients by tissue culture on HeLa cells. Eight
patients were examined by both techniques.
No viruses were detected.
19^
SUMMARY
Although it has been stated in the literature that
conjunctival and corneal infection is common in K.C.S.,
there do not appear to be any publications describing
the prevalence of this complication in a series of
patients. This Chapter is a careful documentation
and investigation of ocular infection in K.C.S. The
conclusion of these studies is that bacterial infection
and fungal colonisation is significantly high in
untreated K.C.S. but that it is greatly reduced by
lubricant therapy. A controlled study of combined
antibiotic/corticosteroid topical therapy revealed a
high fungal infection complication rate. Penicillin
resistant staph, aureus particularly in the presence
of blepharitis are the most prevalent of the
pathogenic bacteria. No viruses were detected.
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THE TREATMENT OP ORATOCOMJBNCTXYXTX8 SICCA
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The prescription of "correct" treatment for
keratoconjunctivitis sicca is only one facet of the
management of this perplexing disease. Encouragement,
explanation and confidence in the medical staff are at
least as important as either topical or systemic drugs.
Knowledge on the part of the administrator is essential
if mishaps are to be avoided (Figure IX, 11 perforation
of cornea following intensive topical anaesthetics).
The most satisfactory way of supervising Sjogren
patients is to create "dry eye" clinics from which a
close liaison between patient, ophthalmologist and
physician can be developed. This is a record of the
achievements and failures of such an enterprise which
spanned the years 19^5 to 1970»
Success in the management of the ocular
manifestations of Sjogren's syndrome has bee n claimed
by many authors and a bewildering variety of treatments
have been in fashion from time to time. Table IX,1
shows the types of local therapy and their exponents from
1924 onwards. It is noticeable that beneficial results
were claimed by some authors for all of the treatments
on the list (except subcutaneous Pilocarpine injections
which produce sweating and salivation but no lacriuation,
Schoninger, 1924). Initially, enthusiastic claims were
made for each of the systemic drugs listed in Table IX,2.
However, later reviews were either more cautious or
completely condemned earlier forms of treatment.
Manschott in 1961 concluded that most forms of systemic
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Cifford and others (1943)
Thonard (1956)
Hatch and Boese (1955)
Thomson and Eadie (1956)
Weill (1957)
Critchley and Meadows, (1933)
Cervical Sympathectomy Leirich (1947)
Weill (1957)
Ovarian Hormones Isakolvitz (1928)
Breinlich (1937)
Vehagen (1943)
Pried and Goldzieher (1944)
Bruchner (1945)
Smith and Smith (1950)
Behrman & Lee (1950)
Thyroid de Roeth (1945)





Frenbel, Hellinga and Groen (1951)
Sjogren (1951)
Cadman and Robertson (1952)
Sjogren and Erikson (1952)
Erlich and Greenberg (1954)
Gaulhofer (1954)
Curling, Bruoe-Pearson and Pond (1954)
Sohaposnik, Bergna and Lohte (1955)
Wigley and Egan (1955)
Kadie and Thomson (1955)





Antimalarial Drugs Heaton (1959)
Immunosuppressive drug«1 Croapton (1968)
Table IX,2 Forms of systemic therapy since 1935.
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were of* no value because they did not strike at the root
cause of the disease, and although systemic steroids
might improve the well-being of the patient, there was
rarely any demonstrable increase in tear secretion.
However, when acute exacerbations are characterised by
lacrimal and salivary gland enlargement or painful
dacryoadenitis a rapid, although short lived, remission
may follow treatment with corticosteroids or
adrenocorticotrophic hormone (Frenkel, Hellings and
Groen, 1951; Gurling, Pearson and Pond, 1951 J Jones
and Coop, 1965)* Despite every effort, some patients
suffering from keratoconjunctivitis sicca continue to
suffer considerable discomfort, which prompted Duke-
Elder and Leigh (1965) to express the somewhat gloomy
view that "in the majority of such cases the
ophthalmologist is reduced to the expedient of judicious
but impotent expectancy".
One point that appears to be certain, from my
perusal of the literature, is the wide variation in the
clinical course of the disease. Hence the effectivity
of any treatment should be examined only when it has
been in use over a lengthy period of time. Furthermore,
since there is no treatment at present that will
eradicate the disease, all that can be achieved is




Ninety-eight patients were supervised for no less
than three years. All were suffering from definite
rheumatoid arthritis, 88 females, 10 malesf mean age
58.4 years; range 32 - 74 years.
Seventy of the patients were cases diagnosed for
the first time by the author, the remaining 28 were
referred by ophthalmic colleagues from various parts
of the West of Scotland.
METHOD OP ASSESSMENT
Progress was estimated in terms of change in the
symptoms and slit lamp signs recorded in Chapter II
(page 39) and constant watch was kept for signs of
infection as described in Chapter VIII (page l6o).
When the studies of bacterial flora had been completed,
on the newly diagnosed patients one month of
Chloromycetin drops four times daily and Chloromycetin
ointment nocte were prescribed. Thereafter, "tear
substitute" therapy was instituted. Each of the 28
patients referred by ophthalmic colleagues had lid
margin, sac and nasal cultures on first acquaintance












Many attempts have been made to replace normal
tear secretions and evidently some success was met with
in at least a proportion of cases (Table IX,1).
Nevertheless, the failure rate was high enough to
stimulate continued search for satisfactory local
treatment. Jones and Coop (19<>5) noted that patients
with keratoconjunctivitis sicca tolerated topical
sulphacetamides and wondered if the alkalinity of the
solutions was an important factor. After a three year
study involving 50 patients they concluded that the
solution now known as BJ6 with a pH of 8.45 was the
most satisfactory one they had tried. They state that
it was quite obvious the patients preferred this
solution to one per cent methylcellulose or any other
artificial tears such as Gifford's drops.
















Improved No change Worse
Patients receiving
alternative

























Improved No change Worse
treatment at end of
time allotted.
1 98 58 2*4 1 6 1 Q
2 79 51 18 1 0 1*4
3 65 *45 10 1 0 9
Table IX,U B.J.6 therapy.
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Method
All patients were given BJ6 drops and instructed
to use thera no less than four times per day. In
addition, the eyes were to be bathed night and morning
with cotton wool swabs soaked in sterile water to which
had been added half a teaspoonful of salt per pint of
fluid. This simple remedy was recommended for the
mechanical removal of any excess discharge.
Results
Sixty-five (62%) of the 98 patients completed
three years of BJ6 therapy without receiving any other
treatment (Tables IX,3 and 4) but only 44 (49%) had
fewer symptoms and signs (Table IX,5 and Fig.IX,1).
Successful treatment can be analysed in three ways;
improvement in symptoms (Table IX,3), in signs (Table IX,
or in both (Table IX,5). More patients showed
subjective than objective improvement but the difference
in this series is not significant. At the end of each
year of BJ6 therapy almost the same percentage of
patients had required alternative or additional therapy,
19 of 98 (18%) in the first year, 14 of 79 (18%) in the
second and 9 of 65 (14%) in the third (Tables IX,3 and
4). The mean percentage "loss" over three years was
therefore 16.6 per cent per year. If this trend were









years treatment Improved No change Worse
1 98 52 10 14
2 79 45 1 6
3 65 44 2 6
T«bl» XX»3 th«rap7






Fig.IX,1ResponsetB.J.6therapy?a=sym toms,bign , c=both.
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required alternative or additional treatment within
years of first receiving BJ6 tear substitutes.
Reasons for changing or supplementing basic
replacement therapy were increase in symptoms (5
patients), signs (9 patients), both (26 patients),
recurrent lid infections (1^ patients) and corneal
lesions treated as suspected infections (7 patients).
Of the 21 patients who showed evidence of infection, 16
were affected more than once. Nevertheless, BJ6 tear
substitute was continued in these patients during and
between courses of antibiotic therapy. 33 patients
required naso—lacrimal duct occlusion and BJ6 was still
useful in 10 cases after operation.
Discussion
Calculation of subjective improvement presents
difficulties because so many factors are involved. The
patientfe personality, home commitments, weariness after
a long ambulance journey and so on may colour the
replies required to enquiries about symptoms.
Nevertheless, some record of the patient*s symptoms is
helpful especially in a chronic disorder like Sjogren's
syndrome even if it only indicates a general trend. In
this study more patients responded subjectively than
objectively to BJ6 tear substitutes but nearly all of
the cases whose signs diminished had symptomatic relief
(Table IX,5)• Sixteen per cent of patients per year
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required alternative or additional treatment such as
antibiotics, obliteration of naso-lacrimal canaliculi
or mucolytic agents and it would appear that all of the
98 patients in this study will have required at least
supplements to BJ6 therapy within 1 ^ years. However,
the carboxymethylcellulose solutions were still useful
in a large number of patients who had required different
treatment at some stage.
Summary
BJ6 therapy improved the symptoms and signs for
three years in k9 per cent of 98 patients suffering from
keratoconjunctivitis sicca. However, each year 16 per
cent of the remaining patients required alternative
or additional treatment and it is therefore unlikely
that BJ6 alone can control the disease indefinitely.
Nevertheless, patients benefit considerably from the
instillation of this tear substitute and it is useful
in conjunction with other remedies.
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(b) Conservation of Tears
Naso-lacrimal Duct Occlusion
"Assuming that these irritable eyes are entirely
the result of a lack of tears, we find ourselves
considering the possibility of making better use of
the tear supply that is available" . (Beetharn, 1935)-
Beetham decided to destroy the naso-lacrimal ducts
in four patients suffering from filamentary keratitis
sicca with the idea in mind that the few tears being
produced would be conserved in front of the eye for
longer periods. In each case the improvement was
immediate, pericorneal injection, corneal filaments
and mucoid discharge disappeared and punctate staining
areas were diminished. In addition, the measurable
amount of tear secretion was increased. Beetham
emphasised the need for diathermy of the canaliculi as
well as the puncta to guarantee permanent occlusion.
Since then many investigators have used this method and
have met with varying degrees of success (Table IX,1).
The main problem appears to be selection of suitable
cases. Holm (19^9) suggested that symptoms should
have persisted for at least one year and that there
should be heavy staining of both conjunctivae and
corneae with rose bengal dye. Jones and Coop (196.5)
emphasised that patients must have visibly abnormal
corneal epithelium and that occlusion should not be










Improved No change Worse
1 1 1 10 1 -
2 7 5 1 1
3 14 10 3 1
32 25 5 2









Improved No change Worse
1 1 1 8 3 -
2 7 4 2 1
3 14 8 5 1
32 20 10 2











Improved No change Worse
1 1 1 7 - -
2 7 k 1 1
3 8 3 1
32 19 k 2
Table IX,8 Obliteration of canaliculi and puncta.
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Method
Thirty two (3*1$) of the 98 patients suffering from
Sjogren's syndrome required naso-lacrimal duct
obliteration. Twenty five (27$) were selected because
of increased symptoms and signs and 7 05$) because of
increased signs only. All of the patients had been
supervised for at least one year and had received BJ6
during that time. In three patients the signs affected
the conjunctivae only. The naso-lacrimal ducts arid
lacrimal puncta, upper and lower, were obliterated
simultaneously by a diathermy current of 40 to 60
milliamperes. No fixed duration of application was
used. When the skin overlying the canaliculus blanched
the probe was slowly removed and the punctum sealed.
Generally, 5 to 10 seconds was sufficient.
Results
The results are shown in Tables IX,6,7 and 8. A
total of 25 of the 32 patients (76$) benefited from the
procedure, 19 (57$) subjectively and objectively, 6 (18$)
gaining symptomatic relief but no change in signs
(Figures IX,2,3t*1 and 5).
Eleven of the 32 patients (33$) were followed for
one year, 7 (21$) for two years and 14 (^2$) for three
years. As in the previous study with JtfJ6 therapy, the
number of patients gaining symptomatic relief was greater
Fig.IX,2 Patient No. 2-7, appendix IX, 3 years
after N-L obliteration - no injection, normal
moist eye.
Pig.IX,3* Patient No.17# appendix IX, 48 hours
after N-L obliteration — slight injection still
present — no mucous*
Fig.IXp4. Patient No.6ht appendix IX.
Symptoms improved following N—L obliteration
but signs still present. Site of previous
corneal ulcer at 7 o'clock now quiescent.
Folliculitis of lash follicles a recurrent
problem with this patient.
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than those showing objective improvement but the
difference is not significant. About the same
percentage of patients continued to show subjective
and objective benefit with the passing of each year.
Seven of 11 (63%) after one year, 4 of 7 (57$) after two
years and 8 of 14 (57$) after three years (Figure IX,2).
However, two patients continued on a downhill course
despite obliteration of naso—lacrimal passages and
BJ6 therapy (Table IX,6) and 8 patients were unaffected
by the procedure. Ten of the 32 subjects (30$) continued
with BJ6 after occlusion but were easier to control as a
result of the surgery.
Discussion
The majority (76$) of the patients in this series
who underwent naso-lacrimal canaliculus obliteration
benefited from the procedure and there was no tendency
for deterioration over a three years' period. Holm
(19*19) performed this operation on 23 cases. He
observed the long term results in 14 patients finding
that 8 (57$) were still much better, 6 of them free of
trouble after 5 to 6 years. Although Holm was impressed
by the relief of symptoms, he detected little difference
in signs. In the majority of his cases filaments,
mucous shreds and heavy rose bengal staining persisted.
Only 6 patients (18$) in this series improved
symptomatically without shotting any change in signs.




Furthermore, Jones and Coop (1965) were of the opinion
that provided abnormal corneal epithelium was present,
occlusion of lacrimal outflow was always followed by
improvement in both symptoms and signs. They emphasise
the need to choose patients carefully. One of their
failures had only slight corneal staining and had more
trouble with the epiphora after operation than with
his symptoms beforehand. In the present study, three
patients with heavy conjunctival staining but no corneal
activity were successfully treated and one of them has
been followed for three years since the operation.
There would appear to be three possible explanations
for this apparent contradiction of Jones and Coop*s
criteria.
(1) Abnormal corneal epithelium was present in these
three patients in between visits to the Clinics,
(2) The keratoconjunctivitis sicca was only saved
from progressing to corneal involvement by the
obliteration of the naso-lacrimal ducts.
(3) Abnormal corneal epithelium need not be the
presiding factor influencing the decision for
operation.
Mucous shreds and heavy conjunctival staining may
be present in the absence of corneal filaments hut in
the presence of marked symptoms. In addition, Holm
(19^9) noted that even in patients who showed
considerable symptomatic relief after occlusion of
214
lacrimal outflow, corneal filaments may persist. In
this study 6 patients gained symptomatic relief without
any change in their signs, These findings suggest that
visibly abnormal corneal epithelium need not be the only
criterion and that perhaps resistance of symptoms despite
intensive topical therapy should be regarded as of prime
importance in the decision to obliterate naso-lacrimal
canaliculi and puncta.
Ten of the successfully treated patients were
improved still further by the continued use of BJ6 tear
substitutes. It is apparent that there is a need for
more than one approach to the problem of treating
keratoconjunctivitis sicca.
Summary
Thirty - two of the 98 patients with Sjogren*s
syndrome did not respond to at least one year of BJ6
therapy and therefore underwent occlusion of the naso¬
lacrimal canaliculi and puncta. The majority of the
33 patients, 76 per cent, benefited from the procedure,
57 per cent both objectively and subjectively and
improvement continued at the same level for up to three
years. Visibly abnormal corneal epithelium need not
be present in every case before operation is considered.
Three patients in this group with normal epithelium
benefited from occlusion of the lacrimal outflow. It
is suggested that symptoms which resist current topical
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therapy should be regarded as at least as important
as the presence of corneal filaments.
Haptic Contact Lenses
Very few investigators have reported the result of
treating keratoconjunctivitis sicca with contact lenses
(Table IX,1). Only 3 patients in this group were
fitted with haptic lenses and the results were
uniformly bad. All three were severe examples of
Sjogren's syndrome who did not respond to BJ6 therapy
or naso-lacriraal canaliculi occlusion. None of them
was able to tolerate the lenses. Since simpler methods
give relief to the majority of patients it would appear




It is very likely that excessive mucus is at
least partly responsible for the corneal changes
typical of keratoconjunctivitis sicca and corneal
filaments seem to consist largely of mucin (Chapter II,
page kz)• Therefore, one aim in the treatment of
keratoconjunctivitis sicca is the reduction of excess
of mucus.
N-acetyl-L cysteine lowers viscosity by the
reducing action of the free sulphydryl group in the
molecule on the disulphide bonds of the muco-proteins
in mucus. Its action finds widespread application in
the treatment of respiratory tract disease (Webb, 1962),
Jones and Coop (1965) reported encouraging short term
results in the treatment of keratoconjunctivitis sicca
with a 20 per cent solution of acetyl cysteine and
Absolon and Brown (1968) in a double blind cross over
trial lasting four months observed better results than
with BJ6 tear substitute.
Method
Acetyl-cysteine reacts with rubber and begins to
deteriorate after *>8 hours exposure to air. Opened
containers should be kept in a refrigerator at between
4 and 10°C (Stephens, Medical Information Department,
British Drug Houses, 1968). In this study the drops








Improved No change Worse
1 20 8 1 1 1
2 20 10 9 1
3 19 1 1 8 -
4 19 9 10 -
5 19 8 1 1 -
6 19 8 1 1 -
Table XX,9 Response to acetyl-cysteine.
Duration of No. of patients Effect on Signs
treatment completing
months treatment Improved No change Worse
1 20 10 9 1
2 20 10 9 1
3 19 10 9 -
4 19 8 1 1 -
5 19 7 1 2 -
6 19 7 1 2 —
Table IX,10 Response to acetyl-cysteine.
»T Effect on bothDuration of No. of patients Symptoms and Signstreatment completing
(months) treatment imnrnv^H No change
1 20 8 9 1
2 20 8 8 1
3 19 8 6 -
k 19 7 9 -
3 19 6 10 -
6 19 6 10 -
Table XX,11 Response to aoetyl-oysteine*
-£ I /
were dispensed in plastic top bottles diluted to 5$
solution with sodium bicarbonate added to a pH of 8.^.
Patients were instructed to apply the drops at least
four times per day, to keep the bottles in a
refrigerator and to renew them after ^8 hours.
Patients
Twenty patients who continued to display mucous
shreds and corneal filaments after more than one year of
BJ6 therapy were selected for treatment with 5$ acetyl¬
cysteine. Eight of the patients had had their naso¬
lacrimal ducts occluded without any beneficial effect.
To comply with instructions from British Drug Houses,
only those patients who had access to a refrigerator
were included in the trial which was carried out over a
period of 6 months.
Results
Results are shown in Tables IX,9,10 and 11, the same
classification being adopted as in the previous studies.
There was no difference in subjective and objective
improvement throughout the 6 month period of the trial.
One patient was withdrawn after two months of treatment
because her symptoms and signs were worse. Her general
health had also deteriorated, however, and secondary















infection was demonstrated. At the end of 6 months,
8 patients (40$) felt better, 7 (35$) had fewer signs
and 6 (30$) had improved subjectively and objectively
(Pig.IX,6).
Discussion
This small group of 20 patients was highly selected
and therefore not truly representative of
keratoconjunctivitis sicca patients as a whole. They
had all failed to respond to at least one year of BJ6
therapy and 8 in addition had not benefited from
occlusion of lacrimal outflow. Since acetyl-cysteine
is a mucolytic agent, only patients who displayed
corneal filaments and/or mucus threads were chosen for
treatment. Therefore, this group of patients may have
been worse examples of keratoconjunctivitis sicca than
those reported by Jones and Coop in 19^5 and Absolon and
Brown in 1968. In addition selection in the present
series was further reduced to those patients who had
access to a refrigerator - a point not mentioned by
either of the other two groups of investigators. All
of the patients in the present group had definite
keratoconjunctivitis sicca and rheumatoid arthritis
(Sjogren's syndrome). The associated diseases in Jones
and Coop's group (1965) were not annotated and only 22
of the 30 patients in Absolon and Brown's study had
rheumatoid arthritis.
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Jones and Coop (19*>5) and Absolon and Brown (1968)
prescribed 20 per cent acetyl-cysteine at a pH of 7*
However, Stephens (British Drug Houses Ltd.) suggested
that a 20 per cent solution might be irritating to the
eyes and recommended dilution to 10 or 5 per cent. In
this context, it is interesting to observe that Absolon
and Brown (1968) thought some of their patients may have
been unable to distinguish discomfort caused by the
acetyl-cysteine from symptoms due to the disease.
Furthermore, since mucus is dissolved more easily in an
alkaline solution, the pH in this study was adjusted to
8.4. Over a period of 6 months, 30 per cent of the
patients showed both objective and subjective
improvement. Jones and Coop (1965) reported striking
relief of symptoms in 13 of 15 patients (87$) with
complete disappearance of mucus strands and ropy
discharge but the duration of their observations is not
stated. Absolon and Brown (1968) observed more
improvement in signs in 30 patients treated for two
months with acetyl-cysteine than with BJ6 but no
difference in symptoms was reported.
The results of the present investigation are
gratifying in that 30 per cent of 20 patients who were
untouched by previous treatment reacted favourably to
5$ acetyl-cysteine. Clearly, a longer trial is
necessary and some method of preserving acetyl-cysteine




20 patients suffering from Sjogren's syndrome who
had received at least one year of BJ6 therapy without
benefit were treated for 6 months with the mucolytic
substance 5 per cent acetyl-cysteine in solution at a
pH of 8.'u Eight of the group had also undergone naso¬
lacrimal duct and puncta obliteration without success
and only those patients with corneal filaments and/or
mucous threads were selected. Thirty per cent improved
both subjectively and objectively and this was regarded
as an encouraging result since the patients had been
resistant to other forms of therapy. In the future a
longer trial should be carried out and efforts should
be made to find a suitable formula for stabilising
acetyl—cysteine.
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(d) Hygiene, Antibiotics and Topical Steroids
The prevalence of* microbial agents in the dry eye as
compared with the moist eye was examined in Chapter VTII.
Evidently, the dry eye, especially the untreated one, is
more susceptible to bacterial and fungal colonisation
than the healthy eye. This being so the practice of
strict personal hygiene must be a primary consideration
in the management of keratoconjunctivitis sicca. The
present group have been instructed to use separate face
cloths and towels in an attempt to minimise infection
from other members of their households. They have been
warned of the dangers of rubbing their eyes with hands
which may be unclean and have been advised against eye
baths for the same reason. Inevitably, the catchment
area for the patients studied in this series include
sections of Glasgow not endowed with modern toilet
facilities. In a few cases, the author has been able
to initiate improvements in living conditions or even
the provision of alternative accommodation.
Part of the regime of "replacement therapy" is
twice daily bathing with dilute salt water prepared by
the patient at home. When home conditions are
inadequate and the patient's personal hygiene is in
doubt, it is better to forgo this simple but effective
supplement to the treatment of keratoconjunctivitis
sicca.
Jones and Coop (1965) observe that staphylococcus
aureus infections were so common in keratoconjunctivitis
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sicca that there was "something to be said for the
intermittent use of chloramphenicol ointment at night
in many cases". In the previous Chapter (VIII) the
prevalence of bacterial isolates, pathogenic
staphylococcus in particular was shown to be higher on
the lid margins and in the conjunctival sacs of
untreated keratoconjunctivitis sicca patients than in a
control series of rheumatoid arthritics. Overt
blepharitis, sometimes accompanied by folliculitis,
styes or yellow conjunctival discharge was present in
about 30 per cent of newly diagnosed cases and the
prevalence of staphylococcus aureus was highest of all
in this group. Most of the pyogenic staphylococci
were resistant to penicillin but not to Chloromycetin
or tetracycline.
All of the newly diagnosed patients and also those
referred by ophthalmic colleagues were treated with
Chloromycetin drops four times per day and ointment
nocte for the first month of their supervision. Repeat
cultures were performed 011 the patients suffering from
belpharitis and the antibiotics were continued until no
bacteria could be detected. Nevertheless, 21 of the 98
patients (21.3^) developed evidence of infection during
treatment with BJ6 tear substitute. Most of them
suffered from belpharitis (1 li) the remainder from
various corneal lesions and 16 of the group (16%) had
recurrent bouts of infection requiring several courses
of antibiotics (Fig.IX,7)*
Topical steroids have never been prescribed for any
Fig.IX,7 Patient No.69» appendix IX,
Staph, pyogenes corneal ulcer photographed
one week after commencing topical Chloromycetin,
Ulcer at 6 o'clock. Mucous shreds at
h o'clock and 8 o'clock.
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of the Sjogren patients during the period of supervision
under consideration. The prevalence of bacteria is so
high and fungi colonise the untreated dry eye so readily
that the author decided against corticosteroid therapy.
One patient, a year old rheumatoid arthritic of 10
years' duration had been using topical steroids for four
years before referral to the clinic. She presented
with bilateral steroid cataracts (Crews, 19^3, Grade XV)
and glaucoma as well as her keratoconjunctivitis sicca.
Both cataracts had to be removed and drainage procedures
performed. Thereafter, her ocular symptoms were quite
adequately controlled with BJ6 tear substitute.
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(e) Management of Complications
Serious corneal complications are unusual in
Sjogren*s syndrome (Duke-Elder, 1965)* Nevertheless,
in this series 10 (10%) of the 98 patients suffering
from keratoconjunctivitis sicca developed severe corneal
lesions. The cases described in this section are by
necessity highly selected in that none of them
responded to at least one year of BJ6 therapy and
obliteration of lacrimal outflow made no difference to
their signs or symptoms. However, in other respects,
age, duration and stage of arthritis, duration of ocular
symptoms and laboratory data, they were no different
from the rest of the keratoconjunctivitis sicca
patients. Nor did the appearance of the corneal
complications, in this study, coincide with an
exacerbation of the patients' arthritis. The
management of these patients and that of a further two
cases is discussed under three headings, marginal
corneal infiltration with vascularisation, perforation
of the cornea and symblepharon with insufficient lid
closure.
Marginal Corneal Infiltration with Vascularisation
Marginal corneal infiltration was diagnosed in six
female patients. In two cases, the condition was present
when they were referred by ophthalmic colleagues; the
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others developed while under supervision at the "dry
eye" clinics. In five instances, infiltration was
monocular, in one binocular.
The anterior fibres of the stroma were the first
to be involved generally at the lower third of the
corneal margin. Gradual extension round the lirnbus
and into middle stroma in some cases, was accompanied
by vascularisation which was first evident as
capillary loops lying behind the anterior edge of the
infiltrated area. Three patients pursued a chronic
course with slow advance in this pannus-like
vascularisation. However, acute exacerbations
characterised by disruption of Boman's membrane and
the overlying marginal epithelium were a recurrent
feature of the others, one of whom also suffered two
attacks of extensive corneal infiltration and anterior
uveitis (Fig.IX,8).
Pathogenic staphylococci were isolated on three
occasions from two of the patients who developed acute
exacerbations but from none of the three whose disease
followed a chronic course.
The significance of bacterial infection in this
condition is difficult to judge. Chloromycetin was
prescribed at the earliest sign of the corneal lesions.
In retrospect, this action may have been unnecessary in
the chronic cases who might have responded to topical
steroids with a reduction in capillary formation. Beta
radiation had no effect on one patient, but produced an
impressive regression in the capillary loops in another,
Fig.IXt8 Patient No.7^» appendix IX.
Repeated courses of topical antibiotics were
necessary for this patient. Photograph
taken one week after current course of
neosporin had been started. Early pannus
formation showing between k and 6 o'clock.
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a beneficial result which has lasted for one year.
Electrocautery applied to larger vessels had no lasting
effect on a further two patients.
Perforation of the Cornea
Uniocular perforating corneal ulceration developed
in three of the 98 patients under discussion (1 male and
2 female) and in a further case who was referred because
of this complication. Corneal sensitivity was depressed
in each case and ulceration began centrally with loss of
epithelium and Bowman's membrane proceeding to stromal
lysis and perforation within one to six weeks. One
patient who had a three month history of ocular symptoms
had received topical anaesthetics for six weeks and
was referred as an emergency because of perforation of
the cornea (Figure IX,It). The other three patients
had been under supervision at the "dry eye" clinics|
two had had occlusion of outflow and all three were in
receipt of BJ6 therapy.
No bacterial organisms were isolated. However, a
species of Candida albicans was cultured from the cornea
and genito-urinary tract of one patient who in addition
had rosistent staphylococci in a thigh wound following
hip joint surgery (Figure IX,10).
The first case to present had a series of small
central perforating ulcers of less than 0.5 mm. in
diameter. She was treated conservatively with bed rest,
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firm bandaging of the eye, topical Chloromycetin and
atropine four hourly, and systemic sodium fusidate
(prescribed because of the high levels that this
antibiotic can attain in human aqueous and vitreous,
Williamson, Russell, Doig and Paterson, 1970). The
corneal ulcers healed within a few days on three
separate occasions; there have been no recurrences
for the past 18 months.
The second patient, however, presented with a
central corneal ulcer of 3 mm. diameter which had
developed rapidly in the course of one week. The same
treatment as in the previous case failed to prevent
perforation which took place three days after admission
to hospital. Iris prolapse, uveitis and secondary
glaucoma resulted in a blind eye three weeks later
(Pig.IX, 9). As a result of this disaster the methods
adopted with future cases were less conservative.
The third patient was subject to recurrent guttate
ulceration of the central cornea and had received
several courses of antibiotics. She presented with a
Descemtocele and was treated conservatively for three
days. However, the cornea perforated and, with the loss
of the anterior chamber, the lens came into contact with
the posterior surface of the cornea. The next day
after an ab externo approach the lens was extracted with
a cryostat. The corneal perforation healed and the
anterior chamber reformed within ^8 hours. One year
later there have been no further perforations and the
patient has 6/18, N8 corrected vision (Fig.IX,10),
Fig. IX#9 Patient No.23t appendix IX.
Collapsed anterior segment Following
perforation of left corneal ulcerf
uveitis and secondary glaucoma.
Fig.IX,10 Patient No.2k, appendix IX, one year
following extraction of lens. Eye white because
of topical acetyl-cysteine and N-L occlusion but
tendency to guttate ulceration at 6 o*clock still
present. No further perforation.
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The last patient was referred because perforation
had developed following: intensive topical anaesthetics.
The diagnosis of keratoconjunctivitis sicca had not been
suspected although the patient was known to be suffering
from severe sero positive rheumatoid arthritis. Lysis
of the ulcer with rapid extension to the limbus occurred
two days after admission to hospital (Figure IX,11).
Simple lens extraction was rejected because of the
enormity of the perforation and a full thickness 10 mm.
corneal graft incorporating a rim of sclera from 8 to
2 o'clock with extraction of the lens and complete
iridectomy was performed (Figure IX,12). Systemic
corticosteroids were prescribed in an effort to reduce
the risk of rejection of the scleral rim (60 mgm.
Prednisolone per day for 7 days, 50 mgm. per day 7 days,
reduction by 5 mgra. per day to 20 ingm. maintenance dose
for 8 weeks, 7.5 mgm. per day thereafter for six months).
Unfortunately, iris presented through the wound which
failed to heal in its lower third and two attempts at
resuturing were only partly successful. Nevertheless,
the graft maintained its clarity and three weeks after
the original operation an amniotic membrane was placed
across the entire anterior segment of the eye to
protect the iris until vascularised tissue had grown
over it. The amnion, however, was rejected within
2k hours. Nevertheless, at the fourth post-operative
week vascularised conjunctival tissue began to grow over
the prolapse. The patient was discharged from hospital
Fig.IX,11 Patient referred with perforating
corneal ulcer, treated for 6 weeks with
topical anaesthetic solutions. Iris
adherent to posterior surface of corneal
ulcer. Mucous shreds evident over lower
third of cornea.
Fig.IX,12 Patient shown in Fig.IX,11 following
corneo-scleral graft and lens extraction -
small prolapse of iris at 5 o'clock.
Fig#IXf13 Contra! pcjrforatinj ulcar in &raft
of patient shown in Figs.ixf1t and 12.
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8 weeks after admission, with a clear graft and a small
temporal prolapse. Progress continued satisfactorily
until the 14th post-operative week when a central ulcer
developed in the graft and perforated within 48 hours
(Fig.IX,13). Although the ulcer healed, bacterial
infection could not be avoided and a panophthalmitis
developed. The eye was removed 6 months after the
graft operation.
Symblepharon with Insufficient Lid Closure
In advanced examples of Sjogren's syndrome some
degree of symblepharon may develop (Duke-Elder, 19^5)»
The need for surgical intervention arose with only one
patient in the series and in another referred as a case
of essential shrinkage of the conjunctiva.
The first patient, a female of 73 years, had a
history of symblepharon affecting the lower fornices of
both sacs on two occasions during the preceding 6 years.
The adhesions had been severed and were not present
when the patient first came under care at the "dry eye"
clinics. After three years of supervision the patient
showed no improvement in signs and symptoms had
increased. Syrablepharon recurred in the right lower
fornix and within 6 months of its appearance had
resulted in defective lid closure. The adhesions were
divided with round ended scissors and the fornix kept
open by hourly glass rodding and Chloromycetin ointment
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for three days followed by four hourly treatment for one
week. The patient refused systemic steroids because she
had developed severe fluid retention 10 years previously
following 6 months* of cortisone. There has been no
further increase in the patient*s symptoms or signs and
no recurrence of the symblepharon over the past year.
The second patient, a male of 76 years, presented
with essential shrinkage of the conjunctivae affecting
the upper and lower fornices of both eyes (Fig.IX,14).
He had a three year history of dimness of vision,
recurrent episodes of pus discharge and a 10 year
history that indicated the possibility of
keratoconjunctivitis sicca (Chapter II, page 35). A
diagnosis of Sjogren's syndrome was made when examination
revealed clinical and radiological evidence of rheumatoid
arthritis. The eyelids were firmly adherent to the
eyeball and were in a permanently open position three to
four mm. wide. There was considerable pus discharge
and the exposed corneal epithelium had sloughed.
Ulceration extended into the deep stromal layers and
pannus-like vascularisation encroached on the peri¬
central cornea especially in the left eye. A pocket
of amniotic membrane containing a haptic corneal lens
was inserted into the fornices of the left eye and
secured with black silk sutures. The upper lid was
stitched down to the cheek for four days during which
time ocular movements were encouraged (Figures IX,15»
16 and 17)* The contact lens was removed on the 12th
post-operative day by which time most of the amnion had
Fig. IX, I** Essential shrinkage of conjunctivae
in a 76 year old male rheumatoid arthritic
with keratoconjunctivitis sicca. The eyelids
on both sides are being forced as far apart as
possible for the photograph. Slight movement
in the right upper lid but none in the right
lower lid is possible. The left eyelid
movements are better following amniotic
membrane graft s•
Fig.IX,15 Lids forced apart and dissected
off the eyeball* Extensive pericorneal
adhesions evident.
Fig*IX,16 Insertion of amniotic membrane.
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been discarded. The procedure was repeated in the
right eye.
One year later, both eyes showed considerable
improvement. The fornices were about half* normal depth,
lid closure though not complete was sufficient to
protect the corneae and vision had improved to 6/36, N14
right eye, 6/60, N24 left eye.
Discussion
Ten per cent of the 98 patients in this series
developed severe corneal lesions and a further two cases
were referred for treatment. The clinical and
laboratory data of the patients who developed these
complications were not significantly different from the
rest of the keratoconjunctivitis sicca group.
Marginal corneal infiltration with vascularisation
was diagnosed in six female patients, three of whom
developed acute exacerbations associated with pathogenic
staphylococci. Although response to antibiotics was
dramatic in these three cases, pannus-like vascularisation
continued to progress towards the centre of the cornea
in all six. The anti-inflammatory effect of topical
steroids was denied the patients because of the fear of
infection (Chapter VIII). In retrospect, this approach
may have been too cautious and in future steroids will
be used in chronic phases and as a sequel to antibiotic
therapy. Beta radiation caused regression in capillary
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loops in one case but neither radiation nor electrocautery
had any effect on vascularity of the cornea that had
progressed beyond the capillary stage. It is proposed,
therefore, that Beta radiation should be resorted to at
the earliest sign of pannus formation.
The management of perforating corneal ulcers in
Sjogren's syndrome was not clarified in any way by the
results in the four cases reported above. All four
patients had reduced corneal sensitivity at the time the
complications were diagnosed but it is difficult to see
what can be done about this - if anything. Prophylactic
tarsorrhaphy would appear to be a drastic procedure
particularly since ulceration with perforation appears
to be an inconstant complication of reduced sensitivity
(Chapter II). Candida albicans was isolated from the
eye and vulvae of one patient but examination for
bacteria was negative in all cases. There does not
appear to be any increased prevalence of infection,
therefore, in patients suffering from this complication.
Two patients developed small iris prolapses, the lens
coming into contact with the posterior surface of the
cornea around the edges of the perforation. The first
was treated conservatively with disastrous results, the
second responded well to lens extraction and abscission
of iris prolapse. Consequently, it would appear that
surgical intervention in these cases carries a better
prognosis. On the other hand, another patient who
developed small perforating ulcers without iris prolapse,
responded well to firm bandaging and bed rest. The
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remaining patient had been treated with topical
anaesthetics for six weeks and presented with corneal
perforation which extended rapidly towards the lirabus
necessitating a corneo-scleral graft with lens
extraction. The immediate post-operative period was
complicated by iris prolapse which resulted in defective
wound healing. Perforation occurred in the graft three
months after the operation and bacterial infection resulted
in a blind eye. There are several factors that may have
affected the outcome in this patient; topical
anaesthetics, extent of the surgery required, iris
prolapse and secondary infection. Clearly the only
avoidable one was the prescription of topical anaesthetics.
Symblepharon requiring surgical intervention
presented in two patients. The simple expedient of
snipping the tissue with scissors and keeping the fornix
free by glass rodding and ointment was quite sufficient
in one case who had undergone the procedure on several
occasions with results that lasted for several years at
a time. Another patient responded satisfactorily to
amniotic membrane grafts and haptic contact lenses.
It would appear, however, that this extensive surgical
approach could have been avoided if the symblepharon
had been dealt with at an early stage.
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Summary
Ten per cent of the 98 patients in this series
developed severe corneal complications which were
classified as marginal corneal infiltration with
vascularisation, perforating corneal ulcers arid
syrablepharon with insufficient lid closure.
Acute exacerbations associated with staphylococcus
aureus infection characterised some of the cases with
marginal infiltration. Nevertheless, it is advocated
that a trial of topical steroids following antibiotic
therapy might result in reduced vascularisation. Beta
radiation resulted in an impressive regression of
capillary loops in one patient but had no effect on
larger blood vessels in two other cases.
Perforating corneal ulcers present a complicated
problem. All of the patients in this group had
depressed corneal sensitivity and excessive topical
anaesthetic drops appeared to contribute to the extent
of the perforation in one instance. Candida albicans
was isolated from the cornea in one case but no
bacteria were detected. Conservative management would
appear to be sufficient in the presence of small
perforations. However, in the event of iris prolapse
with the lens brought into apposition with the edge of
the ulcer, abscission of the protruding uveal tissue
and lens extraction appear to give the best chances of
recovery,
Symblepharon causing defective lid closure
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responded satisfactorily in one patient to simple
division with scissors. Extensive amniotic membrane
grafts and haptic contact lenses produced an improvement
in lid closure in a further case with severe shrinkage
of the conjunctivae. It is suggested that earlier
intervention in this case would have avoided the need
for such radical surgery.
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(f) Future Developments
The cause of keratoconjunctivitis sicca in
Sjogren's syndrome is, like that of rheumatoid arthriti
obscure. There are no known prophylactic measures and
it would appear preventive therapy must a*vait further
elucidation of the whole disease process. For the
moment, the ophthalmologist has to content himself with
seeking better or at least alternative palliative
treatment. In this context, it is noted that reduced
lysozyme concentration in tears may precede all other
evidence of keratoconjunctivitis sicca and is a
constant feature of the established disease (Chapter II
page 44) • A lysozyrne solution designated MT-L
ophthalmic has been used recently in the treatment of
various inflammations of the external eye with good
results (Matsushita, Tani and Miyaura, t9^9)•
Consequently, a trial of this enzyme in
keratoconjunctivitis sicca patients is being arranged
at the time of writing.
In 1945, Maclean described glasses fitted with
reservoirs containing fluid that could be conducted
by means of a fine bore tube into the fornices of the
wearer. He reported encouraging results with this
apparatus in the management of keratoconjunctivitis
sicca patients. Flynn and Schulraeister working in
Australia (1967) recorded their experiences with
similar models and came to the conclusion that further
development was desirable. The concept of a constant
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drip of fluid into the dessicated eye is certainly
appealling, but to date satisfactory prototypes have
not been developed in this country. At the present
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Abbreviations and Symbols in Sequence
Appendix II




K.C.S. = Keratoconjunctivitis Sicca
R.A. = Rheumatoid Arthritis
Appendix IV
L.T. = Latex test for rheumatoid factor
A.N.F. = Antinuclear factor
Glob. = Serum Globulin
Alb. = Serum Albumin
Alk. Phos. = Alkaline Phosphatase
Appendix VII
B = Biopsied thyroid gland
H * Hypothyroid not receiving treatment
Prec. Test « Precipitin test
T.R.C. test= Tanned red cell test
Fluor. *C.F,' test = Fluorescent 'complement
fixation* test
S.T. as Schirmer II tejst
Family History + of pernicious anaemia
0 of thyroid disease
2k8
P.T.G. * Palpable thyroid gland
P.O.A. = Parietal cell antigen
T.A. * Thyroglobulin autoantibodies (all types)
Appendix VIII
S = Staph# aureus coagulase positive
C.I. a Clinical infection
Appendix IX
N-L = Naso-lacrimal puncta and canaliculi
obliterations
Acet. Cyst. = Acetyl cysteine 5 per cent
Symptoms ) improved
Signs ) 0 no change





































Effect of Temperature and Humidity
Age and Sex of Patients Studied
250 females| 88 males
0 1 2 3 4 5 6 7 8 9
46 54* 71 72 58 56 6o 56* 61
64 67 57 34 25 18 18 27* 58 61
55* 52 55 65 59 59 68 68* 70 61
56* 54* 47 72 56 61 52 64 53 59
64* 51 37* 53 57* 60* 64* 58 49 72
52 59 54 58 68 56 61 61 57 72
33 53 52 72 68 71 63 68 56 58*
57 61 58 52 48 61 46 42 39 71
49 60 54 55 50 58* 57 48 38 68
64 62 63 71 18 25 35 38 44* 56
59 63 68* 61* 54 56* 56 57 51 49
69* 22 31 49 58* 59 70* 56 58 52
64 58* 63 68 67* 67* 67* 67 66 65
55 54 38* 44 64 62* 62* 62 63* 68
70 69 70 69 71 52 50* 50 49 50
51 58 59 61 62 63 56 51 50 48
47 61 71 61 * 56 64 71 23 29 56
59 70 48 59 38 56 64 51 50 55
67 52* 54 57 62* 19 35 42 58 64
72* 55 57* 41 * 57* 51 68 64 70* 48
56 55 31 63 62 51 59 57 62 47
58 57* 61 70 63 65 63 44* 70* 54
60* 63 48 56* 57* 49 44 55* 60* 51
50 60* 64 62 61 55* 46 60* 47* 38
62 70 70 62* 50 50 51 56 50 66
70 60 70 62 56 55 62 29 44* 62
61 57* 59 66 59 51 67 69 68 61 *
61 58* 44 19 38 40 42 56 55 64
68 50 50 61 * 62 51 50 61 64 71
25 38 42 49 50 52 52* 55 53 55*
49 54 41 58* 58 54 56 63* 51 53*
55* 46 44 56 57* 62 39 31 33 64
54 56* 58 61 61 70 55 30 34 41
71 64 65 63 62 57 56* 54 66
Age Range 18-72 years Mean = 55*47 years
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The Keratoconjunctivitis Sicca Index
for Physicians
The method of scoring is illustrated on page 250.
The left hand column contains the numbers one to 17»
Numbers one to 10 represent the 10 symptoms set out
in Table 11,2, numbers 11 to 17 the macroscopic signs
set out in Table 11,3 (following page 3^ of the thesis).
Each of the symptoms and signs was given a "loading
value". For example, symptom one was valued at plus
5 points when present and minus one point when absent.
The values for each of the 17 facts were evolved once
the ^0 newly diagnosed K.C.S. patients and 40 control
patients had been examined.
The method was approved by Dr. John Anderson,
Department of Biomathematics, University of Oxford.
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AN ILLUSTRATIVE CASE






















CASE NO.I 1 Female, M.S., aged 54 years.
DIAGNOSIS! Definite K.C.S.
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Original K.C.S. Group of 40 Patients Index Score
1-32 female| 33-40 male




















































Control Group of 40 Patients Index Score
1-28 female| 29-40 male




4 54 - 1
5 61 6
6 62 - 1
7 70 - 6
8 64 6
9 70 6
10 68 - 6
11 44 - 1






18 61 - 5
19 64 3





25 59 - 6
26 41 - 1
27 42 5
28 49 - 6
29 55 10
30 54 - 6
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Patient No. Age Score
31 38 4
32 44 - 3
33 42 - 3
34 61 0
35 54 - 2
36 57 - 2
37 51 - 1
38 59 - 2














Scores in 100 R.A. patients to whom the
K.C.S. Index was applied
(Ca3e numbers adjusted for ease of recording)
Case 1-30 Score -6 to 0
Case 31 - 50 Score 0 to 4
Case 51 - 92 Score 4 to 9






Appendices to Chapters III, V and VI are
recorded on magnetic computer tape, and are available
on request from Dr. W.M. O'Brien, Department of
Preventive Medicine, University of Virginia School

































































































































































































































































































































Clinical State — Cerebrovascular Disease
Age Sex K.C.b. L.T. A.N.F. Total Protein
80 M ♦ 7.4
80 M ♦ ♦ ♦ 8.0
81 M ♦ 7.2
80 M + 7.0
82 M 7.0
80 M ♦ 6.8
84 M ♦ 8.0
80 M 7.4
86 M ♦ + + 7.6
95 M ♦ 7.0
81 M + +■ 7.8
82 M 7.0
84 M + 7.0
83 M ♦ 7.0
88 M + CM«t^-
89 M ♦ 7.2
92 M 7.6
80 M ♦ 7.8
81 M + 00 . o
82 M ♦ o•00
83 M ♦ 8.0
84 M 7.4
81 M 7.4
82 M ♦ 7.6
90 M 7.6
91 M ♦ 7.4
80 M + 7.0
81 M 6.8
82 M ♦ 6.8
83 M + 6.8
84 M ♦ 7.0
87 M ♦ 7.2
86 M + 6.8
Alb. Glob. Alk. Phos. Bilirubin Glutamic Acid
3.2 4.2 6.8 0.46 27
4.0 4.0 8.4 0.48 28
3.8 3.4 8.6 1.00 29
3.6 3.4 8.2 0.40 28
3.6 3A CO.CO 1 .20 32
3.4 3.4 9.0 1.00 34
3.6 4.4 8.4 1.2 30
3.8 3.6 8.4 0.46 34
4.2 3.4 8.0 0.48 30
3.6 3.4 6.8 0.48 22
4.2 3.6 6.8 0.44 20
3.4 3.6 7.0 0.40 26
3.4 3.6 7.0 0.60 26
3.6 3.4 7.8 0.60 26
3.8 3.4 7.8 0.50 26
4.0 3.2 8.2 0.62 28
4.6 3.0 8.4 0.50 28
4.8 3.0 8.0 0.48 28
4.6 3.4 o.00 0.44 26
4.6 3.4 9.4 0.46 26
4.2 3.8 9.0 0.44 24
3.4 4.0 9.0 0.48 20
3.6 3.8 5.8 1.0 20
3.6 4.0 6.0 1.2 20
4.2 3.4 6.2 0.54 20
3.0 4.4 6.4 0.50 20
3.8 3.2 6.8 0.48 28
3.8 3.0 7.2 0.46 22
3.8 3.0 7.2 0.44 24
3.6 3.2 7.4 0.42 26
3.8 3.2 7.8 0.40 26
4.0 3.2 7.8 0.48 28
3.4 3.4 8.0 0.48 28
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Age Sex K.C.S. L.T. A.N.F. Total Protein
80 M ♦ 6.6
80 M 6.8
80 M + 7.6
81 M + 7.0
81 M 7.0
81 M 7.2
82 M ♦ 7.8
83 F 7.6
94 F 7.4
87 F ♦ + + 7.2
84 F ■f 7.6
82 F 7.8
80 F + 7.4
80 F + 7.0
81 F 7.0
82 F + ♦ 7.0
83 F ^3 . 00
85 F + 7.8
80 F ♦ + 6.4





86 F + 8.4
81 F ♦ + 7.0
88 F + ♦ 7.4
88 F ♦ ♦ 7.4
80 F ♦ 7.6
80 F ♦ 7.6
80 F ♦ 7.6
80 F 7.6
81 F 4.0
82 F •f + + 8.0
82 F + 7.2
Alb. Glob. Alk.Phos. Bilirubin Glutamic
3.2 3.4 8.4 0.52 30
3.4 3.4 8.2 0.56 32
4.0 3.6 8.2 0.58 30
4.2 2.8 8.0 0.60 30
3.6 3.4 8.0 0.62 30
3.2 3.6 8.4 0.64 28
4.4 3.4 5.0 0.48 24
3.4 4.2 6.4 0.48 27
3.8 3.6 10.0 0.50 28
3.4 3.8 10.0 0.50 30
3.8 3.8 5.0 0.60 30
4.2 3.6 6.8 0.60 30
3.4 4.0 8.4 0.80 28
3.4 3.6 8.6 0.40 30
3.4 3.6 8.4 0.20 27
3.6 3.4 8.0 0.48 26
4.2 3.6 7.8 0.48 26
3.8 4 .0 5.0 0.46 24
2.8 3.6 4.8 0.46 20
3.2 3.6 8.6 0.44 22
3.2 3.8 8.4 1 .0 22
3.0 4.0 8.0 1.0 28
3.0 4.2 8.0 1 .0 32
4.0 3.8 8.0 1 .2 22
4.8 3.6 8.0 0.4 26
4.0 3.0 8.0 0.6 28
4.6 2.8 8.4 0.6 30
00. 4.6 8.6 0.4 30
3.6 4.0 8.6 0.4 30
3.6 4.0 8.8 0.48 32
3.6 4.0 7.8 0.60 30
3.6 4.0 8.4 0.50 30
2.6 4.4 9.0 0.60 28
4.4 3.6 9.6 1.0 27
3.4 3.8 8.4 1 .0 24
Ago Sex K.C.S. L.T. A.N.F, Total Protein
82 r + 7.0
82 P + 7.0
82 P + 7.2
83 P ♦ 8.0
84 P + 7.^
82 F + 7. ^
83 F + 7.6
86 P 7.4
86 F + 7.0
82 F + 7.^
82 P ♦ 7.6
86 F + 7.6
85 F ♦ 7.4
84 F 7.6
83 F ♦ 7.8
86 F ♦ 8.2
88 F ♦ 8.4
87 F + 7.0
81 F + 7.4
82 F •f 7.6
88 F + l.h
87 F •f 7.4
84 F + 8.0
84 F + 8.2
84 F ♦ 7.6
85 F ♦ 7.6
80 F ♦ 7.4
81 F ♦ 7.8
80 F ♦ 7.4
81 F ♦ 7.0
80 F ♦ 7.0
80 F ♦ 7*0
Alb. Glob. Alk. Phos. Bilirubin Glutamic Acid
3.6 3.4 8.4 0.48 24
3.6 3.4 8.6 0.46 24
2.4 4.8 5.0 0.44 24
4.6 3.4 10.0 0.30 26
3.8 3.6 8.0 0.38 26
3.8 3.6 9.0 0.46 26
3.2 4.4 4.6 0.44 24
3.6 3.8 4.6 0.44 24
3.2 3.8 9.0 0.42 22
3.2 4.2 5.6 0.40 22
3.4 -c- • F0 5.8 0.40 30
3.4 4.2 6.0 0.38 28
3.4 4.0 8.6 0.44 23
3.8 3.8 8.4 o. 46 32
3.4 4.4 8.2 0.44 30
3.4 4.8 8.0 0.48 25
5.0 3.4 8.6 0.48 28
3.4 3.6 8.2 0.30 26
4.2 3.2 7.6 0.28 26
4.8 2.8 7.8 0.26 26
3.2 4.2 8.0 0.24 26
4.0 3.4 8.6 0.20 26
5.6 3.4 00 • 00 0.18 26
5.6 3.4 8.6 0.44 26
4.2 3.4 o•CO 0.46 25
4.2 3.4 8.6 0.44 26
4.0 3.4 8.4 0.42 26
4.4 3.4 8.4 0.40 26
4.0 3.4 8.0 0.46 25
3.4 3.6 7.8 0.44 24
3.4 3.6 7.8 0.42 24










83 M ♦ 7.0
82 M 7.2
81 F ♦ 7.0




Clinical State - Orthopaedic




80 F ♦ ♦ + 8.0
81 F ♦ 7.8
82 F ♦ 7.6
80 F ♦ 7.6
80 F 7.6
81 F + 7.6
Clinical State - Diabetes
84 F 7.4
84 F 7.6
81 F * 7.6
87 M 7.6
80 M 7.^
Alb. Glob. Alk. Phos. Bilirubin Glutamic
3.6 3.4 5.8 0.38 23
4.0 3.0 7.8 0.36 20
4.2 3.0 5.8 0.38 24
4.0 3.0 5.0 0.36 28
4.4 3.4 9.0 0.40 28
4.4 3.2 8.4 0.44 20
3.0 4.4 8.0 0.46 20
3.0 4.6 7.8 0.48 20
3.4 4.4 5.0 0.44 20
3.2 3.8 4.8 0.48 32
4.2 3.6 6.2 0.44 20
4.0 4.2 10.0 0.48 28
3.2 4.8 6.4 0.50 24
3.0 4.8 10.2 0.54 26
3.4 4.2 10.2 0.60 24
3.4 4.2 4.8 1.0 20
2.6 5.0 5.6 1.0 32
2.6 5.0 5.8 0.48 30
3.0 4.4 8.0 0.50 32
3.4 4.2 8.4 0.50 30
3.6 4.0 9.2 1 .0 30
3.4 4.2 8.0 0.44 27
3.0 4.4 00 • J\5 0.46 28
Clinical State - Pernicious Anaemia
Age Sex K.C.S. L.T. A.N.P. Total Protein
83 P + 7»b
93 P ♦ 7.2
9k P + 7.b
89 P + 7.0
87 F 7.0




81 M 7 ,b
83 M 7.0
Clinical State - Hypertension











Glob. Alk. Phos. Bilirubin Glutamic Acid
k.O 3.b 8.2 0.k6
3.6 3.6 8.0 0. k6
k.o 3.k 8.2 0.38
3.2 3.8 7.8 0.30
k.O 3.0 7.8 0.28
3.6 3.k 8.0 0.k8
3.k 3.6 7.6 O.kk
3.8 3.8 8.0 0.k6
3.2 k.2 7.6 0.k8
3.0 k.o 7. k 0.50
3.6 k.O 8.0 0.60
2.6 5.0 8.2 0.60
2.6 5.0 8.6 0.60
3.^ k.k 8.6 0.6k
k.k 3.b 8.0 0.70


















Clinical State - Ifodent Ulcer
Age Sex K.C.S. L.T. A.N.F. Total Protein
93 M 7.0
Clinical State — Gangrene
9k M 7.4
Clinical State - Paget*s Disease
98 F ♦ 7.k
Clinical State - Obesity
91 M 7.2
84 F ♦ 7.4
Clinical State - Hypothyroidism
80 F 7.4
Alb. Glob. Alk. Phos. Bilirubin Glutamic Acid
3.6 3.4 7.8 i.o 30
4.4 3.2 8.0 1.0 30
4.0 3 .4 7.8 0.80 28
3.6 3.6 7.8 0.46 26
3.6 3.8 7.8 0.46 26






































Hashimoto*s Disease (all female)
Thyroid Autoantibody Tests
Status Prec.Test T.R.C.Test Fluor.'C.P.*Test Comments S.T. K.C.S.
H P Neg. +♦ 11
H P Neg. ♦♦
P Neg. ♦
Neg. Neg. ++ B 12
P Neg. ++
P Neg. + +■
P Neg. + 11
Neg. 4,000 ♦ B 12
P Neg. Neg.
P Neg. +•*•
P 4,000 ♦ 3 ♦
P Neg. Neg.
P 256 Neg.





P 4,000 ♦ 8 ♦
P Neg. Neg.
P Neg. Neg.
Neg. Neg. Neg. B
Neg • 1,000 ++ B
P Neg. ♦♦
P Neg. Neg.





P 64 Neg. 10
P 256 +





Age Status Prec.Test T.R.C.Test Fluor.»C.F.*Test Comments S.T.
45 P Neg. ♦ 4
63 P 1 ,000 Neg. R.A. 11
69 P Neg. Neg. R.A,
66 P 64 ♦+ R.A.
61 P 16 ++ R.A.
63 P 16 ++
44 P Neg. ♦+ 2
60 P Neg. •*+









41 P + +
56 P ♦ +
50 P ♦ + 7
38 P
50 P ♦ + 8
47 P Neg.





























Ql±n±cal Thyroid Autoantibody Tests




























































































































Clinical Thyroid Autoantibody Tests






















































































Simple Goitre (all female)
Thyroid Autoantibody Tests






























PERNICIOUS ANAEMIA MALE PATIENTS (37)
1 2 3 4 5 6 7 8 9 10




S.T. 7 4 13 14
K.C.S.
P.T.G. + ♦ + +
Hb. 11 10 12 13 11 9 8 10 13 11
P.C.A. ♦ ♦ + + + + + +
T.A. •f ♦ +
T.R.C. ■*" + + + ♦
11 12 13 14 15 16 17 18 19 20




S.T. 12 1 1 10 8 8
K.C.S.
P.T.G. ♦ ♦ ♦
Hb. 11 11 1 1 12 11 11 11 10 11 13
P.C.A. ♦ + ■f ♦ +
T.A.
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21 22 23 24 25 26 27 28 29 30




S.T. 7 1 11
K.C.S. +
P.T.G. + ♦ ♦ +




31 32 33 34 35 36 37











Pernicious Anaemia Female Patients (40)
1 2 3 4 5 6 7 8 9 10





S.T. 8 7 10 5 11 7 9 4
K.C.S. ♦ +
P.T.G. ♦ + + ♦
Hb. 12 11 13 11 10 9 11 8 13 11
P.O.A. ♦ + ♦ + ♦ + + +
T.A. ♦ + ♦ + + +
T.R.C. + + + ♦
11 12 13 14 15 16 17 18 19 20
Age 65 51 65 63 26 44 68 59 52 70
Comments
Family History
♦ + 0 +
S.T. 8 5 13 14 4 8
K.C.S. +
P.T.G. + +
Hb. 11 11 11 11 12 12 11 11 11 11
P.C.A . + + ♦ + + ♦ *
T.A. + ♦ ♦ + + +
T.R.C. ♦ + ♦
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21 22 23 2 4 25 26 27 28 29 30




S.T. 9 8 7 4 6 0
K.C.S. ♦
P.T.G.
Hb. 1 1 11 11 11 11 12 13 14 11 10
P.C.A. ♦ ♦ ■f ♦ + +
T.A. ♦ ♦ ♦ «*■
T.R.C.
31 32 33 34 35 36 37 38 39 40




S.T. 1 12 2
K.C.S. +
P.T.G. ♦ + + ♦ ■f






Age 30 45 40 41 44
42 34 40 20 37
39 44 38 38 33
39 41 40 42 36
Hospital Control Patients - see




60 Arthritic Patients - Clinically Healthy Eyes
(Patients 1-5 malef Remainder female)
Patient Sacs Lids Nose
1 +S +s




6 + + +
7 + + +












20 + + +
21 + + +
22 + + +
23 + +
24 + •f +







Patient Sacs Lids Nose
31 4 4
32 4 4




37 4 4 4
38 4S 4S 4S
39 4S 4
Uo 4 4 4
41 4 4 4








50 4 4 4











65 tftitreated Keratoconjunctivitis Sicca Patienta
Patient Sacs Lids Hose c.:
1 ♦S 4S 4S 4
2 48 48 4S 4
3 +S 4S 4S 4
4 +S 4 4
5 ♦ 4S 4
6 ♦ 4S 4
7 4 4
8 +S 4S 4S 4
9 4S 4
10 ♦s 4 4
11 4S 4
12 4 4S 4
13 4 4
14 ♦s 4S 4 4
15 4S 4 4
16 ♦s 48 4 4
17 4 4S 4
18 4 4S




23 ♦s 4S 4S 4
24 ♦s 4S 4 4
25 •f 4
26 + 48 4S 4
27 ♦ 4S 4S 4
28 + 4S 4S 4
29 4 4S 48 4
30 4 4S 4
31 4S 4S 4
32 4S 4 4
33 4 4S 4 4
290
&tient Sacs Lids Hose c.:
3h 4 ♦s 4 4




39 ♦S 4 4
Uo ♦s 4 4
41 4 4-S 4 4
42 ♦ 4-S 4 4
43 4 4S 4 4
44 4 4-S
45 +s 4
46 4 4-S 4
47 +s 4
48 ♦s 4 4S 4
49 +s 4 4S 4
50 4 4-S 4
51 4 4-S 4
52 +s 4 4S 4
53 +s 4
54 4 4S
55 4 4 4S
56 ♦s 4
57 ♦s 4 4
58 4 4S
59 +s 4 4 4
60 ♦s 4 4 4
61 4S 4 4 4
62 ♦s 4 4 4




65 Keratoconjunctivitis Sicca Patients After One
Month of Tear Substitute Therapy
Patient Sacs Lids Nose














^b +s + +
15 +s +





















































S m staph* aureus
293
Clinically Healthy Group
(Patients1 numbers adjusted for ease of recording)
Patient No. Age Sex Culture
1-39 M Negative
40-56 F Negative
57 8 F Isaria
58-160 M Negative
161 12 M Aspergillus
162 18 M Candida
163-262 F Negative
263 19 F Candida
264 17 F Papulospora
265 14 F Saccharomyces
266 16 F Rhizopus
267-287 M Negative
288 26 M Penicillium
289-308 F Negative
309 26 F Rhodotorula
310 28 F Rhodotorula
311 20 F Scopulariopsis
312-330 M Negative
331-352 F Negative
353 37 F Penicillium
354-378 M Negative
379 46 M Penicilliuia
380 41 M Penicillium
381-400 F Negative
401 40 F Penicillium












Patient No. Age Sex Culture
403-428 M Negative
429 56 M Penicillium
430 57 M Aspergillus
431-452 F Negative
453 55 F Aspergillus
454 54 F Aspergillus
455 58 F Scopulariosis
456 59 F Nigrospora
457-484 M Negative
485 63 M Penicilliura
486 61 M Rhodotorula
487 60 M Candida
488 64 M Isaria
489 66 M Geotrichum
490 67 M Geotrichum
491-510 F Negative
511 65 F Geotrichuni
512 66 F Horraodendrin
513-533 M Negative
534-551 F Negative
552 75 F Scopulariopsis
553 78 F Isaria







Healthy Eyes Before and After One Week Steroid
and Steroid/Antibiotic
Betamethasone disodium phosphate












Betamethasone disodium phosphate/Neomycin sulphate
Patient 1st Culture 2nd Culture
1 Candida Alb. Candida Alb.
2-10 Negative Negative
11 Negative Candida Alb.
12 Negative Penicillium
13-26 Negative Negative












Patients with External Ocular Disease Receiving
Topical Steroid or Steroid/Antibiotic
Patient
Betamethasone disodium phosphate




Betamethasone disodiutn phosphate/Neomycin sulphate
Patient 1st Culture 2nd Culture
1-44 Negative -
45 Penicillium Negative














1 Penicilliura Negative Negative




/. Candida Alb. Negative Not repeated.
5-14 Negative - -








3 Candida Alb. Negative
4-10 Negative -
11 Tropicalis Negative













Patients 1-8 are the same as patients
33 - ^0 Appendix II







































Years of BJ6 Therapy — 65 Patients Completed Course
Sex Symptoms Signs Both
Selection
N—L. Acet. i
M + ♦ ♦
M + ♦ ♦
M + ♦ ♦
M + ♦ +
M ♦ ♦ +
M * + +
M + + +
M ♦ + +
M + + ♦
M + ♦ +
F 0 0 0 X X
F + + +
F + mm X
F + ■f +
F + •f +
F + -f +
F 0 0 0 X




F - 0 X
F 0 0 0 X X
F X X
F 0 0 0 X
F + + ♦
F X
F X
F ♦ + ♦
F + + +
F + ♦ +
F X
F + + +




































Sex Symptoms Signs Both M T SelectionAcett uyst#
p + + +
F ♦ ♦ +





F + + +
F X
F X








F 0 0 0 X




F + mm X





F + + +
F + + +
F + + +
F •f + +
F 0 - X
F X X


































Sex Symptoms Signs Both N-L.^^Acet? Cyst.
F X
F + + *
F 0
F XX
F ♦ + +
F X









F + + +
F X
F ♦ + +
F + + +
F X
F X
F + + +
F + ♦ +
F - + X
F X
F X
F ♦ + +
F + + ♦
F ♦ + ♦
F ♦ + +
F + 0
304
Naso- lacrimal Duct Obliteration - 32 Patients All Female
Age Symptoms Signs Both
Selection
Acet. Cyst*
62 ■f ♦ +
60 ■f ♦ +
61 - - mm X
62 + + +
51 ♦ + ♦
50 + - X
48 + - X
32 ♦ + +
49 + + ♦
58 + ♦ ♦
41 - - - X
68 + + +
64 ♦ + +
38 + +
55 + —
66 + + +
67 + +
70 ♦ + ♦
55 + •f +
59 ♦ - X
56 + ♦ +
56 + +
48 ♦ ♦ ♦
39 - - - X





56 0 0 0 X
62 0 0 0 X
59 + ♦ ♦
305
6 Months of Acetyl-Cysteine Therapy -»
20 Patients All Female
Age Symptoms Signs Both
61 0 0 0
50 ♦ ♦ +
48 - ♦
41 ♦ + +
59 + + +
- +
56 ♦ + +
62 + -
48 ♦ +
59 - - -
61 + ♦ +
62 - - -
61 mm - -
54 - - mm
54 - - -
56 - - mm
66 - - -
57 - - -
62 mm _ _
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EFFECT OF TEMPERATURE AND HUMIDITY IN
THE SCHIRMER TEAR TEST*f
by
JOHN WILLIAMSON J
Ophthalmic Institute, Glasgow Royal Infirmary
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The Schirmer I tear test developed and standardized by Halberg and Berens, New
York City (Contactisol Inc. Lindenhurst, N.Y.) is a useful screening procedure for
keratoconjunctivitis sicca in large numbers of patients suffering from various con¬
nective tissue disorders.
When all the patients attending a centre for rheumatic diseases were subjected to
this test it was noted that a surprisingly high percentage of in-patients had positive
Schirmer I readings (less than 15 mm.). At the time of writing, 338 in-patients
(age range 18 to 72 years, mean 56) including 250 females and 88 males, had been
examined. In 65 patients (20 per cent.) whose ages ranged from 25 to 70 years
(mean 50-5), 123 eyes had shown apparently reduced tear flow, 78 producing less
than 5 mm. of wetting. When, however, the test was repeated within the week at an
ophthalmic out-patients department, all the results were negative.
The 65 patients were tested the following week in the rheumatic hospital and tear
flow was again apparently reduced in 110 eyes.
Investigations
A thermographic recording and simultaneous measurements of the humidity using a
whirling string hygrometer (wet and dry bulb), were made in both hospitals over a period of
20 days.
Fig. 1 (opposite) shows part of the tracing from the rheumatic hospital, where the mean
temperature was 72-3°F. (22-3°C.), and the humidity 40-5.
Fig. 2 (opposite) shows part of the tracing from the eye hospital, where the mean tem¬
perature over the same period was 57-4°F. (14-1 °C.), and the humidity 48.
During the recording time, twelve of the patients (age range 40 to 58 years; mean 49)
with apparently reduced tear flow were moved between the two hospitals on three occasions.
Six recordings of the Schirmer I tear test were made available in each eye, three from the
rheumatic centre and three from the ophthalmic hospital. The Table (opposite) shows
the results.
All had rose bengal 1 per cent, instilled into the conjunctival sac and were examined by
a modern Zeiss slit-lamp. None of the patients had keratoconjunctivitis sicca.
Clearly the Schirmer tear test was consistent in each hospital, but it was always consis¬
tently lower in the higher temperature and lower humidity of the rheumatic wards.
An interesting feature of this experiment was that the tear flow was not noticeably
reduced until after 12 hours' in-patient stay in the rheumatic wards.
* Received for publication March 7, 1966.
t Address for reprints:
t Present address: Department of Ophthalmology, Southern General Hospital, Glasgow.
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Fig. 1.—Thermograph recording in a rheumatic hospital.
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Fig. 2.—Thermograph recording in an ophthalmic out-patients department.
Table
Case No. Sex
Three Recordings (average of two eyes)
At Rheumatic Flospital At Ophthalmic Hospital
1 F 11, 12, 11 15, 18, 18
2 F 8, 7, 7 20, 20, 19
3 M 4, 8, 7 16, 18, 17
4 F 3, 7, 5 20, 18, 20
5 F 8, 12, 11 20, 20, 20
6 M 12, 11, 12 22, C.W., C.W.
7 M 14, 15, 10 18, 18, 20
8 M 15, 11, 14 19, 20, 20
9 M 14, 12, 13 22, C.W., C.W.
10 F 12, 9, 8 20, 18, 16
11 M 7, 6, 4 20, 16, 20
12 F 3, 2, 0 20, C.W., 20
(C.W. = completely wet)
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The twelve patients were then followed up during the next 20 days, the Schirmer I test
being repeated every second night. During this time, there was no tendency for the patients
to compensate by increased production of tears, i.e. the results remained consistently low.
Within 3 days of hospitalization, ten of the patients complained that their eyes felt hot and
dry towards early afternoon, and within the week so did the rest.
Discussion
65 out of 338 patients (20 per cent.) admitted to a rheumatic centre showed
apparently reduced tear flow (less than 15 mm.) after 12 hours' hospitalization, as
judged by the Schirmer I tear test. All were measured within the week at an ophthal¬
mic out-patients department and were found to have normal tear flow. The findings
appear to be related to the differences in temperature and humidity in the two
hospitals. Twelve of the patients were repeatedly measured in both departments and
the results were consistent. Over a period of 20 days, no tendency to compensate
for the high temperature and low humidity in the rheumatic wards was observed.
Symptoms of dry eyes developed in 3 days in ten of the patients and in all within the
week.
A number of interpretations may be put on this observation. The apparently
reduced tear flow may have been the result of increased evaporation in the warm, dry
rheumatic wards. If this were correct, however, then the apparent diminution in
tear flow would not have taken 12 hours to develop from the time of admission.
Further, it may be asked why it should have affected only 20 per cent, of the patients
and not all of them and why this effect remained consistent for this selected group of
in-patients.
If the tear flow was actually increased for emotional or other reasons during the
first 12 hours of admission, this might account for the apparently normal Schirmer I
tear tests.
On the other hand, there may be a true lack of response to dry heat in some indi¬
viduals, i.e. these findings may be physiological. The only way to prove this would
be to admit a group of patients, suffering neither from connective tissue disorders
nor from any disease believed to have an immunological basis, to the rheumatic
centre for several days. Clearly this is impractical.
Finally, the lack of response to temperature and/or humidity may occur only or
more readily in patients who are likely to develop keratoconjunctivitis sicca at a later
date. It will be extremely interesting, therefore, to follow these patients over the
next decade.
Summary
A temperature of around 72°F. (22°C.) and/or humidity of around 40-5 results
in a reduced Schirmer I tear test after 12 hours of in-patient stay in about 20 per cent,
of patients suffering from connective tissue disorders. No tendency to compensate
for this reduction was noted in twelve patients over 20 days despite the fact that they
developed symptoms of dry eyes. The possible significance of this observation is
discussed.
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Sjogren's syndrome is a chronic benign systemic disease of unknown aetiology
which involves principally the lacrimal and salivary glands and may occasionally
also affect the naso-pharyngeal, buccal, oesophageal, and tracheo-broncheal glands
and the sweat glands (Sjogren, 1943, 1951; Stoltze, Hanlon, Pease, and Henderson,
1960; Bloch, Buchanan, Wohl, and Bunim, 1965). The majority of patients studied
have underlying connective tissue disease such as rheumatoid arthritis, systemic
lupus erythematosus, progressive systemic sclerosis, polymyositis, or polyarteritis
nodosa (Bloch and Bunim, 1963; Bloch and others, 1965), each of which is charac¬
terized by circulating autoantibodies to cells or cell constituents.
Anderson, Gray, Beck, and Kinnear (1961); Bunim (1961); Bloch and Bunim
(1963); Anderson, Beck, Bloch, Buchanan, and Bunim (1965), have also shown that
the prevalence.of thyroglobulin autoantibodies is increased in patients with Sjogren's
syndrome, but the corresponding prevalence of Sjogren's syndrome in patients with
autoimmune thyroid disease has not been evaluated. The histological features of
autoimmune thyroiditis, Hashimoto's thyroiditis, and spontaneous myxoedema and
those of the lacrimal and salivary glands in Sjogren's syndrome are, however, very
similar, as first noted by Hashimoto (1912). For this reason it appeared to be impor¬
tant to determine whether the two conditions occur together with significant fre¬
quency. Since thyroid autoantibodies are also found in patients with thyrotoxicosis
(Roitt and Doniach, 1958; Buchanan, Alexander, Crooks, Koutras, Wayne,
Anderson, and Goudie, 1961; Buchanan, Koutras, Crooks, Alexander, Brass,
Anderson, Goudie, and Gray, 1962; Anderson, Gray, Middleton, and Young, 1964),
the incidence of Sjogren's syndrome in this disorder was also determined. In each
group of patients the incidence of Sjogren's syndrome was compared with that in a
group with simple goitre and that in another control group of hospital patients.
* Received for publication June 7, 1966.
t Address for reprints: J. Williamson, Department of Ophthalmology, Southern General Hospital, Glasgow, Scotland.
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Lacrimal gland function is difficult to assess accurately even where the gland is
healthy, and routine biopsy is not a practical procedure; the most reliable clinical
indication of lacrimal gland involvement is the presence of kerato-conjunctivitis
sicca which is readily diagnosed and this is the index we have used in the investigation.
Examination of the salivary glands was also made in a large number of patients by
means of sialography and the incidence of abnormalities was determined.
Material and Methods
Patients
339 female patients comprising five groups were examined for kerato-conjunctivitis sicca.
The mean age and age range are shown in Table I.
Table I









No. Per cent. No. Per cent. No. Per cent.
Hashimoto's Thyroiditis 83 550 37-75 5 60 11 13-3 7 8-4 3 3-6
Primary Hypothyroidism 69 67 0 33-74 6 8-7 12 17-3 5 7-2 5 7-2
Thyrotoxicosis 68 43-2 16-66 7 10-3 1 1 -4 — — 6 8-6
Simple Goitre 46 39-5 15-67 2 4-3 — — 5 110 2 4-3
Hospital Controls 72 51 -9 31-74 5 6-9 10 13-9 6 8-3 5 6-9
Group 1. Hashimoto's Thyroiditis (83).—The diagnosis was based on five patients on
histological examination of the gland using the criteria of Joll (1939) and in the remaining
78 on the presence of a positive precipitin test for antithyroglobulin autoantibodies in a
euthyroid or hypothyroid patient (Buchanan and others, 1961). Three of these patients
were hypothyroid when studied, but the remaining eighty were receiving 0-2 mg. sodium
thyroxine and were euthyroid when studied. Four had "definite" rheumatoid arthritis by
the American Rheumatism Association criteria (Ropes, Bennett, Cobb, Jacox, and Jessar,
1958).
Group 2. Spontaneous Primary Hypothyroidism (69) (hypothyroidism without a goitre).—
The diagnosis was based on the clinical and laboratory criteria described by Wayne (1960)
and Wayne, Koutras, and Alexander (1964). Ten patients were hypothyroid when ex¬
amined and the remaining 59 were receiving 0-2-0-3 mg. sodium thyroxine and were euthy¬
roid. Four had "definite" rheumatoid arthritis by the American Rheumatism Association
criteria (Ropes and others, 1958).
Group 3. Thyrotoxicosis (68).—21 patients had become hypothyroid following radio¬
active iodine (131I) therapy; twenty of them were euthyroid at the time of examination and
were receiving 0-2-0-3 mg. sodium thyroxine per day and the other was hypothyroid. The
remaining 47 were euthyroid following antithyroid drug therapy, subtotal thyroidectomy,
or 131I therapy.
Group 4. Simple Goitre (46).—All these were euthyroid, and none had systemic disease.
Group 5. Hospital Controls (72).—These were all women attending as outpatients at the
clinics associated with the Western and Royal Infirmaries, Glasgow. They had a variety
of general medical conditions, none of which, however, had any known association with
thyroid disease or autoimmune disorders.
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Methods
Autoantibodies to Thyroglobulin were tested by a precipitin test using the Ouchterlony-
Elekplate technique (Anderson, Buchanan, Goudie, and Gray, 1962) and by the tanned red
cell haemagglutination test using thyroglobulin-coated formalized tanned sheep red cells
(Burroughs Wellcome), (Fulthorpe, Roitt, Doniach, and Couchman, 1961). The lowest
serum dilution tested in the tanned red cell haemagglutination test was 1 in 16. Autoanti¬
body to thyroid "microsomes" was measured by an immunofluorescence technique on
unfixed frozen sections of thyroid slices (Holborow, Brown, Roitt, and Doniach, 1959),
using test serum diluted one in four in the first layer.
Examination for Sjogren's Syndrome.—Each patient underwent an ophthalmic examina¬
tion. This included a Schirmer I test using the standardized sterile strips developed by
Halberg and Berens (Contactisol Inc. Lindenhurst, New York, U.S.A.). The wetting of the
paper strip was read at 5 minutes and the mean of the two eyes was recorded. Patients
with less than 15 mm. wetting were subjected to a Schirmer II test, using 10 per cent,
ammonia held by the patient for 5 minutes 6 in. from the nose. Rose bengal 1 per cent,
was instilled into the conjunctival sac of each eye and immediately followed by irrigation
with normal sterile saline; the patients were then examined by a Zeiss or Haag-Streit slit
lamp for punctate and filamentary keratitis. Staining over the area previously in contact
with the Schirmer filter paper was ignored. Kerato-conjunctivitis sicca was diagnosed
when the Schirmer II test gave less than 5 mm. wetting after 5 minutes and when there was
associated strongly positive rose bengal staining of the conjunctivae and/or corneae.
To minimize bias in this study the medical diagnosis was not known to the ophthalmol¬
ogists until after the eye examinations were complete.
Sialography.—This was performed in 109 patients, 41 with Hashimoto's thyroiditis,
32 with primary hypothyroidism, and 36 control subjects. A hydrostatic technique was
employed, using Triosil "45" (sodium metrizoate) a.s a contrast medium. Apparatus
consisting of a 20 ml. glass syringe, polythene tubing, and a tapered catheter was used to
convey the contrast medium to the duct and gland. The glass syringe was set at a fixed
height above the patient's head (70-90 cm.). The contrast medium flowed into the gland
using only the force of gravity and therefore a relatively constant pressure was obtained
(Park and Mason, 1966). This method rarely led to over-filling and was less painful for
the patient. The water-soluble contrast medium is rapidly expelled from the gland and
therefore a secretory phase film was exposed 5 minutes after the filling phase was complete.
Between the two'phases, the patient was asked to suck a slice of lemon to stimulate salivary
flow.
Results
The results of the ophthalmological examination are summarized in Table I.
Only a small minority in each group had definite kerato-conjunctivitis sicca. The
highest prevalence was found in Group 3 treated thyrotoxicosis (8-6 per cent.), but
this was not significantly different from that in Group 5 hospital controls (6-9 per
cent.). The 43 patients treated with 131I therapy were re-assessed separately (Table
II, overleaf). Six of those with kerato-conjunctivitis sicca came from this group and
none of the remaining 25 treated by drugs and/or surgery had kerato-conjunctivitis
sicca. No correlation was, however, found between the presence of kerato¬
conjunctivitis sicca and the number of doses, total dosage of 131I, or the interval since
the last dose of 131I.
None of the 83 patients with Hashimoto's thyroiditis and none of the four with
primary hypothyroidism plus rheumatoid arthritis had kerato-conjunctivitis sicca.
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Table II
Relation of Kerato-conjunctivitis Sicca to the Number of Doses and Total Dosage
of Radioactive Iodine (131I) Therapy in Thyrotoxic Patients
No. of Patients No. of Doses of 131I
Mean and Range of1311 Doses (mc.) No. with
Kerato-conjunctivitis
SiccaMean Range
15 1 91 8-10 2
18 2 18-7 16-20 3
10 3 29-1 24-30 1
None of the five patients with Hashimoto's thyroiditis in whom the diagnosis was
confirmed by biopsy had kerato-conjunctivitis sicca.
Abnormal sialograms were found in eighteen cases: seven (16 per cent.) of the
41 patients with Hashimoto's thyroiditis, five (16 per cent.) of the 32 with primary
hypothyroidism, and in six (16 per cent.) of the 36 in the hospital control group
(Table III). Only two patients with Hashimoto's thyroiditis showed globular
sialectasis, the remaining patients having only minor abnormalities consisting of
punctate sialectasis with or without intermediate duct changes. Mild xerostomia
was found in sixteen of these eighteen patients. None had a history or clinical evi¬
dence of salivary gland enlargement. Two of the hospital control subjects had unex¬
plained xerostomia but normal sialograms. None of the patients with Hashimoto's
thyroiditis or with primary myxoedema who had rheumatoid arthritis had xerostomia
or abnormal sialograms.
Table III
Results of Sialography in Cases of Hashimoto's Thyroiditis and Primary




















Hashimoto's Thyroiditis 41 7 16 3 2 2 6 0
Primary Hypothyroidism 32 5 16 3 -2 4 0
Hospital Controls 36 6 16 4 2 6 0
Discussion
This study shows no increased prevalence of kerato-conjunctivitis sicca in patients
with proven autoimmune thyroid disease (Table 1). The prevalence is higher than
that in an ophthalmic control series of 6,200 (0-2 per cent.) in the United States
(de Roetth, 1945), but the age and sex distribution of de Roetth's patients was not
recorded. The number of patients with xerostomia and sialographs abnormalities
consistent with Sjogren's disease affecting the parotid glands was also no higher in the
groups with Hashimoto's thyroiditis and primary hypothyroidism respectively than
in the hospital control group (Table III).
The prevalence of kerato-conjunctivitis sicca in patients with thyrotoxicosis
(8-6 per cent.) was higher, but not significantly higher, than in the patients with
simple goitre (4-3 per cent.) and the hospital controls (6-9 per cent.). 64 per cent, of
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the patients with thyrotoxicosis received treatment with 131I therapy, but no correla¬
tion was found between the number of doses or the total amount of 131I given.
One of us (Williamson, unpublished observations) has detected significant amounts
of 131I in tears one hour after a therapeutic dose of 131I given to thyrotoxic patients.
It does not appear, however, that this results in subsequent irradiation damage to the
lacrimal and accessory lacrimal glands of the eye. It is of interest to note, however,
that irradiation parotitis and xerostomia have been noted in patients receiving
similar doses of 131I therapy for thyrotoxicosis (Chapman and Maloof, 1955).
The prevalence of thyroglobulin autoantibodies in patients with Sjogren's syn¬
drome is, however, increased (Anderson and others, 1961; Bunim, 1961; Bloch and
Bunim, 1963; Anderson and others, 1965), and thyroglobulin autoantibodies have
also been reported to occur with increased frequency in the connective tissue diseases,
rheumatoid arthritis (Anderson and others, 1961; Bloch and others, 1965), and
systemic lupus erythematosus (Anderson and others, 1961; Hijmans, Doniach,
Roitt, and Holborow, 1961), all of which may be associated with established kerato¬
conjunctivitis sicca. The absence of an increased prevalence of kerato-conjunctivitis
sicca in autoimmune thyroid disorders in contrast to that in autoimmune systemic
disorders may, however, be consistent with the concept that autoimmune thyroiditis
is an organ specific disorder.
Summary
83 patients with Hashimoto's thyroiditis, 69 with primary hypothyroidism, and
68 with thyrotoxicosis were examined for kerato-conjunctivitis sicca by Schirmer
tear tests, staining of the conjunctiva and cornea by rose bengal dye, and slit-lamp
examination. The prevalence of kerato-conjunctivitis sicca in these patients was no
higher than in 46 patients with simple goitre and in 72 hospital controls matched for
age and sex. Sialography was performed in 41 patients with Hashimoto's thyroidi¬
tis, 23 with primary hypothyroidism, and 36 of the hospital controls. Sialographic
abnormalities suggestive of Sjogren's syndrome were found as frequently in the
hospital controls as in the patients with Hashimoto's thyroiditis and primary
hypothyroidism.
We are greatly indebted to Prof. E. M. McGirr, University Department of Medicine, Royal Infirmary,
Glasgow, for allowing us to examine patients attending his clinics.
Dr. W. Watson Buchanan, Centre for Rheumatic Diseases, Baird Street, Glasgow, gave invaluable direc¬
tion and advice in organizing and conducting this survey; without his help we would have been unable to
complete our task.
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by
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Although the role of fungi as ocular pathogens has become more widely recognized
(Maddren, 1941; Sykes, 1946; Mendelblatt, 1953; Mitsui and Hanabusa, 1955; Roberts,
1957; Haggerty and Zimmerman, 1958; Mikami and Stemmermann, 1958; Fine and
Zimmerman, 1959; Chick and Conant, 1962; Currie, 1963; Ainley and Smith, 1965;
Jelcnkiewicz, 1965; Dominiczak, Branicka, and Lewenstam, 1965), relatively little attention
has been given to the fungal flora of the healthy or diseased eye. Previous lengthy investi¬
gations conducted in Europe (Fazakas, 1935, 1953) and in the U.S.A. (Hammeke and
Ellis, 1960) have shown some disparity in the frequency of occurrence of fungi in the healthy
conjunctival sac; studies of smaller groups of patients (Mitsui and Flanabusa, 1955;
Azevedo, 1962) are less conclusive owing to the small size and selectivity of the samples.
Furthermore, some ocular mycoses may have an exogenous source, especially after surgery
or trauma (Fine and Zimmerman, 1959) and an accurate knowledge of the species most
likely to be encountered in the conjunctival sac is of more than academic interest. The
first purpose of this paper, therefore, is to report the results of an investigation of rhe
fungal flora of the clinically healthy conjunctivae of a large and representative sample of
suojects in various age groups.
Our second purpose is to study the variations of fungal flora in corticosteroid-treated
patients. It is well documented that steroids reduce tissue resistance to a wide variety of
bacterial, viral, and fungal agents (Zimmerman, 1950; Kligman, Baldridge, Rebell, and
Pillsbury, 1951; Selve, 1951), and it would appear that, the increase of ocular mycoses within
recent years may be associated with the extensive use of systemic and topical corticosteroids
and of broad-spectrum antibiotics (Hogan, Thygeson, and Kimura, 1954; Suie and Havener,
1963; McLean, 1963). Consequently, we have investigated the effects of (a) topical steroids,
(b) topical steroids combined with antibiotics, and (c) systemic steroids, on the conjunctival
flora of various groups of patients.
The third section is concerned with the fungal flora of the eye in Sjogren's syndrome.
The characteristically dry eye encountered in this syndrome (keratoconjunctivitis sicca) is
associated with depletion of normal tear flow and impaired mechanical removal of foreign
material, and may therefore be more susceptible to colonisation by microbial agents.
Material and Methods
Patients
(1) Clinically Healthy Conjunctivae
553 patients comprising 284 males and 269 females (1,106 eyes), without clinical evidence of
* Received for publication February 1, 1967.
+ Address for reprints: Southern General Hospital, Glasgow.
J Now at Southern General Hospital, Glasgow
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external ocular inflammation, were chosen for the investigation of the fungal flora of the healthy
conjunctival sac. Each decade of age was represented by at least forty patients, equally divided
between the sexes (Table I). The children in the 0 to 9 year age group were obtained mainly from
an orthoptic department; the 10 to 19-year-olds from an ophthalmic out-patient department and
from a mass radiography centre.
Table 1
Patients with Clinically Normal Conjunctivae, by Age Group and Sex






















Total Patients 57 209 44 42 49 53 57 42 553
The association of conjunctival fungi with topical steroid therapy was examined in two scries of
patient.).
(2) Clinically Healthy Conjunctivae subjected to Topical Therapy
Adult patients with no clinical evidence of external ocular disease were selected from an ophthal¬
mic out patient department and from a centre for rheumatic diseases.
(а) Cultures were taken before and after a course of betamethasone disodium phosphate. (01 per cent, in
water-miscible base) in 86 patients (26 males and 60 females; 165 eyes). The age range was 30 to 78 years
(mean 62). 36 patients had various forms of cataract, 35 had refractive errors, and fifteen had glaucoma.
(б) Cultures were taken, from 52 patients (17 males and 35 females; 104 eyes) before and after a course of
betamethasone disodium phosphate (0-1 per cent.) and neomycin sulphate B.P. (0-5 per cent.) in water-
miscible base) (Betnesol-N, Glaxo) applied three times daily for 1 week. The age range was 28 to 75 years
(mean 60-5). 25 of the patients in this group had various forms of cataract, three refractive errors, 23
rheumatoid arthntis, and one systemic lupus erythematosus. Altogether 138 patients (269 eyes) with
clinically healthy conjunctivae were thus "treated" with the topical steroid or with the steroid'antibiotic
drops for one week, the fungal flora of the conjunctival sac being determined before commencement and
after the completion of treatment.
(3) Diseased External Eyes subjected to Topical Steroid Therapy
The second main clinical category comprised patients with various forms of external ocular
disease, for which either betamethasone disodium phosphate or betamethasone disodium phosphate
combined with neomycin sulphate had been prescribed.
(«) 46 patients (10 males and 36 females; 74 eyes; age range 15 to 58 years, mean 53) had been receiving
the steroid preparation. Table II shows the conditions being treated, and Table III the duration of steroid










Anterior Uveitis 15 20
Scleritis 1 1
Total 46 74
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(6) 55 patients (10 males and 45 females; 75 eyes; age range 23 to 61 years, mean 54-5) had been receiving
the steroid/antibiotic drops. The conditions under treatment are shown in Table IV and the duration of
therapy in Table V. Mydriatics were being instilled into six of these eyes.
Table IV Table V
Ocular Disease Duration of Treatment
























(4) Conjunctivae of Patients receiving Systemic Steroid Therapy
The association of conjunctival fungi with systemic steroid therapy was examined in thirty
randomly chosen ward patients who were being treated in a centre for rheumatic diseases.
There were eight males and 22 females; age range 18 to 57 years (mean 52). Two of the patients had a
probable recurrence of rheumatic fever and the remainder had rheumatoid arthritis. The duration of
therapy varied from 1 month to more than 3 years, and the daily prednisolone intake from 5 to more than
16 mg. The total dosage of steroid ranged from 1 -5 to over 9 g.
(5) Conjunctivae of Patients with Sjogren's Syndrome
The last clinical group chosen for the investigation of the fungal flora of the conjunctival sac
consisted of 37 patients (3 males and 34 females; 74 eyes; age range 37 to 80 years, mean 55-2)
with severe keratoconjunctivitis sicca attending a special "dry-eye" clinic. The clinical diagnosis
was based on a history of dry, irritable, or itchy eyes, a strongly positive Schirmer II tear test (less
than 5 mm.) using 10 per cent, ammonia, and the presence of marked staining of both conjunctiva
and cornea with 1 per cent, rose bengal. In addition, all of these patients had rheumatoid arthritis
based on American Rheumatism Association criteria (Ropes, Bennett, Cobb, Jacox, and Jessar,
1958), and they were all attending a centre for rheumatic diseases. Fourteen of the subjects were
receiving systemic prednisolone (5-15 mg. daily), but none was receiving topical steroids or anti¬
biotics. Topical treatment was discontinued for 3 to 4 days before the initial culture in order to
allow as much discharge as possible to collect.
Collection of Specimens
In all cases, specimens for culture were taken from both conjunctival sacs using a stiff nickel-
chrome wire loop, with which the lower fornices were vigorously scraped. In the case of the
keratoconjunctivitis sicca patients, any ropy discharge was also utilized for culture. Any cultures
found to be positive were repeated. Two hundred blank tubes, inoculated in the clinics under
similar working conditions, were submitted to the laboratory interspersed in irregular batches with
the clinical samples. Cultures were also taken at irregular intervals from the mydriatics, miotics,
vital dyes, and methyl cellulose drops in current use at the ophthalmic out-patient department.
Cultivation of Yeasts and Fungi
The mycological growth medium employed throughout this investigation was 2 per cem. malt
extract agar, containing 0 036 per cent, potassium tellurite as a bacterial inhibitor. The medium
was dispensed as drops in cotton-wool-plugged sugar tubes. After inoculation and transmission to
the laboratory, all tubes (including the blanks) were incubated at 25°C., and were examined for
evidence of fungal growth at intervals of 7 days. Negative cultures were reincubated and no tube
was discarded before the end of 4 weeks' incubation.
Yeasts and veast-like fungi were identified according to the taxonomic descriptions of Ladder
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and Kreger-Van Rij (1952). In particular, the specific identification of Candida species was based
upon the results of sugar fermentation and carbohydrate assimilation tests (Lodder and Kreger-
Van Rij, 1952). The identity of Candida albicans was confirmed by the demonstration of charac¬
teristic germ tubes in human serum, as described by Taschdjian, Burchall, and Kozinn (1960), and
by the demonstration of chlamydospore formation on corn meal agar slide cultures. The identifi¬
cation of the filamentous fungi was based upon their gross colonial morphology on malt agar, and
upon the nature and arrangement of their spores on malt agar slide cultures. The technique of
slide culture was as described by Riddeil (1950). In order to reduce bias during the study, the
bacteriologist was not informed of the sources of the cultures.
Results
Table VI shows the frequency and generic identity of the fungal isolates from 1,106
healthy conjunctival sacs in various age groups. The overall incidence of fungi was
2-9 per cent., the lowest frequency (0-8 per cent.) being observed in the 0 to 9 year age group,
and the highest (7 per cent.) in the 60 to 69-year age group. Although there were more
isolates from patients over than from those under the age of 40 years, a progressive increase
of incidence of isolates with increasing age was not demonstrated.
Table VI
Analysis of Positive Fungal Cultures from Healthy Conjunctivae, by Age Group
Age Group (yrs) 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70 + Total
Penicillium Sp. _ J 1 3 I 1 _ 7
Aspergillus Sp. - 1 - - • 3 - - 4
Rliodotorula Sp. - - 2 - - - J - 3
Scopulariopsis Sp. - T - 1 - 1 3
Candida Sp. - 2 - - - - 1 - 3
Isaria Sp. 1 - - - _ •- J 1 3
Geotrichum Sp. - - - _ _ - 3 - 3
Papulospora Sp. - 1 - _ - - - 1
Gliocladium Sp. - - - 1 - - _ 1
Hormodendron Sp. - - - - - - 1 - 1
Saccharomyces Sp. - 1 - - - - - 1
Rhizopus Sp. - 1 - - - - - - 1
Nigrospora Sp. - - - - - 1 - - 1
Total No. 1 6 4 1 4 6 8 2 32
Per cent. 0-8 1-4 4-6 1-2 4 5-6 *7 2-4 2-9
A comparison of the fungal flora of clinically normal external eyes before and after the
topical application of a steroid or steroid/antibiotic preparation for one week is shown in
Table VII (opposite). No significant increase in the frequency of isolation of fungi from the
eyes of 86 patients treated with betamethasone disodium phosphate was observed, but the
application of the betamethasone disodium phosphate/neomycin sulphate preparation was
associated, over the same period of time, with a significant increase in incidence of fungi in
the conjunctival sacs of 52 patients (X? using Yates correction for continuity for small
numbers = 8-2174; P < 0-01). On the other hand (Table VIII, opposite), the conjuncti¬
va! sacs of patients with external ocular diseases being ireated with the steroid or steroid/
antibiotic preparation did not yield fungi any more frequently than the healthy sacs.
There was no significant difference in isolation rates between patients subjected to topical
steroids alone and those subjected to topical steroids combined with an antibiotic. Further
more, repeals of the initially positive fungal cultures were uniformly negative, suggesting
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that fungal contamination was transitory. Only one positive culture was obtained from
the thirty patients receiving systemic steroid therapy.
Table IX (overleaf) shows the occurrence of fungi in the conjunctival sacs.of 37 patients
with Sjogren's syndrome after 4 days without their usual ocular toilet. Four isolates were
obtained from the fourteen patients (28 eyes) receiving systemic prednisolone, and six
isolates from the remaining 23 patients (46 eyes)—an overall incidence of 13-3 per ceiP.
This is a significantly higher incidence than that in a group of patients matched for age and
sex with clinically healthy conjunctival sacs (X2 = 5-258; P < 0-05). Further specimens
taken from these patients following resumption of their usual topical therapy did not yield
fungi. Eight of the ten patients in this group, who had previously harboured conjunctival
fungi, were sampled once again A days after ceasing ocular toilet. Sever, fungal isolates
were obtained, four of which were species of Candida.
Two of the 200 blank cultures yielded aerial contaminants.
Discussion
Picvious surveys of the fungal flora of the healthy conjunctival sac have been undertaken
by Fazakas (1935, 1953) in Central Europe, by Mitsui and Hanabusa (1955) in Japan, bv
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Patients with Sjogren's Syndrome
Treatment No. of
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Hammeke and Ellis (1960) in the United States, and by Azevedo (1962) in Brazil. Ainley
and Smith (1965), the only British workers who have so far undertaken a study of the fungal
flora of the clinically normal conjunctiva, described a small series comprising 43 patients
with no evidence of external ocular disease. The present investigation has utilized material
from 1,106 healthy eyes, and is the largest series so far reported in Great Britain. In a
study of 993 healthy eyes, Fazakas (1953) obtained 253 positive fungal cultures (25-4
per cent.). Hammeke and Ellis (1960) investigated 520 healthy eyes of adults, children,
and neonates; 10-3 per cent, of 416 adults, 5 per cent, of 52 children, and OT per cent, of 52
infants gave positive fungal isolates. Ainley and Smith (1965) studied 43 healthy eyes, and
obtained twelve positive results (27-4 per cent.). We have obtained 32 positive cultures
from 1,106 healthy eyes, a much lower incidence of 2-9 per cent.
Our clinical methods seem to be similar to those of other investigators and the lower
incidence in this series may be partly explained by the cultural techniques employed.
Thus, Ainley and Smith (1965) used Sabouraud's broth with subculture, afier one week, to
Sabouraud's agar plates, and subsequent incubation at 25°C. for up to 6 weeks. Wc used
malt agar slants for primary isolation, and an incubation period extending to 4 weeks at
25°C. Hammeke and Ellis (1960) also employed Sabouraud's glucose agar, but the length
of incubation of their cultures is not stated. In general, primary incubation in broth might
be expected to yield a higher isolation rate than on solid medium.
Previous workers have indicated that variations in the frequency of certain fungi occur
between various geographical regions, e.g. Candida species (Urrets-Zavalia, Remonda, and
Ramacciotti, 1958) and Sporotrichum Sp. (Gordon, 1947; McGrath and Singer, 1952.).
Despite a low overall incidence of fungi, our results are in fairly good qualitative agreement
with those of other investigators in other geographical areas with regard to the genera of
fungi and yeasts most frequently found in the conjunctiva! sac. Thus, Aspergillus Species,
Rhodoiorula, Candida, and Penicillium Species appear to be common inhabitants of the
healthy external eye (Fazakas, 1953; Mitsui and Hanabusa, 1955; Hammeke and Ellis,
1960; Ainley and Smith, 1965). These fungi collectively accounted for 54 per cent, of the
total isolates in our series. Fazakas (1953) found that the majority of his isolates from
healthy eyes were moulds, 28 per cent, of the isolates in his series of 993 eyes belonging to
FUNGAL FLORA OF THE CONJUNCTIVAL SAC 153
the Penicillium group. 22 per cent, of the positive cultures in our "healthy eye" group were
Penicillium.
In contrast to the findings of Hammekc and Ellis (I960), who reported distinct differences
in the frequency of positive fungal isolates from conjunctival sacs in different age groups,
we have not observed a progressive increase in incidence of fungi with increasing age,
although the overall incidence of fungi in the older age groups was somewhat higher than in
the very young age groups.
One may question the significance of the presence of fungi in the healthy conjunctival
sac. In an attempt to provide a partial answer to this question, we repeated all of our 32
positive cultures within 4 weeks of their initial detection, but we obtained only four repeat
positives. Furthermore, in none of these cases was the same species recovered. On the
basis of these findings, we consider that the fungi cultivable from healthy conjunctival sacs
must be regarded as transitory contaminants rather than resident commensals. Although
it would appear, therefore, that little significance should normally be attached to the
presence of fungi in the conjunctival sac, we nevertheless consider that it is important to
have accurate knowledge of the fungal species most likely to be encountered there, even
temporarily. The role of fungi as pathogens in ocular infections is becoming more widely
recognized, and although an increased awareness of the possibility of ocular mycoses may
be partly responsible, there is now well-documented evidence of a real increase in the
incidence of mycotic infections of the eye (Haggerty and Zimmerman, 1958; Mikami and
Stemmermann, 1958; Fine and Zimmerman, 1959; Chick and Conant, 1962), especially
as a sequel to trauma or surgery of the eye (Fine and Zimmerman, 1959), where infection
is believed to be exogenous in origin. In the latter instance, conjunctival saprophytes might
assume a pathogenic role in an "opportunistic" infection, as recently discussed in the
more general sphere of microbial disease by Symmers (1965).
The effect of corticosteroids in reducing resistance to a variety of bacterial, viral, and
fungal infections is well recognized (Zimmerman, 1950; Kiigman and others, 1951; Selye,
1951; Symmers, 1965), and it is believed that corticosteroids may permit fungi, normally
regarded as harmless commensals, to behave as pathogens (Agarwal, Malik, Mohan, and
Khosla, 1963; Suie and Havener, 1963). There is evidence that the extensive systemic and
topical use of corticosteroids and broad-spectrum antibiotics has largely contributed to the
increase of ocular mycoses (Hogan and others, 1954; Suie and Havener, 196<; McLean,
1963; Manchester and Gcorg, 1959; Woller, 1962; Currie, 1963). There is also clear
experimental evidence for the enhancement of the effects of fungus infection by corti¬
costeroids (Mankowski and Littleton, 1954; Ley, 1956; Hirose, Yoshioka, Abe, Kanemitsu,
and Kiya, 1957; Agarwal and others, 1963). Although such experimental conditions may
have little counterpart in human ocular infections, there are frequent reports at the clinical
level of ocular mycoses complicatingsteroid therapy, especially in relation to Candida species.
Svkes (1946), Mendelblatt (1953), Mitsui and Har.abusa (1955), and Roberts (1957) have
all reported corneal infections by Candida albicans. Maddren (1941) reported a case of
severe angular conjunctivitis occurring in the course of extensive candidiasis in a woman,
but Duke-Eider (1938) has stated that fungus infections of the conjunctiva are very rare.
A case of ocular mycosis due to Candida parapsilosis was reported by Manchester and
Georg (1959). Their patient was thought to have received corticosteroid and antibiotic
drops for a long period before developing keratomycosis, the initial lesion being a super¬
ficial punctate keratitis. Currie (1963) described three cases of mycotic keratitis associated
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with corneal ulceration. Candida albicans was implicated, and he considered that steroids
had aggravated the condition. Ainley and Smith (1965) have more recently described a
probable case of secondary keratomycosis due to Candida parapsHosis which responded to
the administration of Nystatin.
It is of interest that both Candida albicans and Candida parapsilosis were recovered in
our series of clinically normal conjunctivae, and that Candida albicans was represented in
our isolates from patients receiving the topical steroid/antibiotic preparation.
Previous studies have been undertaken of the effects of corticosteroid therapy upon the
incidence of fungi in the eye. Mitsui and Hanabusa (1955) obtained 42 positive cultures
from 62 patients receiving topical ocular steroids (67 per cent.), while a control group of
untreated patients had an incidence of 18-5 per cent. The majority of the isolates in their
series were PeniciUium, Aspergillus, Candida, Sacchcromyces, and Rhodororuia species.. In
a second experiment, these authors selected eighteen cases initially negative for fungi by
srnear or culture. After topical application of hydrocortisone ointment for 3 weeks, the
eyes of nine of the subjects were positive for fungi, Penicillium and Rhodolorula species
predominating.- Ainley and Smith (1965) failed to demonstrate any striking change in
fungal flora after the application of a corticosteroid/antibiotic combination (Betnesol-N) to
the eyes. Thus, of fifteen patients initially showing negative cultures, only three became
positive for fungi after the administration of drops or ointment thrice daily for not less
than 2 weeks. They point out that the number of patients studied was too small 1o give a
statistically significant result.
In the present investigation, topical betamethasone treatment of patients with clinically
normal external eyes and of patients with external ocular disease, did not result in any
significant changes in the mycotic flora of the eye. Thus, 86 patients (165 eyes) with
clinically normal external eyes received betamethasone disodium phosphate three times
daily for 1 week; only two pie-treatment isolates and three post-treatment isolates were
obtained. Furthermore, no generally accepted fungal pathogens were represented. 46
patients (74 eyes) with external ocuiai disease, who had been receiving topical betamethasone
disodium phosphate for varying periods of time, yielded one fungal isolate, a saprophytic
PeniciUium species,, and a further conjunctival sac scraping from the same patient was
negative.
Four fungal isolates of no pathogenic significance were obtained from the eyes of 55
patients (75 eyes) with various forms of external ocular inflammation, who had been
receiving the betamethasone disodium phosphatp/neomycin sulphate preparation for
varying periods; repeat cultures were uniformly negative.. The combined steroid/antibiotic
preparation, therefore, produced no significant changes in fungal flora in this group.
The effects of the topical administration of the betamethasone/neomycin preparation to
the patients with clinically normal external eyes deserve comment. Thus, there was one
isolate from 104 eyes before the commencement of therapy, and eleven isolates, including
three strains of Candida albicans after its completion. It is difficult to offer a simple
explanation of the comparatively large increase in ocular fungi in this particular group of
subjects, but it is of interest, that almost 50 per cent, of the patients in this category were
hospital in-patients (23 rheumatoid arthritis, 1 systemic lupus erythematosus). When the
cultural results are considered in relation to the source of the patient, ten of the eleven post-
treatment isolates were derived from the 24 ward patients, whereas only one post-treatment
isolate was obtained from the remaining eighteen out-patients. The higher incidence of
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fungi in the ward patients might possibly reflect a high level of aerial fungal contamination
of the ward environment when the specimens were collected. On the other hand, only one
fungal species was recovered from thirty in-patients with rheumatoid arthritis receiving
systemic steroids in the same wards as the former group.
There is no evidence from the present investigation that the neomycin component of the
combined topical steroid/antibiotic preparation made any significant contribution to the
alteration of fungal flora in patients so treated. Thus, there was no significant difference
in the frequency of isolation of fungi from the eyes of patients with external ocular disease,
whether treated with steroid/antibiotic combination or with steroid alone (Table VIII).
It is, however, relevant to note that numerous workers have shown that antibiotics,
especially the tetracyclines, can enhance the growth of fungi, notably Candida albicans,
and that subjects treated with antibiotics are more often carriers of Candida albicans than
arc untreated controls (McGovern, Parrott, Emmons, Ross, Burke, and Rice, i953; Sharp,
1954). There arc relatively few reports to incriminate neomycin in this respect, though
R.ciersol (1958) observed a marked increase in the incidence of faecal Candida albicans in
patients given oral neomycin, and it is possible that local neomycin therapy might give rise
to a similar increase in the conjunctiva.
The group of patients with Sjogren's syndrome yielded some interesting results. Ten
primary isolates were obtained from 74 eyes. The patients were derived from a "dry-eye"
clinic and they were instructed to use no local treatment, not even saline washouts, for 4
days before the first culture. Thereafter, they were allowed to return to their usual routine
of thrice daily irrigations with saline and instillations of carboxymethyl-cellulose drops
(0-5 per cent, solution) twice or three times daily. The second cultures were taken while
the patients were receiving this irrigation regime, and the totally negative cultural results
could be adequately explained on the basis of mechanical removal of foreign material from
the conjunctival sacs by the irrigations. This thesis is supported by the fact that seven
fungal isolates were subsequently obtained from the eyes of eight patients who consented
to stop all lccal treatment for 4 days before the collection of further specimens. Any
fungistatic effect of the carboxymethyl-cellulose drops (which contains chlorhexidine
digluconate, 0-95 per cent.) was excluded by failure to demonstrate inhibition of twenty
strains of Candida albicans, three strains of Rhodolonila, and two Aspergillus strains, in
simple plate diffusion tests in agar.
Patients receiving systemic steroids and those on alternative treatment showed no
significant differences in the frequency of isolation of fungi, but the results suggest that the
dry eye accompanying Sjogren's syndrome is more susceptible to colonization with fungi
than the healthy eye. Furthermore, patients with Sjogren's syndrome tend to belong to an
ageing group, and intra-ocular surgery for cataract extraction or glaucoma may become a
necessity. In view of the more frequent isolation of fungi from these patients, including
the potential intra-ocular pathogens Candida albicans and Candida parapsilosis, it is con¬
sidered that special pre-operative precautions are necessary, particularly since fungi are
sometimes thought to be introduced as a result of surgical or accidental trauma (Fine and
Zimmerman, 1959).
Summary
Studies were undertaken of the fungal flo.u of the healthy and diseased conjunctival sac
and of the effects of steroids.
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Fungi were'isolated from 2-9 per cent, of 1,106 healthy conjunctival sacs, a higher in¬
cidence being observed in older age groups. Although the majority of the species isolated
were non-pathogenic transient aerial contaminants, some potential intra-ocular pathogens
were also represented.
The effects were studied of the topical administration of betamethasone and of a com¬
bined betamethasone/neomycin preparation to patients with clinically normal externa! eyes.
Topical betamethasone therapy did not result in any significant changes in the fungal flora
of the conjunctival sac: a significantly higher incidence of fungi was observed in the eyes
of hospital in-patients receiving betamethasone/neomycin treatment.
The conjunctival sacs of out-patients with a variety of external ocular diseases being
treated with betamethasone or betamethasone combined with neomycin did not yield fungi
any more frequently than healthy conjunctival sa.es: there was no significant difference in
isolation rales between patients subjected to the topical steroid alone, and those subjected
to the combined steroid and antibiotic preparation.
Fungi were obtained from 13-3 per cent, of the conjunctival sacs of 37 patients with
Sjogren's syndrome. This was a significantly higher incidence than that obtained from a
group of patients with healthy eyes matched for age and sex. The isolates included the
potential intra-ocular pathogens Candida albicans and Candida parapsibsis, and evidence
was obtained that the untreated dry eye associated with this syndrome was more susceptible
to fungal colonisation than the healthy eye. The possible implications of this finding were
discussed.
We should like to acknowledge the continued guidance of Dr. W. Wilson, consultant ophthalmologist,
Ophthalmic Institute, Glasgow, and of Dr. J. C. Gcnlies, medical mycologist, Glasgow University Medical
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Lymphocytic infiltration of the gastric mucosa in chronic gastritis is associated with the
development of pernicious anaemia in a proportion of cases (Anderson, Buchanan, and
Goudie, 1967). More than 40 per cent, of patients suffering from pernicious anaemia can
be shown to have antibodies to gastric parietal cells (Irvine, Davies, Delamore, and
Williams, 1962; Markson and Moore, 1962; Taylor, Roitt, Doniach, Couchman, and
Shapland, 1962; Irvine, 1963a). It occurred to the investigators that the lymphocytic
infiltration in chronic gastritis might be similar to that found in the lacrimal and salivary
glands in Sjogren's syndrome and it is to be noted that a series of patients suffering from
this disease was found to have a high incidence of autoantibodies to gastric parietal cells
(Buchanan, Cox, Harden, Glen, Anderson, and Gray, 1966). Furthermore, patients
suffering from pernicious anaemia have a high incidence of thyroglobulin antibodies
(Irvine and others, 1962; Markson and Moore, 1962; Taylor and others, 1962; Doniach,
Roitt, and Taylor, 1963) as do patients with Sjogren's syndrome (Anderson, Goudie, Gray,
and Buchanan, 1961; Bloch, Buchanan, Wohl, and Bunim, 1965).
Sjogren's syndrome consists of the triad of keratoconjunctivitis sicca, xerostomia, and
rheumatoid arthritis (Sjogren, 1933) or other connective tissue diseases such as systemic
lupus erythematosus (Ramage and Kinnear, 1956; Bain, i960), polyarteritis nodosa
(Ramage and Kinnear, 1956), progressive systemic sclerosis (Ramage and Kinnear, 1956),
and polymyositis (Bloch and others, 1965).
The first purpose of this investigation was to determine the prevalence of Sjogren's
syndrome in patients suffering from proven pernicious anaemia.
In idiopathic Addison's disease there is atrophy of both adrenal cortices with loss of
most of the cortical cells, lymphocytic and plasma cell infiltration, and minimal fibrosis.
Chronic thyroiditis, which demonstrates similar histological changes, is present in approxi¬
mately 50 per cent, of patients with idiopathic Addison's disease examined post mortem
(Wells, 1930; Sloper, 1953; Bloodworth, Kirkendall, and Carr, 1954). Primary
myxoedema has occurred with idiopathic Addison's disease with sufficient frequency to
warrant the term Schmidt's syndrome (Schmidt, 1926). In addition, the chronic
thyroiditis found in idiopathic Addison's disease is associated with thyroid microsomal
antibodies in about 30 per cent, of the patients studied (Blizzard and Kyle, 1963; Irvine,
Received for publication June 18, 1968
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1963a) and thus is probably of the autoimmune type. Pernicious anaemia has been
reported in idiopathic Addison's disease (Blizzard and Kyle, 1963; Irvine, 1963b; Kra and
Barile, 1964). Gastric mucosal biopsies reveal a high incidence of chronic gastritis in
patients with idiopathic Addison's disease (Feyrter and Klima, 1952; Smith, Delamore,
and Williams, 1961). In addition, gastric parietal cell antibodies are more prevalent in
idiopathic Addison's disease than in tuberculous cases (Irvine, 1963b). There is, there¬
fore, strong evidence, clinical, histological, and immunological, pointing to an association
between idiopathic Addison's disease, chronic thyroiditis, and chronic gastritis (which
predisposes to pernicious anaemia).
Antibodies to salivary duct epithelium have been reported in patients with idiopathic
Addison's disease (Blizzard and Kyle, 1963) and similar antibodies have been detected in
patients with Sjogren's disease (Bertram and Halberg, 1964; Halberg, Bertram, Soborg,
and Nerup, 1965; MacSween, Goudie, Anderson, Armstrong, Murray, Mason, Jasani,
Boyle, Buchanan, and Williamson, 1967).
The second purpose of this investigation, therefore, was to determine the prevalence of
Sjogren's syndrome in patients suffering from idiopathic Addison's disease.
Material and methods
PATIENTS
169 patients (120 female, 49 male) comprising three groups (pernicious anaemia, idiopathic
Addison's disease, and hospital concrols) were included in the survey (the mean age and age range
are shown in Table I). All of the patients were examined for evidence of keratoconjunctivitis sicca.
The patients in the first two groups had been investigated as in-patients. Together with the help of
the original case records and further specific examinations, evidence of rheumatoid arthritis, thyroid
disease, and salivary duct atrophy was collected. Most of the hospital control patients were attend¬
ing as out-patients and were not suffering from any disease known to have an autoimmune basis.
Group I Pernicious anaemia (77 patients: 40 female, 37 male)
Four of these had rheumatoid arthritis by the American Rheumatism Association criteria (Ropes,
Bennett, Cobb, Jacox, and Jessar, 1958). Two had Hashimoto's thyroiditis (Buchanan, Alexander,
Crooks, Koutras, Wayne, Anderson, and Goudie, 1961) and one had idiopathic Addison's disease
(Anderson and others, 1967). One patient had thyrotoxicosis as well as rheumatoid arthritis and
another had thyrotoxicosis.
Group II Idiopathic Addison's disease (primary adrenal atrophy) (20 patients: 15 male, 5 female)
The diagnosis was based on the exclusion of obvious causes, e.g. tuberculosis for extensive and
irreversible destruction of the cortex of the adrenal glands (Anderson and others, 1967), and on the
detection of antibodies to adrenal cortical cells (Anderson, Goudie, Gray, and Timbury, 1957;
Blizzard and Kyle, 1963; Goudie, Anderson, Gray, and Whyte, 1966).
Group III Hospital controls (72 females)
These were patients attending clinics associated with the Western and Royal Infirmaries, Glasgow.
None of the variety of general medical conditions from which they suffered had any known association
with pernicious anaemia, thyroid disease, or autoimmune disorders.
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Table I Keratoconjunctivitis sicca in pernicious anaemia and idiopathic Addison's disease
(primary adrenal atrophy)
















Pernicious anaemia 77 62-5 ±ii-i 20-82 11 14-1 14 18-0 12 14-2 6 7-7
Addison's disease 20 36-6 ± 6 20-45 — — — — I 5-0 — —
Hospital controls 72 5i-9 31-74 5 6-9 10 r3'9 6 8-3 5 6-9
METHODS
Antibodies to parietal cells
These were tested using the indirect immunofluorescence technique for the detection of gastric auto¬
antibodies. Antigen was prepared from frozen unfixed sections of normal gastric fundal mucosa
(Taylor and others, 1962).
Autoantibodies to thyroglobulin
These were tested by a precipitin test using the Ouchterlony-E'iekplate technique (Anderson,
Buchanan, Goudie, and Gray, 1962) and by the tanned red cell haemagglutination test using thyro-
globulin-coated formalized tanned sheep red cells (Burroughs Wellcome) (Fulthorpe, Roitt, Doniach,
and Couchman, 1961). Autoantibody to thyroid microsomes was measured by an immunofluores¬
cence technique on unfixed frozen sections of thyroid slices (Holborow, Brown, Roitt, and Doniach,
1959)-
Other laboratory data
Waaler-Rose, latex particle, and haemoglobin tests were recorded in the patients suffering from
pernicious anaemia.
Examination for Sjogren's syndrome
Each patient underwent a complete ophthalmic examination. This included a Schirmer I tear test
using standardized sterile strips developed by Halberg and Berens (Contactisol Inc., Lindenhurst,
New York, U.S.A.). Patients with less than 15 mm. of wetting at 5 minutes had a Schirmer II tear
test using 10 per cent, ammonia held by the patient for 5 minutes at 6 in. from the nose (Williamson,
Cant, Mason, Greig, and Boyle, 1967). Keratoconjunctivitis sicca was diagnosed when the Schirmer
II test gave less than 5 mm. wetting after 5 minutes and when there was strongly positive staining with
the vital dye rose bengal 1 per cent., punctate or filamentary, of the conjunctivae and/or corneae.
Sialography
This was performed on four patients who gave a history of dryness of the mouth and throat and who
had clinical xerostomia (Park and Mason, 1966).
Results
EXAMINATION FOR SJOGREN'S SYNDROME
The results of the examination for keratoconjunctivitis sicca are summarized in Table I.
A small number of patients in Group I (pernicious anaemia) and Group III (hospital
controls) were suffering from keratoconjunctivitis sicca. Although the incidence of the
ocular disease was higher in Group I than Group III the difference was not significant.
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Most of the patients who demonstrated a reduced Schirmer I tear test, unprovoked by
ammonia, had pernicious anaemia. The average age of the anaemia group of patients
was 62-5 years, 10 years more than the hospital control patients, and this may account for
the apparent fall in tear secretion in the anaemia group.
None of the patients with idiopathic Addison's disease had keratoconjunctivitis sicca.
Four of the patients with pernicious anaemia had xerostomia but normal sialograms.
Table II summarizes the principal findings in those patients who had pernicious anaemia
and evidence of Sjogren's syndrome.
Table II Summary of findings in patients with pernicious anaemia, kerato¬














1 + + 0 + 0 0
2 + + + 0 + 0
3 + + 0 0 + +
4 + + 0 0 0
5 + + 0 0 0 0
6 + + 0 0 0 0
7 + 0 + 0 0 0
8 + 0 + 0 0 0
The first four patients listed (Table II) had evidence of involvement of other diseases.
Patient 1 had rheumatoid arthritis, patient 2 xerostomia and Hashimoto's thyroiditis,
patient 3 Hashimoto's thyroiditis and idiopathic Addison's disease, and patient 4 xero¬
stomia.
Three other patients had pernicious anaemia and rheumatoid arthritis but no evidence
of keratoconjunctivitis sicca. One of the patients with pernicious anaemia and rheumatoid
arthritis also suffered from thyrotoxicosis.
OTHER INVESTIGATIONS
A family history of pernicious anaemia was obtained from fourteen (18-2 per cent.) of the
77 patients suffering from this disease and a history of thyroid disorders in eight (10-4
per cent.).
There was no history of pernicious anaemia or thyroid disease in the families of those
suffering from idiopathic Addison's disease.
25 (32-4 per cent.) of the 77 patients with pernicious anaemia had palpable thyroid
glands. In twenty patients the glands were soft, in five firm. Two of the firm glands lay
beneath operation scars, one for thyrotoxicosis, the other for Hashimoto's thyroiditis.
Five of the patients with pernicious anaemia had proven thyroid disease; two had Hashi¬
moto's thyroiditis, two thyrotoxicosis, and one primary myxoedema.
LABORATORY DATA
All of the patients with pernicious anaemia were receiving Cytamen injections, the mean
current haemoglobin being 11-5 i 2-1 g./ioo ml.
Antibody to gastric parietal cells was detected in the sera of 35 (77 per cent.) of 46
patients, antibodies to thyroid microsomes in eighteen (39 per cent.) of 46 patients, and
tanned red cell titres were positive in thirteen (28 per cent.) of 46 patients suffering from
pernicious anaemia.
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Discussion
This study shows no increased prevalance of keratoconjunctivitis sicca in patients suffering
from pernicious anaemia (Table I). The prevalence is higher than in Sjogren's series
(Sjogren, 1933), in which his nineteen patients were distributed among 36,000 hospital
patients (0-05 per cent.), and in the ophthalmic control series of de Roetth (1945) in which
he found 0-2 per cent, of 6,200 patients with keratoconjunctivitis sicca. However, in
neither series was the age and sex distribution recorded. The number of patients suffering
from proven autoimmune thyroid disease who develop keratoconjunctivitis sicca is also no
higher than in a hospital control group (Williamson and others, 1967). In the present
series, it is interesting to observe that two of the six patients with pernicious anaemia and
keratoconjunctivitis sicca also had autoimmune thyroiditis—Hashimoto's disease (Table
II)—and that one of them in addition had idiopathic Addison's disease. However, it is
accepted that a patient with any one organ-specific disease has a higher than normal
tendency to develop another organ-specific disorder (Anderson and others, 1967). In
Sjogren's syndrome there are organ-specific features in that there is specific destruction of
the lacrimal and salivary glands. Nevertheless, a non-organ-specific connective tissue
disorder, usually rheumatoid arthritis, is present in over 50 per cent, of patients with
Sjogren's syndrome (Bloch and others, 1965). In this series one of the pernicious anaemia
patients who had keratoconjunctivitis sicca was also suffering from rheumatoid arthritis.
Three others with rheumatoid arthritis and pernicious anaemia did not have Sjogren's
syndrome.
The number of patients with xerostomia was no higher than in the hospital control group
reported previously (Williamson and others, 1967).
No cases of Sjogren's syndrome were detected among the twenty patients who had a
primary diagnosis of idiopathic Addison's disease. Their mean age (36-6 years) is,
however, much younger than either the pernicious anaemia group or the hospital control
group. One patient in the pernicious anaemia series who had idiopathic Addison's
disease and keratoconjunctivitis sicca has been discussed already.
The prevalence of gastric parietal cell antibodies and thyroglobulin antibodies, however,
is increased in Sjogren's syndrome (Buchanan and others, 1966; Anderson and others,
1961; Bloch and others, 1965). Both of these antibodies occur with increased frequency in
pernicious anaemia (Irvine and others, 1962; Markson and Moore, 1962; Taylor and
others, 1962; Irvine, 1963a; Doniach and others, 1963) and in idiopathic Addison's disease
(Blizzard and Kyle. 1963; Irvine, 1963b). Thyroglobulin antibodies are more frequent in
the connective tissue diseases rheumatoid arthritis (Anderson and others, 1961; Bloch and
others, 1965) and systemic lupus erythematosus (Anderson and others, 1961; Hijmans,
Doniach, Roitt, and Holborow, 1961), both of which may be associated with established
keratoconjunctivitis sicca. The absence of an increased prevalence of keratoconjunctivitis
sicca in pernicious anaemia or in idiopathic Addison's disease in contrast to that in auto¬
immune systemic disorders is consistent, however, with the concept that pernicious
anaemia and idiopathic Addison's disease are organ-specific disorders.
Summary
77 patients with pernicious anaemia and twenty with idiopathic Addison's disease were
examined for keratoconjunctivitis sicca by Schirmer tear tests, staining of the conjunctiva
and cornea by rose bengal dye, and slit-lamp examination. The prevalence of keratocon¬
junctivitis sicca in these patients was no higher than in 72 hospital controls. Sialography
was performed on four patients who had xerostomia but no abnormalities were detected.
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Sj0gren's disease, first described in 1933 (Sj0gren,
1933), consists of chronic inflammation of the
lacrimal and salivary glands leading to dryness of
the eyes (keratoconjunctivitis sicca) and dryness of
the mouth (xerostomia); in a proportion of patients
lacrimal and salivary gland enlargement may also be
present (Bloch, Buchanan, Wohl, and Bunim, 1965;
Talal, 1966). In 50 to 60 per cent, of patients the
disease may be associated with a connective tissue
disorder, usually rheumatoid arthritis, but occasion¬
ally also with polymyositis, polyarteritis nodosa,
progressive systemic sclerosis (scleroderma), and
systemic lupus erythematosus. The term "sicca
syndrome" or "sicca complex" is applied to those
cases of Sjogren's disease not associated with
rheumatoid arthritis or other connective tissue
disorders.
In Sjogren's disease, even in the absence of
rheumatoid arthritis or other connective tissue
disease (i.e. the sicca syndrome), there is hyper-
gammaglobulinaemia and a high incidence of ab¬
normal immunological reactions, such as anti-
nuclear factors, rheumatoid factors, precipitating
antibodies to tissue constituents, autoimmune
complement-fixation tests, and passive cutaneous
anaphylaxis in guinea-pigs (Jones, 1958; Stoltze,
Hanlon, Pease, and Henderson, 1960; Anderson,
Gray, Beck, and Kinnear, 1961; Anderson, Gray,
Beck, Buchanan, and McElhinney, 1962; Bunim,
Buchanan, Wertlake, Sokoloff, Bloch, Beck, and
Alepa, 1964; Beck, Anderson, Bloch, Buchanan,
and Bunim, 1965; Bloch and others, 1965). In
addition to these non-organ specific reactions, the
* Present address—Department of Pathology, The University of
Liverpool,
t Medical Student
prevalence of low titre thyroid auto-antibodies is
slightly higher than expected (Anderson, Goudie,
Gray, and Buchanan, 1961; Bloch and others, 1965)
and gastric parietal cell auto-antibodies with
chronic atrophic gastritis show a higher prevalence,
at least in patients studied in Glasgow (Buchanan,
Cox, Harden, Glen, Anderson, and Gray, 1966).
These serum factors indirectly favour the view that
Sjogren's disease may have an autoimmune basis.
Bertram and Halberg (1964) and Halberg, Bertram,
Soborg, and Nerup (1965) reported the demonstra¬
tion by immunofluorescence of antibody against
salivary duct epithelium in eleven of nineteen
patients with Sjogren's disease, and they considered
that the antigen might be organ specific, i.e. peculiar
to salivary tissue. In the present paper we report
the incidence of this salivary duct antibody (SDA)
in groups of patients with the sicca syndrome (Sc),
patients with Sjogren's disease complicated by
rheumatoid arthritis (Sj-RA), patients with rheuma¬
toid arthritis alone (RA) and patients with various
other arthritides. The presence of the antibody has
been further studied in relation to a number of
clinical and laboratory findings.
Materials and Methods
Patients
231 patients were studied. The clinical diagnosis, sex
distribution, mean age, and age range are shown in Table
I (opposite).
The diagnosis of Sjogren's disease was based on the
criteria described by Bloch and others (1965), and patients
were required to show at least two of the three major
components of the syndrome. The diagnosis of rheuma¬
toid arthritis was based on the criteria of the American
Rheumatism Association (Ropes, Bennett, Cobb, Jacox,
and Jessar, 1958).
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Table I
INCIDENCE OF SALIVARY DUCT ANTIBODY IN VARIOUS CONDITIONS




Male Female Mean Range No. Per cent.
Sicca Syndrome 13 I 12 64 53-78 2 15
Sjogren's Disease with Rheumatoid Arthritis. . 17 4 13 55 29-81 11 65
Rheumatoid Arthritis 129 54 75 48 6-73 34 26
Systemic Lupus Erythematosus 4 — 4 35 20-60 1 25
Psoriatic Arthritis 9 1 8 49 20-65 — -
Reiter's Syndrome 9 9 — 35 19-45 2 22
Ankylosing Spondylitis 1 1 — 43 — — —
Gout 6 4 2 58 36-83 — -
Osteo-arthritis 43 12 31 58 23-78 — —
Ophthalmological Examination
This was performed by the method described by
Williamson, Cant, Mason, Greig, and Boyle (1967).
Each patient was examined for evidence of keratocon¬
junctivitis sicca by one of us (J.W.) who was unaware of
the clinical diagnosis. A Schirmer I tear test was carried
out using standardized sterile paper strips developed by
Halberg and Berens (Contactisol Inc., Lindenhurst, New
York, U.S.A.) in an atmosphere between 60-70° F. with a
relative humidity greater than 40 (Williamson and
Allison, 1967). Wetting of the filter paper was read
after 5 minutes and the mean of the two eyes recorded.
Patients with wetting exceeding 15 mm. were considered
normal and were not examined further. Those with
wetting less than 15 mm. had a Schirmer II tear test and a
Rose Bengal dye test performed. The Schirmer II test
consisted of repeating the Schirmer I test while exposing
the patient to a 10 per cent, solution of ammonia held 6
inches from the nose for 5 minutes. The Rose Bengal
test consisted of instilling a I per cent, solution of the dye
into the conjunctival sacs, followed immediately by
irrigation with normal saline, and by examination with a
Zeiss or Haag-Streit slit lamp for punctate and/or fila¬
mentary keratitis. Staining in the area previously in
contact with the Schirmer paper was ignored.
A "definite" diagnosis of keratoconjunctivitis sicca was
diagnosed when either the Schirmer I or Schirmer II test
showed wetting less than 15 mm. but more than 5 mm.,
and the Rose Bengal dye test showed at the most only
faint staining of the conjunctivae. Patients with a
"possible" diagnosis did not have punctate and/or
filamentary keratitis on slit-lamp examination.
Each patient was carefully questioned regarding a
history of xerostomia and of associated oral and pharyn¬
geal symptoms of Sjogren's disease (Bloch and others,
1965). Salivary flow studies were performed using a
modified Carlson-Crittenden cup with an outer chamber
diameter of 20 mm. and an inner chamber diameter of
10 mm. Parotid saliva was collected from each patient
under resting condition and after stimulation with fruit
gums and lemon juice.
Many patients admitted to having a dry mouth
(symptomatic xerostomia) but without experiencing
insufficiency of saliva and/or difficulty in mastication, or
requiring increased fluid intake. Their mouths appeared
to be moist and salivary flow studies on a sample of them
were within the normal range.
Sialography was performed on all the 231 patients,
using the hydrostatic technique described by Park and
Mason (1966). The criteria of abnormality in the
sialograms were based on those described by Bloch and
others (1965).
Other Clinical and Laboratory Data
In addition to the age and sex of the patient and the
ophthalmological and oral examinations described, the
following clinical facts were recorded:
Duration of arthritis, presence of subcutaneous
nodules, functional grade, and x-ray classification
(Steinbrocker, Traeger, and Batterman, 1949).
Laboratory investigations included:
Haemoglobin concentration, erythrocyte sedimentation
rate (Westergren), white cell count, and assay of serum
globulin.
Serological Methods
Salivary Duct Antibody (SDA).~ Blocks of human
submandibular gland obtained at autopsy not more than
10 hours after death were frozen on to metal chucks with
C02 snow and by. sections were cut in a cryostat. The
sera were applied undiluted to the unfixed section for 30
minutes at room temperature. After washing in normal
saline buffered with veronal (pH 7-2) for 10 minutes,
fluorescein-conjugated goat anti-human globulin serum
was applied for 30 minutes. After a final 10 minutes
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wash in buffered saline the sections were mounted in
buffered glycerol and examined with a Gillett and Sibert
conference microscope using blue light. To reduce non¬
specific fluorescent staining, the fluorescein-conjugated
anti-human globulin serum was absorbed twice with dried
rat liver powder.
Anti-nuclear Factor (ANF) was detected using the
indirect fluorescence method described by Beck (1961)
with rat liver as substrate. The sera were initially tested
at a dilution of 1 in 16 and positive sera were then titrated
in quadrupling dilutions till an end point of nuclear
staining was obtained.
Anti-thyroglobulin was detected by the tanned red cell
haemagglutination test described by Fulthorpe, Roitt,
Doniach, and Couchman (1961), using thyroglobulin-
coated formolized tanned sheep red cells (Burroughs
Wellcome). The sera were initially tested at a dilution
of 1 in 16 and positive sera were titrated in quadrupling
dilutions.
Thyroid "Microsomal" Antibody was detected by the
indirect immunofluorescence technique described by
Holborow, Brown, Roitt, and Doniach (1959), using
unfixed thyrotoxic thyroid tissue as substrate and with
the test sera diluted 1 in 4.
Gastric Parietal Cell Antibodies were demonstrated by
an indirect immunofluorescence technique (Adams,
Glen, Kennedy, Mackenzie, Morrow, Anderson, Gray,
and Middleton, 1964), using unfixed human gastric
mucosa as substrate and testing the sera undiluted.
In the tests for SDA a highly reactive fluorescein-
conjugated goat anti-human globulin provided by Dr.
J. S. Beck was used, while in the other immunofluorescent
tests commercially available fluorescein-conjugated rabbit
anti-human globulin (Burroughs Wellcome) was used.
Rheumatoid Factor was determined by the Hyland latex
(RA) test technique (Hyland Laboratories, California).
All sera were screened at a dilution of 1 in 32 and the
presence of agglutination was recorded 15 and 45 seconds
after mixing the reagents. Agglutination at either 15 or
45 seconds was recorded as positive. Positive sera were
then titrated in doubling dilutions.
Non-specific Tissue Precipitin Tests were performed,
using the method described by Anderson, Gray, and
others (1961) with human thyroid tissue as antigen.
All specimens were tested undiluted and at a dilution of
1 in 8.
Results
Fig. 1 (opposite) shows positive and negative
staining of salivary duct epithelium. Positive
immunofluorescent staining varied in intensity, but
even with the brightest staining pattern it was found
that the antibody was present in low titre, none
exceeding 1 in 32.
In the following statistical analysis x2 has been
calculated (when appropriate) using Yates's correc¬
tion for small numbers. Comparisons which do not
yield statistically significant differences are not
discussed.
Whole Series: Incidence of SDA in Various Conditions
(Table I, see p. 403).
In patients with Sc, the antibody was found in only
two of thirteen (15 per cent.). In contrast, the
antibody was present in eleven of seventeen patients
(65 per cent.) with Sj RA. In the RA group 34 of 129
patients (26 per cent.) had SDA in their serum, an
incidence not differing significantly from that found
in the Sc group, but lower than that in the Sj-RA
group (x2 = 12-23; P<0-001).
Of the various other groups examined, one of the
four patients with systemic lupus erythematosus
and two of nine males with Reiter's syndrome had
SDA.
The patient with systemic lupus had definite
keratoconjunctivitis sicca, severe xerostomia with
objective evidence of reduced salivary flow rate,
punctate sialectasis and intermediate duct changes
on sialography, and a history of intermittent parotid
swelling. Of the two patients with Reiter's syn¬
drome, one had definite keratoconjunctivitis sicca,
but no other stigmata of Sjogren's disease were
found.
None of the 43 patients with osteo-arthritis was
found to have SDA.
Sc and Sj-RA Groups (Tables II and III, overleaf)
Patients with Sj-RA had SDA more often than did
those with Sc (x2 = 5-43; P<0-02). The two
groups also differed in that the Sc patients were
older (t = 3-89; P<0-001), and had more sialo¬
graph^ abnormalities (x2 = 12-6; P<0-001) and a
lower erythrocyte sedimentation rate (/=3-47;
P<0-001). In Sj-RA there was a negative corre¬
lation between SDA and ANF (x2 = 8-24;
P<0-01).
RA Group (Tables IV and V, Fig. 2, overleaf)
SDA was found significantly more frequently in
older rheumatoid patients and in those with more
severe rheumatoid disease as judged by functional
grade, x ray stage, erythrocyte sedimentation rate,
and the prevalence of rheumatoid factor. As
shown in Fig. 2, the prevalence of rheumatoid factor
for all titres except 1 in 32 as well as the highest
titres were seen in SDA positive patients.
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c
Fig. 1.—Frozen sections of human submandibular gland stained by indirect immunofluorescence
(a) With a serum containing salivary duct antibody: there is brilliant fluorescence of the duct epithelium, while the nuclei remain dark.
\b) With a normal serum: the ductal elements are just outlined
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Table II







No. of Patients 13 17
Salivary Duct Antibody
Present Absent Present Absent











Sex 2F 10F, 1M 8F 3M 5F, 1M
No. of Cases 2 11 11 5

























Salivary Gland Enlargement 0 7 1 2

























Subcutaneous Nodules — — 3 3
± Standard deviation
Table III







No. of Patients 13 17
Salivary Duct Antibody
Present Absent Present Absent
2 11 11 6








11 - 7± 1 -8
9-7-14-1




























3 - 8 ±0-54
3-3-4-7
Rheumatoid Factor Positive 1 6 8 6
Antinuclear Factor Positive 1 3 2 6
Non-specific Tissue Precipitin Positive 0 4 2 1
Thyroglobulin Antibody 0 3 3 1
Thyroid Microsomal Antibody 1 5 3 2
Gastric Parietal Cell Antibody 0 4 5 1
± Standard deviation
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Table IV













Sex 16F, 18M 57F, 38M —
"Possible" Keratoconjunctivitis Sicca 15(44%) 20 (21 %) X! = 6-67
P<001
Symptomatic Xerostomia 14(41%) 9(9%) x2=17-18
P<0 001


























Subcutaneous Nodules 7(21%) 12(13%)
± Standard deviation
Table V



















/ = 2 • 94
P<0-001














Rheumatoid Factor Positive 29 (85-3%) 43 (45 • 2 %) X2= 16-27
P<0-001
Anti-nuclear Factor Positive 13(38%) 20 (21 %) —
Non-specific Tissue Precipitins Positive 1 (3%) 4(4%) —
Thyroglobulin 3(9%) 7(7%) —
Thyroid Microsomal Autoantibody 8(23%) 17(18%) —
Gastric Parietal Cell Antibody 9(26%) 11 (H%) —
L Standard deviation
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Reciprocal of titre of rheumatoid factor
Fig. 2.—Histogram showing percentage of cases positive for rheuma¬
toid factor in patients with rheumatoid arthritis with or without
salivary duct antibody
A higher incidence of "possible" keratoconjunc¬
tivitis sicca and of symptomatic xerostomia was
found in those with SDA. Table VI compares the
frequency of "possible" keratoconjunctivitis sicca,
symptomatic xerostomia, and abnormal sialograms
in rheumatoid patients and in those with other
rheumatic diseases—psoriatic arthritis, Reiter's
syndrome, ankylosing spondylitis, gout, and osteo¬
arthritis. There is no significant difference. The
sub-group of rheumatoid patients with SDA had
symptomatic xerostomia more frequently than other
patients (x2 = 6-4; P<001).
Comparison of Sj-RA and RA Groups
Among all the patients with rheumatoid arthritis,
Sj-RA was found in those who were older (t = 2 • 1;
P < 0 • 05), had had their arthritis for a longer
period (t = 1-98; P<0 05), and had more severe
rheumatoid disease as judged by the erythrocyte
sedimentation rate (/ = 3 • 5; P < 0 • 02) and the
presence of subcutaneous nodules (x2 = 4-5;
P<0 05). The Sj-RA group also had a higher
prevalence of SDA (x2 = 12-23; P<0 001) and of
rheumatoid factor (x2 = 4-37; P<0 05).
Similarly, when Sj-RA patients were compared
with SDA-positive RA patients, the former were
shown to have had their arthritis longer (t = 1-73;
P<0-05) and to have a higher erythrocyte sedimen¬
tation rate (t = 2-4; P<0 02). No age difference
was, however, found.
Discussion
Bertram and Halberg (1964) first described the
occurrence in Sjogren's disease of an antibody
against salivary duct epithelium. Since sera con¬
taining the antibody did not give immunofluorescent
staining of salivary gland acini or of thyroid, they
considered that the antibody might be specific for an
antigen peculiar to salivary duct epithelium.
Feltkamp (1967) has shown that the antibody could
be absorbed from the serum with extracts of salivary
gland, but extracts of a number of other tissues,
including thyroid, liver, and kidney, failed to do so.
We have shown that the antibody reacts with the
individual's own tissues (i.e. it is an autoantibody)
and also causes immunofluorescent staining of small
lacrimal ducts, but not of gastric, thyroid, or
prostatic epithelium. The mitochondral antibody
found in a high percentage of patients with primary
biliary cirrhosis (Walker, Doniach, Roitt, and
Sherlock, 1965; Goudie, Macsween, and Goldberg,
1966) gives an immunofluorescent staining pattern
with salivary gland similar to that seen with SDA
positive sera. Preliminary experiments, however,
have shown that the SDA differs from the mito¬
chondrial antibody in that only the latter can be
absorbed from sera with rat liver mitochondria.
The SDA thus shows some organ-specificity, but
final confirmation must await further experimental
investigation.
In our present studies we have found SDA in 15
per cent, of patients with Sc, but in 65 per cent, of
Table VI
"POSSIBLE" KERATOCONJUNCTIVITIS SICCA, SYMPTOMATIC XEROSTOMIA, AND ABNORMAL SIALOGRAMS IN







No. of Patients 129 34 95 67
"Possible" Kerato-Conjunctivitis Sicca 35 (27%) 15(44%) 20 (21 %) 20(30%)
Symptomatic Xerostomia 23 (27%) 14(41%) 9(9%) 12(18%)
Abnormal Sialogram 7(5%) 4(12%) 3(3%) 4(6%)
*Other arthritides = psoriatic arthritis, Reiter's syndrome, ankylosing spondylitis, gout, and osteo-arthritis.
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patients with Sj-RA. In RA the incidence of the
antibody was 26 per cent. In none of the large
series of patients with osteo-arthritis was the anti¬
body present. The antibody is thus not peculiar
to Sjogren's disease. It is most commonly found in
Sj-RA, but is also present in one in four of patients
with RA, and in one in seven of Sc patients. These
observations suggest that the antibody is in some way
related to the rheumatoid disease process, whether
or not there be clinical evidence of salivary gland
involvement. This is further emphasized in that,
among RA patients, SDA was found significantly
more frequently in older patients and those with
more severe rheumatoid disease. Furthermore,
Sj-RA also occurred in patients who were older,
had had their arthritis longer, and had more severe
rheumatoid disease. Circumstantial evidence of
lacrimal and salivary gland involvement by the
rheumatoid process was provided by the significantly
higher incidence of "possible" keratoconjunctivitis
sicca and of symptomatic xerostomia noted in the
SDA positive RA patients as compared with the RA
patients without the antibody. This might suggest
that a subclinical form of Sjogren's disease was
present in the SDA positive RA patients.
Histological evidence of salivary gland involve¬
ment in rheumatoid arthritis was provided by
Waterhouse and Doniach (1966), who found focal
lymphocytic sialadenitis in all of twelve females
and in four of five males with rheumatoid arthritis.
They considered the salivary lesion regularly found
in rheumatoid arthritis to be Sjogren's disease in
miniature. It is thus perhaps not entirely surprising
that, in rheumatoid arthritis, without clinical evi¬
dence of salivary or lacrimal gland involvement,
there should be a high incidence of salivary duct
antibodies.
The finding of a significantly lower incidence of
SDA in the Sc patients than in the Sj-RA patients is
of considerable interest. The previous detailed
studies of Bloch and others (1965), Beck and others
(1965), and Bunim and others (1964)—summarized
in Table VII—have shown differences between these
two sub-groups of Sjogren's disease. Furthermore,
Talal, Leventhal, and Waldorf (1966) found that
lymphocytic transformation in response to phyto-
haemagglutinin and streptolysin was less in Sj-RA
than in Sc. However, with dinitrochlorobenzene
skin sensitization, these workers found that
differences between the two groups were not
apparent. Reference to Table VII shows that, with
the exception of anti-Gm factors, non-organ-
specific autoantibodies have been found to be
consistently more prevalent in the Sc patients. It is
therefore surprising that in our present studies in
patients with Sc, which clinically appears to be an
organ-specific disease, the possibly organ-specific
SDA should be significantly less common than in the
Sj-RA patients. The number of Sc patients is small
in our series, but our findings, taken in conjunction
with the observations of other workers, clearly
indicate the need for a more detailed comparison of
Sc patients and patients with salivary and lacrimal
gland involvement accompanied by a connective
tissue disorder.
Summary
(1) An immunofluorescent autoantibody to
salivary duct epithelium has been found in two of
thirteen patients with sicca syndrome, in eleven of
seventeen patients with Sjogren's disease and
rheumatoid arthritis, and in 34 of 129 patients with
uncomplicated rheumatoid arthritis.
Table VII
COMPARISON OF SICCA SYNDROME (Sc) WITH SJOGREN'S DISEASE WITH RHEUMATOID ARTHRITIS (Sj-RA)
Bloch and others (1965) and Bunim and others (1964)
Diagnosis Sc Sj-RA Reference
Serum Globulin (g./lOO ml.). . Mean 4.4 3-6 Bloch and others (1965)
Range 2-8-6-8 20-5-7
Antinuclear Factor 14/16(88 %) 14/25 (56%) Bloch and others (1965)
Pattern of Nuclear Fluorescence Staining . . Homogeneous 7/16 8/18 Bloch and others (1965)
Speckled 5/16 2/18
Nucleolar 5/16 0/18
Auto-immune Complement-Fixation Test 15/19 5/26 Bloch and others (1965)
Precipitating Autoantibodies 13/16 1/18 Bloch and others (1965)
Anti-Gm Factors 4/20 14/27 Bunim and others (1964)
Reticulum Cell Sarcoma 4/23 0/32 Bloch and others (1965)
Numerator = number of patients with positive tests
Denominator = number of patients tested
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(2) In patients with rheumatoid arthritis, the
antibody was found significantly more frequently in
older patients and in those with more severe
rheumatoid disease.
(3) The antibody appears to be a manifestation
of the rheumatoid disease process, in which other
workers have shown a high incidence of chronic
focal sialadenitis.
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L'occurrence de l'anticorps contre l'epithelium du canal
salivaire dans la maladie de Sjogren, l'arthrite rhumatis-
male et dans d'autres arthritides; etude clinique et de
laboratoire
Resume
(1) On trouva un anticorps immunofluorescent contre
l'epithelium du canal salivaire chez deux sur treize
malades atteints de syndrome sicca, chez onze sur
dix-sept patients atteints de maladie de Sjogren et d'arth-
rite rhumatismale et chez 34 sur 129 patients atteints
d'arthrite rhumatismale sans complications.
(2) Pour l'arthrite rhumatismale, l'anticorps fut
trouve bien plus souvent chez des malades plus ages et
chez ceux dont la maladie rhumatismale fut plus severe.
(3) L'anticorps semble etre une manifestation du
processus morbide rhumatismal dans lequel d'autres
auteurs ont demontre une grande frequence de la sialade-
nite focale chronique.
La ocurrencia del anticuerpo contra el epitelio del eon-
ducto salivario en la enfermedad de Sjogren, la artritis
reumatoide y en otros artritidicos; estudio clinico y de
laboratorio
sumario
(1) Un anticuerop inmunofluorescente contra el
epitelio del conducto salivario fue encontrado en dos de
trece enfermos con sindrome sicca, en once de diecisiete
pacientes con enfermedad de Sjogren y artritis reumatoide
y en 34 de 129 pacientes con artritis reumatoide sin
complicaciones.
(2) Respecto a la artritis reumatoide, el anticuerpo
fue encontrado con frecuencia significativamente mayor
en enfermos mas viejos y en casos de enfermedad reuma¬
toide mas grave.
(3) El anticuerpo parece representar una manifesta-
cion del proceso morboso reumatoide en el cual otros
autores han encontrado una frecuencia aumentada de la
sialadenitis focal cronica.
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LYMPHOCYTIC SIALADENITIS IN THE BUCCAL MUCOSA,
IN SJOGREN'S DISEASE, RHEUMATOID ARTHRITIS AND
OTHER ARTHRITIDES
A Clinical and Laboratory Study
By
K. Whaley, D. M. Chisholm, W. W. Downie, W. C. Dick
and J. Williamson
INTRODUCTION
Sjogren's syndrome, first described by the Swedish ophthalmologist
Henrik Sjogren in 1933 (8), is now recognised as the triad of keratocon¬
junctivitis sicca (dry eyes), xerostomia with or without salivary gland
enlargement and in one half to two thirds of patients rheumatoid arthritis
or other connective tissue disease (1, 2). The keratoconjunctivitis sicca
and xerostomia are due to reduced secretion by the lacrimal and salivary
glands respectively, which are the seat of chronic inflammatory changes.
Approximately 10 to 15 per cent of patients with rheumatoid arthritis
have keratoconjunctivitis sicca or some of its components (2) and
approximately just over 25 per cent have mild xerostomia without
evidence of diminished salivary secretions or abnormal sialograms (4).
An immunofluorescent autoantibody to salivary duct epithelium has
been demonstrated in 15 per cent of patients with Sjogren's syndrome
not associated with rheumatoid arthritis or other connective tissue disease,
in 65 per cent of patients with definite Sjogren's syndrome and rheuma-
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toid arthritis, and in 26 per cent of patients with uncomplicated rheuma¬
toid arthritis. The autoantibody in the latter group of patients was related,
however, to evidence of possible keratoconjunctivitis as judged by
diminished tear secretion (7) and to symptomatic xerostomia. There
was thus circumstantial evidence that the autoantibody to salivary duct
epithelium reflected a subclinical form of Sjogren's disease (4). Water-
house and Doniach (10) found focal lymphocytic sialadenitis in sixteen
of seventeen patients with rheumatoid arthritis, and suggested that this
lesion represented Sjogren's disease in miniature.
The present study was undertaken to determine the prevalence and
nature of sialadenitis in the buccal salivary glands in Sjogren's syndrome
with or without rheumatoid arthritis, and other arthritides.
MATERIALS AND METHODS
Patients
One hundred and eleven patients were studied. Table I shows the age
and sex distribution and clinical diagnosis of these patients.
Sjogren's syndrome was diagnosed based on the criteria described by
Bloch et al. (l): keratoconjunctivitis sicca, xerostomia with or without
salivary gland enlargement, and rheumatoid arthritis or other connective
tissue diseases. The diagnosis of Sjogren's syndrome required at least
two of these three major components of the syndrome. The diagnosis
of "sicca syndrome" was made in patients with keratoconjunctivitis
sicca and xerostomia with or without salivary gland enlargement, but
who had no evidence of rheumatoid arthritis or other connective tissue
disease. The diagnosis of rheumatoid arthritis was based on the
diagnostic criteria of the American Rheumatism Association (6). The
majority of patients with rheumatoid arthritis, included in the study,
whether associated with Sjogren's syndrome or not, had positive tests
for rheumatoid factor and/or erosions on x-ray: all satisfied the criteria
of "definite" or "classical" disease.
In addition to the age and sex of the patient the following clinical
features were recorded: duration of arthritis, presence of subcutaneous
nodules, functional grade and x-ray classification (9). Laboratory in¬
vestigations included: full blood count, white cell count erythrocyte
sedimentation rate (Westergren) and determination of serum globulin.
Each patient was examined for keratoconjunctivitis sicca by one of
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TABLE I
The Incidence of a Focal Lymphocytic Sialadenitis in the Buccal Mucous
Membrane in the Clinical Groups Studied.
No. of patients
Sex Age (yrs.) With lymphocytic
sialadenitis
Male Female Mean Range No. Per cent.
Sicca syndrome 10 2 8 55.9 27—66 6 60.0
Rheumatoid arthritis and
Sjogren's syndrome 20 3 17 60.1 48—77 13 65.0
Rheumatoid arthritis alone 40 10 30 54.1 20—73 11 27.5
Psoriatic arthritis 8 2 6 49.7 19—88 1 12.5
Ankylosing spondylitis 10 5 5 47.8 23—73 2 20.0
Reiter's syndrome 6 6 — 34.5 18—52 — —
Still's disease 1 — 1 29.0 — — —
Systemic lupus erythematosus 1 — 1 21.0 — — —
Progressive systemic sclerosis 4 — 4 31.5 16—40 1 25.0
Gout 1 1 — 60.0 — — —
Osteoarthritis 10 3 8 64.9 53—74 1 10.0
us (JW) who was unaware of the clinical diagnosis, by the method
described by Williamson et al. (12). A Schirmer I tear test was carried
out in an atmosphere between 60 and 70°F. with a relative humidity greater
than 40 (11) using standardised sterile paper strips supplied by Contacti-
sol Inc., Lindenhurst, New York, U. S. A. Patients with wetting of the
paper exceeding 15 mm. after 5 minutes were considered normal. Those
with wetting less than 15 mm. had a rose bengal test and Schirmer II tear
test. The rose bengal test was performed by instilling one per cent of the
dye into the conjunctival sac, followed by irrigation with normal saline, and
by examination with a Zeiss or Haag-Streit slit lamp for punctate and
filamentary keratitis. Staining in the area previously in contact with the
paper was ignored. The Schirmer II tear test consisted of a Schirmer
I tear test while exposing the patient to a 10 per cent solution of ammonia
held 6 inches from the nose for 5 minutes.
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Fig. 1. Normal buccal mucosa. 190x.
A diagnosis of "definite" keratoconjunctivitis sicca was made only
when both the Schirmer I and II tear tests showed wetting less than 15
mm., and punctate and/or filamentary keratitis was present on slit lamp
examination. Patients with a "possible" diagnosis of keratoconjunctivi¬
tis sicca had a Schirmer I or II tear test less than 15 mm., but more
than 5 mm. and the rose bengal dye test showed at the most only faint
staining of the conjunctivae: patients with "possible" keratoconjunctivitis
sicca did not have punctate and/or filamentary keratitis on slit lamp
examination.
Each patient was carefully questioned regarding a history of
xerostomia and associated dental symptoms of Sjdgren's syndrome (l).
Many patients stated that they had a dry mouth (symptomatic xerostomia)
but had no diminished salivation and/or difficulty in mastication or
deglutition requiring increased water intake. These patients' mouths
appeared moist on examination and salivary flow studies using a modified
Carlson-Criltenden cup were normal. In a previous study we had noted
302 WHALEY, CHISHOLM, DOWNIE, DICK & WILLIAMSON
Fig. 2. Diffuse lymphocytic infiltrate. 190x.
that symptomatic xerostomia occurred in 27 per cent of patients with
rheumatoid arthritis uncomplicated by overt Sjogren's syndrome as
compared to 18 per cent of patients with other forms of arthritis such
as psoriatic arthritis, Reiter's syndrome, ankylosing spondylitis, gout and
osteoarthritis (4).
Sialography was performed using the hydrostatic technique of Park
and Mason (5) in all 112 patients. The criteria of abnormality in the
sialograms were based on those described by Bloch et al. (1).
RESULTS
The histological appearances of the buccal mucous membrane, were
divided into 3 types, a) normal, fig. 1, b) a diffuse lymphocytic
infiltration, fig. 2, and c) a focal lymphocytic sialadenitis, fig. 3.
Both diffuse and focal infiltrations could be further subdivided into
two stages, based on the severity of the infiltrate (3). In this way five
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Fig. 3. Focal lymphocytic Infiltrate. 75x.
stages of lymphocytic infiltration in the buccal mucous membrane biopsy
were identified.
Stage 0 — Normal biopsy appearance.
Stage I — Fine diffuse lymphocytic infiltrate.
Stage II — Marked diffuse lymphocytic infiltrate.
Stage III — Focal infiltration of lymphocyte.
Stage IV — Very heavy focal infiltration of lymphocytes.
Both stage III and IV, in addition to foci of lymphocytes, showed
a diffuse infiltration of lymphocytes. Figure 4 shows the frequency with
which the various stages of lymphocytic sialadenitis occur in the clinical
groups included in the study. It can be seen that diffuse lymphocytic
infiltrates are quite uncommon in all clinical groups. However, in post¬
mortem studies, stages I and II were quite common (3), and so these
were not included as positive in this series.
Table I shows the incidence of positive biopsies in the groups included
in the study.
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TABLE II
The Relationship of Focal Lymphocytic Sialadenitis in the Buccal Mucosa and
the Clinical Features of Patients with Rheumatoid Arthritis.
Present Absent







Sex 10 F. 1 M. 20 F. 9 M.
Possible keratoconjunctivitis sicca 1 (9.1 %) 4 (13.8%)
Symptomatic xerostomia 1 (9.1%) 8 (29.4%)































Nodules 2 (18.2%) 8 (27.6%)
In Sjogren's syndrome, with or without rheumatoid arthritis, the inci¬
dence of positive biopsies is virtually equal (65 % and 60 % approx.).
Both of these are significantly higher than the incidence of 27.5 % in
rheumatoid arthritis.
In the other arthritides, 2 patients with ankylosing spondylitis had
positive biopsies, but neither had features suggestive of Sjogren's
syndrome.
The one patient with osteoarthritis who had a positive biopsy, had a
diminished Schirmer II test, but no evidence of rose bengal staining
of the cornea. He was thus placed in the category of possible
keratoconjunctivitis sicca, and this may explain the positive biopsy.
In psoriatic arthritis, 1 of the 8 patients included in the study had a
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TABLE III
The Relationship of Focal Lymphocytic Sialadenitis in the Buccal Mucosa and
the Laboratory Features of Patients with Rheumatoid Arthritis.
Present Absent Significance































focal lymphocytic sialadenitis in the buccal mucosa. He also had possible
keratoconjunctivitis sicca.
In the connective tissue disorders one of four patients with progressive
systemic sclerosis had a stage IV infiltrate, however, this patient had no
evidence of Sjogren's syndrome.
In table II, the clinical features of the patients with rheumatoid
arthritis are shown. There is correlation between any of the clinical
features and the presence of a focal lymphocytic sialadenitis in the buccal
mucosa. This included the features of symptomatic xerostomia, and
possible keratoconjunctivitis sicca, which may represent an early mild
form of Sjogren's syndrome in rheumatoid arthritis (4).
The laboratory features of these patients are shown in table III.
Patients with a focal lymphocytic infiltrate of the buccal mucosa had a
significantly lower hemoglobin concentration, white cell count, and a
significantly higher erythrocyte sedimentation rate, than those with a
normal biopsy.
DISCUSSION
The incidence of a focal lymphocytic sialadenitis in the buccal mucosa,
is very high in Sjogren's syndrome, with or without rheumatoid arthritis.
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The incidence in rheumatoid arthritis is 27.5 %. However, there
is no correlation with symptoms suggestive of early Sjogren's syndrome
(possible keratoconjunctivitis sicca and symptomatic xerostomia). This
may be due to examining the wrong salivary glands; the work of Water-
house and Doniach (10) was performed on submandibular glands. In
this respect, biopsy of lacrimal and parotid glands may give us a much
better indication as to whether possible keratoconjunctivitis sicca and
symptomatic xerostomia do in fact represent miniature Sjogren's syn¬
drome, as is suggested by the work of MacSween et al. (4) on the
salivary duct antibody. It is obviously of interest to further investigate
the incidence of the salivary duct antibody in the patients studied and
correlate its presence with the histological appearance of the buccal
mucosa, and also to the other autoantibodies, which are known to occur
frequently, and at a high titer in Sjogren's syndrome.
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SUMMARY
The buccal mucous membrane biopsy has been examined histologi¬
cally for focal lymphocytic sialadenitis, in patients with Sjogren's
syndrome, Sjogren's syndrome with rheumatoid arthritis, rheumatoid
arthritis alone, and other arthritides.
Focal lymphocytic sialadenitis was found in approximately 60 % of
all patients with Sjogren's syndrome — with or without rheumatoid
arthritis — and in 27.5 % of patients with rheumatoid arthritis. In
rheumatoid arthritis, this did not correlate with symptomatic xerostomia,
or possible keratoconjunctivitis sicca, both of which may be manifestations
of a mild form of Sjogren's syndrome.
Fig. 4 for inclusion with the article Lymphocytic Sia¬
ladenitis in the Buccal Mucosa in Sjogren's Disease,
Rheumatoid Arthritis and Other Arthritides, pp. 298
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Fig. 4. A histogram showing the frequency of various grades of lymphocytic siala¬
denitis in Sjogren's syndrome, rheumatoid arthritis with Sjogren's syndrome, rheu¬
matoid arthritis alone and other arthritides.
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RESUME
La biopsie de la muqueuse buccale a ete exploree histologiquement
pour l'inflammation lymphocytique focale des glandes salivaires chez
des malades atteints du syndrome de Sjogren seul ou avec polyarthrite
chronique evolutive, de polyarthrite chronique evolutive seule et d'autres
arthrites.
L'inflammation lymphocytique focale des glandes salivaires a ete
constatee dans 60 % de tous les malades atteints du syndrome de Sjogren
—■ avec ou sans polyarthrite chronique evolutive — et dans 27.5 % des
cas de polyarthrite chronique evolutive. Dans ces derniers cas il n'y avait
pas de correlation avec la xerostomie symptomatique, ou la kerato¬
conjunctivitis sicca, ces deux affections pouvant etre des manifestations
d'une forme benigne du syndrome de Sjogren.
ZUSAMMENFASSUNG
Die Biopsie der Mundschleimhaut wurde fur fokale lymphocytische
Sialadenitis histologisch an Patienten mit Sjogrens Syndrom mit oder
ohne chronischer Gelekentziindung, mit Gelenkentziindung allein und
mit anderen Gichtkrankheiten untersucht.
Die fokale lymphocytische Sialadenitis wurde bei ungefahr 60 % von
samtlichen Patienten mit Sjogrens Syndrom — mit oder ohne chronischer
Gelenkentziindung — und bei 27.5 % von Patienten mit Gelenkentziin-
dung festgestellt. Bei Fallen mit chronischer Gelenkentziindung gab es
keine Korrelation mit der symptomatischen Xerostomie, oder einer
etwaigen Keratoconjunctivitis sicca, welche beide als Erscheinungen einer
milden Art von Sjogrens Syndrom betrachtet werden konnen.
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SUMMARY
No correlation between the occurrence of the salivary duct antibody and focal
lymphocytic sialadenitis in the labial mucosa was found in ten patients with the
sicca syndrome, twenty-seven patients with Sjogren's syndrome and rheumatoid
arthritis, and forty-seven patients with rheumatoid arthritis alone. No correlation
between the variables was found in any of the groups examined. Post-mortem
studies on the labial mucosal biopsy show that the results of biopsy are repro¬
ducible, and so the lack of correlation is not due to sampling error when the
biopsy is taken. It is suggested that the salivary duct antibody is an epipheno-
menon of rheumatoid arthritis rather than a manifestation of Sjogren's syndrome
per se.
INTRODUCTION
An autoantibody to the cytoplasm of salivary small duct epithelial cells has been demon¬
strated by indirect immunofluorescence in patients with Sjogren's syndrome (Bertram &
Halberg, 1964; Halberg et al., 1965; MacSween et al., 1967; Feltkamp & Van Rossum,
1968). This autoantibody is found in approximately 15% of patients with the sicca syndrome
(keratoconjunctivitis sicca, xerostomia with or without salivary gland enlargement, but not
rheumatoid arthritis or other connective tissue disease), 65% of patients with rheumatoid
arthritis and Sjogren's syndrome, and in 26% of patients with rheumatoid arthritis alone
(MacSween et al., 1967). Feltkamp & Van Rossum (1968), however, found the salivary
duct autoantibody in the sera of approximately 50% of patients with the sicca syndrome
and also in the same number of patients with Sjogren's syndrome with rheumatoid arthritis.
The reason why patients with rheumatoid arthritis who have Sjogren's syndrome develop
Correspondence: Dr K. Whaley, The Centre for Rheumatic Diseases, Baird Street, Glasgow, C.4.
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this autoantibody is unknown. Waterhouse & Doniach (1966) demonstrated focal lym¬
phocytic sialadenitis in sixteen of seventeen patients with rheumatoid arthritis examined
at post-mortem. The possibility, therefore, exists that the salivary duct autoantibody
found in uncomplicated rheumatoid arthritis may reflect a subclinical form of Sjogren's
syndrome (MacSween et al., 1967).
Since biopsy of the major salivary glands is not without risks, and since the labial mucosal
glands are frequently involved in Sjogren's syndrome (Bloch et al., 1965; Chisholm &
Mason, 1968), we thought it of interest to study the association between focal lymphocytic
sialadenitis of the labial glands and salivary duct autoantibody in the serum of patients
with Sjogren's syndrome, rheumatoid arthritis or other arthritides and connective tissue
diseases.
MATERIALS AND METHODS
One hundred and thirty patients were included in the study. The clinical diagnosis, age and
sex distribution are shown in Table 1.
The diagnosis of Sjogren's syndrome was based on the presence of any two of the three
major components of the disease: keratoconjunctivitis sicca, xerostomia with or without
salivary glands enlargement, and rheumatoid arthritis or other connective tissue disease
(Bloch et al., 1965). The diagnosis of 'sicca syndrome' was made when the patient had the
first two of these components but did not have either rheumatoid arthritis or other con¬
nective tissue disease. Rheumatoid arthritis was diagnosed using the criteria of the American
Rheumatism Association (Ropes et al., 1958). All the patients with rheumatoid arthritis
had 'definite' or 'classical' disease.
Ophthalmological examination 11
JEach patient was examined by the method described^y Williamson ct al. (1967). One of
us (J.W.) who was unaware of the clinical diagnosis, examined all the patients in the study.
A Schirmer I tear test was carried out using standardized sterile paper strips (35 x 5 mm)
developed by Halberg & Berens (Contactisol Inc., Lindenhurst, New York, U.S.A.), at a
room temperature between 60° and 70°F, with a relative humid itygreatertffan 40 (William¬
son & Allison, 1967). After 5 min the length of wetting of theflTterp^gg^vas measured, and
the mean between the two eyes recorded. T*hose_w[lh-wetting over 15 mm were regarded as
normal, but those with wetting less than .15 rant had a Schirmer II test Perf/rmed. This
test is identical to the Sbhirm€rlVe50TutTacrimation is stimulated usjjpg-g/jjo% solution
of ammonia, held 6 in. tc£>m the nose for 5 min7A 1% sol^icritjbf/kose Bengal dye wasinstilled into the conjunctival sacs, immediately mllo^fec^/by irrigation with normal saline.
The eye was then examined for evidence of a/ironctate or Alimentary keratitis, using a
Zeiss or Haag-Streit slit lamp. Staining in tha area previously in contact with the filter
paper was ignored.
'Definite' keratoconjunctivitis sicca was diagnosed by the presence of a diminished Schir¬
mer I and II tear test, and a punctate or filamentary keratitis. Patients with diminished tear
secretion, as shown by a subnormal Schirmer I and Schirmer II test but without evidence of
a punctate or filamentary keratitis on slit lamp examination were classified as having
'possible' keratoconjunctivitis sicca.
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Each patient was questioned closely for a history of xerostomia and any associated oral
or pharyngeal symptoms of Sjogren's syndrome (Bloch et at., 1965). Salivary flow studies
were performed on each patient using a modified Carlsson-Crittenden cup, with an outer
chamber diameter of 20 mm and an inner chamber diameter of 10 mm. Only parotid saliva
was collected under both resting conditions and following stimulation with fruit gums and
lemon juice.
Many patients with rheumatoid arthritis complain of xerostomia, but without difficulty in
swallowing or mastication, or increase in fluid intake. There is no evidence of xerostomia
on oral examination, and salivary flow studies are normal. These patients are classified
as having 'symptomatic' xerostomia (MacSween et at., 1967).
Sialography, using the hydrostatic technique of Park & Mason (1966), was performed
on all patients. The criteria of Bloch et at. (1965) were used as a basis for the diagnosis of
abnormality.
Other clinical and laboratory data
Apart from the age, ophthalmological and oral examinations, the following laboratory
investigations were also recorded: haemoglobin concentration, erythrocyte sedimentation
rate (Westergren), white cell count and serum globulin level.
Serological methods
Salivary duct antibody (SDA). Human submandibular gland, obtained within 10 hr of
death, was frozen to metal chucks with COz snow, and 6-/i sections cut in a cryostat. The
sera were applied undiluted to the unfixed section for 30 min at room temperature, then each
section was washed with normal saline buffered with veronal (pH 7-2) for 10 min, followed
by the application of fluorescein-conjugated goat anti-human globulin serum for 30 min.
Finally the section was re-washed with buffered saline for 10 min, mounted in buffered
glycerol, and examined under a Gillett and Sibert conference microscope, using blue light.
The fluorescein-conjugated anti-human globulin serum was absorbed twice with dried rat
liver to reduce non-specific fluorescent staining.
Antinuclear factor (ANF). Beck's indirect immunofluorescence method (1961) was
employed, with rat liver as the substrate. The test sera were diluted 1:16 for initial testing,
and positive sera were then titrated in quadrupling dilutions until an end point of nuclear
staining was reached.
Anti-thyroglobulin. This was detected using the tanned red cell haemagglutination
technique of Fulthorpe et al. (1961), using thyroglobulin coated formolized tanned sheep
red cells (Burroughs Wellcome). Initially the sera were tested at a 1:16 dilution, and positive
sera were titrated in quadrupling dilutions.
Thyroid 'microsomal' antibody. The indirect immunofluorescence technique of Holborow
et al. (1959), using unfixed thyrotoxic thyroid tissue as substrate was used. The test sera
were applied at a 1:4 dilution.
Gastric parietal cell antibodies were demonstrated by an indirect immunofluorescence
technique (Adams et al., 1964) using unfixed human gastric mucosa as substrate and
undiluted test serum.
A highly reactive fluorescein-conjugated goat anti-human globulin prepared by Dr J. S.
Beck was used for testing for the salivary duct antibody, but the other immunofluorescence
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tests were performed using commercially prepared fluorescein-conjugated rabbit anti-
human globulin (Burroughs Wellcome).
Rheumatoid factor was detected using the Hyland latex (R.A.) test technique (Hyland
Laboratories, California) and also by the sheep cell agglutination test, a titre of 1:32 or
greater being considered positive
Non-specific tissue precipitin tests were performed, using the method of Anderson et al.
(1961) with human thyroid tissue as antigen. All sera were tested undiluted and at a 1:8
dilution.
Fig. 1. Focal lymphocytic sialadenitis of labial mucosa. FI & E, x 150.
Labial mucous membrane biopsy. The biopsy was taken from the lower lip under local
anaesthesia (Chisholm & Mason, 1968). Focal lymphocytic sialadenitis was sought on 6-p
thick paraffin sections stained by haematoxylin and eosin. A focus of lymphocytes was
defined as an aggregate of over fifty lymphocytes (Chisholm & Mason, 1968; Whaley et
al., 1969). A typical example of focal lymphocytic sialadenitis is shown in Fig. 1.
The autologous reaction of salivary duct autoantibody with the labial salivary glands
was demonstrated in two patients using the indirect immunofluorescence technique (Fig. 2).
Tableshows the prevalence of salivary duct autoantibody and focal lymphocytic siala¬
denitis in the clinical groups studied.
Salivary duct autoantibody was present in 10% of patients with the sicca syndrome, in
70-4% of patients with Sjogren's syndrome and rheumatoid arthritis, and 44-6% of patients
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Fig. 2. (a) Autologous reaction of salivary duct antibody. Indirect immunofluorescent staining
of labial salivary tissue from patient with Sjogren's syndrome. Section treated with the patient's
own serum which contained salivary duct antibody, (b) Control. Adjacent section to that
shown in (a) but treated with normal serum instead of Sjogren serum. No immunofluorescent
staining of salivary ducts.
Table 1. Labial mucosal lymphocytic sialadenitis and salivary duct antibody in the clinical groups studied
With lymphocytic With salivary
Diagnosis No. of Sex Age (years) sialadenitis duct antibody
patients
studied Male Female Mean Range No. V/o No. V/o
Sicca syndrome 10 2 8 55-9 27-66 6 600 1 100
Rheumatoid arthritis and 27 6 21 60-3 48-78 17 630 19 70-4
Sjogren's syndrome
Rheumatoid arthritis alone 47 13 34 53-2 20-73 13 27-7 21 44-6
Psoriatic arthritis 11 4 7 49-3 19-88 2 18-2 — —
Ankylosing spondylitis 10 5 5 47-8 23-73 2 200 1 100
Reiter's syndrome 6 6 — 34-5 18-52 — — — —
Still's disease 1 — 1 29-0 — — — — —
Systemic lupus 1 — 1 21-0 — — — — —
erythematosus
Progressive systemic 4 — 4 32-0 16-40 1 200 — —
sclerosis
Gout 2 1 1 610 60-62 — — — —
Osteoarthritis 11 3 8 64-9 53-74 1 91 — —
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A
with rheumatoid arthritis uncomplicated by Sjogren's syndrome. The prevalence of salivary
duct autoantibody in patients with the sicca syndrome^apcj^ Sjogren^ syndrome/Md rheu-
ymiato^d^Lthritis is similar to that found in thus laboratoryjby MncSwceii et al. (1967),^ut' the/ prevalence of salivary duct autoantibody in patients with rheumatoid arthritis
alone is highe^than that rcported-by MacSween et al-. (1967) (thirty-four of 129 patients,
26%).
Of the forty-six patients with other arthritides and connective tissue diseases only one
had salivary duct autoantibody present. This was a 63-year-old woman with definite


















































ankylosing spondylitis and a positive sheep cell agglutination test for rheumatoid factor at a
titre of 1:256, but without clinical evidence of Sjogren's syndrome or rheumatoid arthritis.
The prevalence of labial focal lymphocytic sialadenitis was the same in patients with
sicca syndrome and Sjogren's syndrome and rheumatoid arthritis (60 and 63%, respectively).
The prevalence in rheumatoid arthritis alone was 27-7%.
Two patients with psoriatic arthropathy had focal lymphocytic sialadenitis, but neither
had salivary duct autoantibody. One of these patients had 'possible' keratoconjunctivitis
sicca.
Two patients with ankylosing spondylitis had focal lymphocytic sialadenitis, and one of
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these, mentioned above, had salivary duct autoantibody present. Neither of these two
patients had any evidence of Sjogren's syndrome.
Of the four patients with progressive systemic sclerosis one had focal lymphocytic siala¬
denitis, but no evidence of Sjogren's syndrome.
One patient with osteoarthritis had a positive buccal mucosal biopsy and had evidence
of 'possible' keratoconjunctivitis sicca. No salivary duct autoantibody was detected in this
patient's serum.
Table 3. Laboratory and immunological features of patients with Sjogren's syndrome and
rheumatoid arthritis
Present Absent Significance






























Salivary duct antibody 12(61%) 7 (70%) —
Rheumatoid factor 16 (94%) 7 (70%) —
Antinuclear factor 8 (47%) 3 (30%) —
Non-tissue specific precipitating
autoantibody
4 (23-5%) — —
Thyroglobulin autoantibody 3 (17-6%) 1 (10%) —
Thyroid microsomal autoantibody 5 (29-4%) 3 (30%) —
Gastric parietal cell autoantibody 4 (23-5%) — —
The relationship of the salivary duct autoantibody and other autoantibodies and labora¬
tory data in patients with the sicca syndrome, Sj0gren's_syndrome and rheumatoid arthritis,
and rheumatoid arthritis alone is shown in Tables 2s4. It can be seen"that"in none of these
three groups did the salivary duct autoantibody correlate with focal lymphocytic siala¬
denitis. None of the other autoantibodies including rheumatoid and antinuclear factors,
non-tissue specific precipitins, anti-thyroglobulin, anti-thyroid 'microsomes' and gastric
parietal cell autoantibodies correlated with focal lymphocytic sialadenitis in any of the three
clinical groups, with the exception of the antinuclear factor in patients with rheumatoid
arthritis (TableX) (P<0-02). None of the other laboratory features correlated with the
[/' % >Q
//
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finding of focal lymphocytic sialadenitis in patients with Sjogren's syndrome whether
associated with rheumatoid arthritis or not. In patients with rheumatoid arthritis alone the
haemoglobin (/><0-001) and white cell count (P<0-02) were significantly lower in patients
with focal lymphocytic sialadenitis and the erythrocyte sedimentation rate was significantly
higher (P <0-001).
DISCUSSION
Sjogren's syndrome is a chronic benign disorder which is characterized by chronic inflam-
Table 4. Laboratory and immunological features of patients with rheumatoid arthritis
Present Absent Significance































Salivary duct antibody 5 (38-5%) 16 (47-1%) —
Rheumatoid factor 13 (100%) 29 (85-3%) —
Antinuclear factor 7 (53-8%) 6 (17-6%) P<002
Non-tissue specific precipitating
autoantibody
3 (23-1%) 2 (5-9%) —
Thyroglobulin autoantibody 5 (38-5%) 6 (17-6%) —
Thyroid microsomal autoantibody 4 (30-8%) 7 (20-6%) —
Gastric parietal cell autoantibody 2(15-4%) 9 (26-5%)
matory changes, not only in the lacrimal and major salivary glands, but also in the small
mucus-secreting glands of the conjunctiva, mouth, nasal passages, pharynx, trachea and
bronchi and also in the sweatglmrds (Blocfiet al., 1965). In this study-wediiavo'need biopsy
of the labial mucous membranefto investigate the relationship of salivary duct autoantibody
to focal lymphocytic sialadenitis of the oral mucosa in patients with Sjogren's syndrome
with or without rheumatoid arthritis, rheumatoid arthritis alone, and other arthritides and
connective tissue disorders.
Salivary duct autoantibody was present in only one of ten patients with the sicca syndrome
(Sjogren's syndrome uncomplicated by rheumatoid arthritis or other connective tissue
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disease), although six had focal lymphocytic sialadenitis on labial mucosal biopsy. In
contrast, nineteen of the twenty-seven patients (70-4%) with rheumatoid arthritis and
Sjogren's syndrome had salivary duct autoantibody, although the prevalence of focal
lymphocytic sialadenitis in this group was the same as in patients with the sicca syndrome.
This suggests that salivary duct autoantibody may be a manifestation of Sjogren's syndrome
associated with rheumatoid arthritis rather than a reflection of Sjogren's syndrome per se.
This conclusion is supported by the finding of a very high prevalence of salivary duct auto¬
antibody in patients with rheumatoid arthritis alone (twenty-one of forty-seven, 44-6%) and
the comparatively low prevalence of focal lymphocytic sialadenitis in this group (thirteen
of forty-seven, 27-7%). This high incidence of the salivary duct autoantibody probably
represents a selection bias-(MacSwcun ei ut.," l%7f: Furthermore, there was a complete
lack of correlation between salivary duct autoantibody and focal lymphocytic sialadenitis
in patients with the sicca syndrome, Sjogren's syndrome with rheumatoid arthritis, and
rheumatoid arthritis alone. These findings are in agreement with those of Bertram (1967)
who performed palatal biopsies on eight patients with Sjogren's syndrome, six (75%)
of whom had heavy lymphocytic and plasmacytic infiltrates and occasional myoepithelial
cell islands. Of these six patients only two had salivary duct autoantibody present in their
serum.
It may be argued that the lack of correlation between the salivary duct antibody and
lymphocytic sialadenitis may have been due to a sampling error, the changes in the labial
mucosa being patchy rather than generalized. However, in twelve post-mortem specimens,
identical changes were found when biopsies were taken from both sides of the mouth. It is
also possible that biopsy of the major salivary glands may have shown a correlation, but it
is not feasible to carry out biopsy of these glands during life since the procedure carries
definite risk of injury to the facial nerve, and of salivary fistulae, as well as leaving the patient
with a scar. However, in post-mortem studies performed by Chisholm & Waterhouse (1968)
a positive correlation between the findings in the submandibular and labial minor salivary
glands could be made (P<001).
The salivary ducLantibody reacts with the epithelial cytoplasm of tJj|Mci^ra£fund salivary
glands and hag-Eree**/shown toJuug a^Um^ictiyityij^'necasc fjEfachw>eou 967)..
-We4i.avFSjiki%Ti(W\,o/'3tf^reactiigtyiati-fcaa-EEascar^It has 1^eerT'sliown by Feltkamp & van
Rossum (1968) to be absorbed by extracts of salivary tissue but not by extracts of human
pancreas, liver, thyroid, adrenal or muscle. The apparent organ-specificity of the antibody,
therefore, corresponds to the occurrence of inflaronatory lesions in lacrimal and salivary
gland in Sjogren's syndrome. Nevertheless, from present findings, salivary duct antibody
appears to be an epiphenomenon associated with the pathological changes of Sjogren's
syndrome complicating rheumatoid arthritis rather than with Sjogren's syndrome occurring
alone.
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